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ABSTRACT
The interactions in solution and in.the fibre state of the 
trypanocidal phenanthridine drugs, ethidium bromide, dimidiura bromide and 
prothidium (di)bromide with DNA have been investigated using a variety of 
physical techniques. A number of analytical techniques applicable to 
polymer-ligand interactions have been developed and used in the analysis 
of these results.
For each of the drugs, complexes were prepared with three natural 
DNA's of different nucleotide compositions using a novel mixing scheme.
The solution spectra were analysed in terms of binding affinity, number 
and size of binding sites and base-pair specificity. The binding of 
ethidium and dimidium is limited by neighbour exclusion effects, whilst 
prot’adium is able to bind to higher levels.
Fibre X-ray diffraction showed that dimidium and ethidium caused a 
substantial increase in the DNA pitch at high humidities, probably through 
intercalative binding. In contrast, the binding of prothidium appears 
to cause no change in the DNA secondary structure at any humidity. The 
birefringence and linear dichroism of the fibres used in the diffraction 
study were measured over a range of humidities, using a microspectrophotometer. 
The results are interpreted in terms of the tilt angle of the base-pairs 
and/or drug chromophores, the disorientation of the DNA helices (estimated 
from the diffraction patterns) and the fractions of bound drug. At high 
humidities, a substantial fraction of ethidium or dimidium is oriented 
perpendicular to the helix axis, consistent with intercalation. The X-ray 
diffraction and dichroism measurements considered together give an unwinding 
angle at the intercalation site of about 34°. This is unexpectedly large 
but there are difficulties in combining the results from these two 
techniques. Prothidium shows little preferred orientation in its binding.
A combined external binding scheme is p’^ esented with some molecules 
inclined parallel to the sugar-phosphate chain, and others binding across 
adjacent chains. Computer drawings and molecular models illustrate these 
suggested binding schemes.
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CHAPTER 1 
INTRODUCTION
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1.1 DNA Structure and Function
The fundamental role of deoxyribonucleic acid (DNA) in the replication 
of living cells is well established. It encodes the genetic information 
and transmits it from one generation to the next. The information can 
then be deciphered by the messenger RNA - ribosome-transfer RNA system to 
synthesise the enzymatic and structural proteins for the new organism.
DNA, conjugated with protein, is a major constituent of the genes, which 
are the regions of a chromosome that determine particular genetic traits.
DNA is a long polymer, made up of monomers called nucleotides. Each 
nucleotide consists of three components - a heterocyclic base, a deoxy- 
ribose sugar and a phosphate group - and has a molecular weight of about 
330. There are four different bases that occur commonly in DNA; two 
purines, adenine (A) and guanine (G), and two pyrimidines, thymine (T) and 
cytosine (C). The nucleotides are polymerised to form a sugar-phosphate 
chain (Fig. 1.1) whose direction can be specified by reference to the 
sugar 3* and 5' carbon atoms. The molecular weight of DNA is extremely 
high, ranging from several million to several hundred million depending 
on the species, and this corresponds to many thousands of nucleotides.
The two polynucleotide chains are joined by a specific interaction 
between certain bases. This interaction is in the form of a hydrogen 
bonding scheme in which adenine is always paired with thymine, and guanine 
always with cytosine. The resulting double helix is stabilised with the
s'
hydrophobic bases in the centre and the negatively charged phosphate 
groups, usually neutralised by alkali metal ions such as Na+ , arranged 
externally. The two chains run antiparallel (Fig. 1.2), being related by 
a dyad axis perpendicular to thevhelix axis and passing through each base-
^  Adenine
02' C3*
Sugar
01
Phosphat
Schematic representation-of DNA structure showing 
the nomenclature for pyrimidine and purine bases 
and the conformational angles that define the 
structure. .
Fig. 1.2 Schematic representation of the Uatson-Crick DNA 
model with strands of opposite polarity .
With this model, TpA = TpA
ApG = CpT 
GpA = TpC
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pair (Fig. 1.3). The sugar-phosphate backbones are regular, even though 
the base sequence is random, because the dimensions of the A — T and G — C 
base-pairs are virtually identical.
The importance of the base-pairing scheme with regard to DNA 
replication is that it allows the DNA to act as its own template, since the 
base sequence on one strand specifies the sequence on the other. The 
genetic information itself is coded in terms of the sequence of bases 
along a polynucleotide chain. Groups of three bases, termed codons, code 
for the insertion of a particular amino-acid into a protein.
1.1.1 DNA Conformation
Early fibre X-ray diffraction studies (Wilkins et al., 1953; Franklin 
and Gosling, 1953; Marvin et al., 1958) established that there were three 
distinct conformations, the A, B and C forms, for natural DNA, which are 
all modifications of the same basic structure. The structure of the A 
form was described in detail by Fuller et al. (1965); that of the B form 
by Langridge et al. (1960); and that of the C form by Marvin et al. (1961). 
Recently, more refined structures of the A and B forms have been presented 
(Arnott and Hukins, 1972). The model proposed by Watson and Crick (1953) 
corresponds most closely to the B conformation.
The three conformations of DNA differ in the number of nucleotides 
per helix turn, the helix pitch and the nucleotide conformation (Table 
l.l). The A and B forms are quite different and can be characterised by 
the type of sugar puckering present (Fig. 1.4) and the disposition of the 
base-pairs relative to the helix axis (Fig. 1.3). The sugar pucker is 
determined by the position of C2‘ or C3» relative to the plane defined by 
Cl* - 05' - C4*. The conformation is endo if the most out of plane atom 
is on 1 the same side of the plane as C5‘, and exo if it is on the opposite 
side to C5'. In B DNA the distance D, of the base-pairs from the helix 
axis is small and negative, the base tilt is almost zero, and the sugar
Fig. 1.3 The parameters defining the disposition of a base-pair
relative to the helix axis
Form SugarPucker
Pitch
(A)
Residues 
per turn
Rise per 
Nucleotide 
(A)
Distance
D
(A)
Tilt
(°)
Twist
(°) References
A C3 en^ io 28.15 11 2.56 4.72 20 -1.2 Arnott and Hukins, 1972
B C3 exo 33.8 10 3.4 -0.16 -5.9 -2.1 Arnott and Hukins, 1972
C C3 exo 30.9 9.3 3.22 . -2.13 -6.0 5 Marvin et al., 1961
TABLE 1.1 Helical Parameters of the Three Main Conformations of DNA
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pucker if= C3 • exo. The two polynucleotide chains are wound around each 
other such that two helical grooves, a large one and a smaller one, run 
along the polymer between the two strands. The characteristic 3.4& base- 
pair repeat distance along the helix axis gives rise to strong reflections 
on thé meridian of X-ray diffraction photographs. In the A form the 
base-pairs are moved nearly 5& forward (D positive) from the helix axis 
and the tilt angle is large and positive, whilst the sugar ring pucker is 
C3‘ endo. Although the C form has a number of features which make it 
distinct from the B form, it is similar in having C3* exo sugar puckering 
and negative values both for the distance, D, and the tilt angle.
The conformation depends on the type and concentration of the 
counterion present, and on the relative humidity. At low ionic strengths 
(< 5% excess NaCl) the A form has always been observed at humidities up to 
and including 92%, and occasionally at 98% (Cooper and Hamilton, 1966); 
whilst fibres containing more counterions (> B% excess NaCl) gave B-patterns 
at 75% relative humidity. Fibres containing salt contents intermediate 
between these two values, gave the A form at 75% R.H. and the B form at 92% 
R.H. and above. X-ray diffraction studies have shown that the A form is 
crystalline, giving Bragg reflections over much of the diffraction pattern, 
whereas the B form is semi-crystalline and gives less well defined reflections 
in the centre of the pattern and diffuse diffraction streaks over the 
remainder of the pattern.
With fibres made from the lithium salt of DNA, the A form is not 
observed. Instead the semi-crystalline C form is observed at low salt 
concentrations (< 3% excess Licl) and low humidities 60% R.H.), and à 
crystalline B pattern is obtained at higher ionic concentrations.
Hamilton et al. (1959) showed that the above conformations could be 
obtained from natural DNA's from a wide variety of sources. Bram (1973) 
has reported some differences of the B conformation with G - C content, and 
in particular the possibility of a D conformation, but the effect is not
- 4 -
great. Premilat and Albiser (1975) and Goodwin (1977) have found t’->at the 
base-pair composition of DNA has only a negligible effect on the diffracted 
X-ray intensities, which can be explained by slight changes in the base- . 
pair tilt. So far, no variations of the A form of DNA have been reported, 
although in dried specimens the intermolecular separation of the double 
helices is dependent on the relative humidity.
DNA structure is so closely related to its function that it is possible 
that the different conformations are involved in the cell mechanisms. It 
is generally accepted that the B form of DNA, which is raos1: stable at high 
humidities, is the most probable conformation in solution in the living - 
cell* If different segments of DNA adopt slightly different conformations 
under the same environmental conditions, perhaps as a result of the base- 
pair composition within that segment, it would provide a possible molecular 
basis for control mechanisms in DNA replication and transcription.
A number of recent papers (Rodley et al., 1976; Sasisekharan and 
Pattabiraman, 1976, 1978; Sasisekharan et al., 1977, 1978; Cyriax and G&th,l9E 
Pohl and Roberts, 1978) have suggested that the two strands of DNA do not 
coil around one another but lie side-by-side (the so-called SBS model).
Click et al. (1979) refute this suggestion using evidence from recent gel 
electrophoresis experiments (Keller and Wendel, 1974; Keller, 1975; Shure 
and Vinograd, 1976; Wang, 1978, 1979). They do however concede that the 
experimental evidence for the righthandedness of the original model (Watson 
and Crick, 1953) is still only suggestive and not yet completely compelling. 
Fourier transform studies on the SBS model (R.J. Greenall et al., to be 
published) have shown serious discrepancies Detween the X-ray diffraction 
intensities observed and those calculated using the model.
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1.2 The Interaction of Drugs with DNA
Albert et al. (196 3) showed that the antimicrobial activity of 
phenanthridines and acridines, both of which possess a triple aromatic 
ring (Fig. 1.5), is dependent on the compounds existing as cations. They 
suggested that the drugs act by competing with hydrogen ions for certain 
anionic groups in the organism. These anionic groups probably have a 
pKa of 9 or higher (for example, the hydroxyl groups In the purine or 
pyrimidine bases in DNA). Albert pointed out that there is a correlation 
between the activity of these drugs and the area of flatness in the drug 
molecule. The triple aromatic rings often present in drugs are referred 
to as chromophores, since they are the basis of the characteristic colours 
of these drugs. The chromophores of the phenanthridines and acridines 
are fully conjugated and hence are flat (the atoms in the chromophores 
deviating by less than O.lX from the mean plane through the chromophore 
(Giacomoni, 1973)) and have an area of approximately 38^. Hydrogenation 
of one ring of 5-aminoacridine to yield 5-ami note trahydroacri di ne reduces 
the flat area of the molecular to 28&2 and also reduces its bacteriostatic 
activity by a factor of thirty to a level comparable to that of the drug 
4-aminoquinoline, which also has a flat area of 28&2.
The requirement for planarity was investigated by Leman (1961) in 
studies on the interaction of acridines with DNA. X-ray diffraction 
patterns of DNA-acridine fibres revealed closer side by side packing of 
DNA molecules, suggesting that external binding to DNA was not the dominant 
binding process. Layer lines corresponding to the helical repeat of the 
DNA were not observed but the meridional reflections indicating a monomer 
repeat distance of 3.4& along the structure were still strong. DNA- 
acridine complexes in solution exhibit a marked increase in viscosity and 
decrease in sedimentation coefficient compared with DNA (see also Kersten 
et al,, 1966; O'Brien et al., 19é6; Muller and Crothers, 1968). Other
i « •*
0 OH
Fig. 1»5 Structural formulae''of some compounds which bind to DNA
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cations, lacking the planarity of the acridines, were found to reduce the 
.viscosity of DNA. These observations are compatible with a thinner, 
stiffer DNA helix and Lerman proposed that the drug interacted with DNA 
largely by a process which he called intercalation. This involved the 
sandwiching of a drug molecule between two adjacent DNA base-pairs (Fig. 
1*6). The base-pairs remain perpendicular to the helix axis, but they 
are moved apart to accommodate the drug molecule (of approximately 3.4& 
thickness) which lies in Van der Waal’s contact with the base-pairs above 
and below. The intimate contact between the ir-orbitals of the drug 
molecule and the base-pairs would help to stabilise the complex via 
hydrophobic and charge-transfer forces.
Since the DNA sugar-phosphate chain is virtually fully extended in 
native DNA (no doubt partly due to electrostatic repulsion between 
successive negatively charged phosphate groups), Lerman proposed that the 
helix had to unwind (Fig. 1.7) in order to admit the drug. This leads to 
a local distortion..of the helix. An initial estimate of 45° unwinding 
was suggested, but this was later modified to 36° (Lerman, 1964). This 
distortion of the helix at intercalated sites would destroy the long-range 
regularity of the helix (as long as the sites were not located at regular 
intervals along the DNA molecule), which accounts for the loss of sharp 
layer-line reflections in the X-ray diffraction patterns when a substantial 
amount of drug is bound.
An X-ray diffraction and model building study of ethidium bromide 
binding to DNA by Fuller and Waring (1964) likewise concluded that ethidium 
intercalated into DNA. They proposed that the minimum and possibly the 
preferred unwinding angle for intercalation of ethidium was 12°, since this 
would maintain maximal separation of the charged phosphate groups in the 
perturbed helix. In general, the binding of drugs to DNA has a stabilising
effect on the double stranded structure, as deduced from the increased
\  \\
melting temperature (Leman, 1964). More recent studies (Wang, 1974;
Fig. 1.6 Sketches representing the secondary structure of (i) DIIA 
and (ii) DIIA containing intercalated acridine molecules 
(after Leman (19G1))
(i) (ii)
Fig. 1.7 * Schematic representation of a DNA-drug complex, to show
The distance between base-pairs 
o
is 3.4A, and they are related
by a rotation of <* between each.
The intercalated drug conserves
this 3.4^ separation, but the
. rotation on either side of it
is 3(j£ct) . .
. %
The unwinding angle, ♦ = 2& - a
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Keller, 1975; Sobell and Jain, 1972; Tsai et aO.,,1975) have questioned 
this figure for the unwinding angle and have suggested a value of around 
26°. Fuller and Waring pointed out the similarity in structure between 
the phenanthridine and acridine rings (Fig. 1,5) and suggested that bound 
ethidium lies across and between successive base pairs, with the phenyl 
and ethyl groups lying in the large groove of the DNA. Such a position 
allows tne formation of hydrogen bonds between the 3- and 8-amino groups 
of the ethidium cation (Fig. 1.8) and phosphate groups on both strands of 
the DNA. This was similar to the position for proflavine intercalation 
postulated by Lerman; the nitrogen heteroatom of proflavine did not lie 
in the same position as that of ethidium but the same hydrogen bonds 
could be made although there would be less overlap with the base-pairs.
Craig and Isenberg (1970) tested a number of polycyclic aromatic 
hydrocarbons and validified the criterion that drugs that were wall 
enough to fit between the base-pairs of DNA and be well protected from the 
acqueous medium were more likely to bind.
Later DNA-drug diffraction patterns (Neville and Davies, 1966 - 
acridines; Pigram, 1968 - daunamycin) showed more clearly defined layer 
lines than in the earlier studies, and the lines were more closely spaced 
than in the control DNA pattern indicating that the helix pitch had 
increased. The generally poor definition of the layer lines compared to 
those in DNA patterns was evidence of a disordering of the helix pitch, 
and the increase in magnitude of the pitch was a natural consequence of 
the insertion of the drug and the unwinding of the helix. The increase 
in pitch of the DNA-drug fibres with increasing humidity is in accord with 
the expected hydrophobic nature of intercalation.
Since Lerman's original proposal other evidence supporting an inter­
calation model has accumulated. An autoradiographic study (Cairns, 1962)
showed that DNA molecules increased in length after proflavine was bound
\\ . . .
to them, and this has been confirmed recently (Butour et al., 1978) by
Fift* 1.8 Structural formulae of the three phenanthridine drues
used in this study
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electron microscopy of PM2 DNA molecules treated with either ethidium 
bromide or a covalently dimerised form of acridine. Light scattering and 
low angle X-ray scattering studies (Mauss et al., 1967; Luzzati et al.,1961) 
confirmed a reduced mass per unit length for the DNA-drug complex, and 
flow dichroism, circular dichroism and fluorescence polarisation studies 
(Lerman, 1963; Le Pecq and Paoletti, 1967; Dalgleish and Peacocke, 1971; 
Genest and Wahl, 1972; Leng et al,, 1973; Houssier et al,, 1974) indicated 
that the drug chromophores were bound approximately perpendicular to the 
DNA axis. Unwinding of the supercoils of closed circular DNA (Waring, 
1970), revealed by changes in the sedimentation coefficient, is consistent 
with the idea of an intercalated drug unwinding the DNA molecule. 
Electron-spin resonance studies (Hong and Piette, 1976) strongly favour 
an intercalative binding mode for spin-labelled ethidium, and NMR work 
(Kru6h and Reinhardt, 1975) has suggested a base-pair specificity for the 
intercalation of ethidium bromide.
There is now evidence on an increasing number of other drugs that 
are able to bind to DNA in this fashion. These include the antitumour 
antibiotics daunomycin, adriamycin and nogalaraycin (Calendi et al., 19 6 5; 
Ward et al., 1965; Kersten et al., 1966; Neogy et al., 1973), the 
schistomicidal drug, miracil D (Carchman et al., 1969), the antimalarial 
drug•chloroquine (O’Brien et al., 1966) as well as many carcinogenic 
hydrocarbons (Lesko et al., 1971). Intercalation is also a likely mode 
of binding for actinomycin D (Muller and Crothers, 1968) and propidium 
iodide (Hudson et al., 1969),
Structural formulae of some of these drugs are shown in Fig, 1,5, 
and it will be noted that all possess a planar triple aromatic ring system 
except for chloroquine which has only a two-ring chromophore. The flat 
ring systems are important, since it is an obvious requirement of the 
intercalation theory that the drug molecule must possess a reasonably 
large flat portion (but not too large or bulky) if it is to slip in between
- 9 -
the flat base-pairs of the DNA helix. In fact it has been shown (Muller 
et al., 1973) that a proflavine derivative, 2, 7-di-t-buty1-proflavine, 
does not intercalate, and this had been predicted by molecular model 
building studies which showed that the steric hindrance involving the 
bulky- side groups would prevent intercalation of the ring system.
There is evidence from equilibrium studies of the binding of drugs 
to DNA (Waring, 1965; Blake and Peacooke, 1968; Zunino et al,, 1972) for 
the co-existence of more than one binding mode, although the original 
interpretation of some of these results may be open to question (see 
Chapter 3). Intercalation is thought to predominate at low drug/DNA 
ratios, but an external binding (i.e. non intercalative) mode may be 
important at large drug/DNA content. Relaxation kinetics experiments 
(Li and Crothers, 1969; SdniKhel and Crothers, 1971) have suggested that 
some external binding is present even at low drug content. In fact, 
intercalation may occur via a multi-step reaction, with the external 
binding mode as an intermediate stage (Sobell et al., 1977). The external 
binding mode probably involves an electrostatic attachment of the cationic 
drug molecules to the negatively charged phosphate groups along the 
outside of the DNA helix, since this mode appears to be more sensitive to 
the ionic strength of the complex. ‘ External binding may also exhibit a 
specificity towards particular DNA types by forming specific hydrogen bonds 
to certain base-pairs, and externally bound planar drug molecules (such as 
the acridines) may stack together along the sugar-phosphate backbones.
Intercalation has been used as a model to explain how frameshift 
mutations are caused by aminoacridines and how some drugs may act as 
translation/replication inhibitors (Brenner et al., 1961; Streisinger et al., 
1966). The insertion of a drug molecule into DNA could alter the reading 
sequence of a hypothetical genetic code such that a radically altered non­
functional gene product would result, if indeed any product were made at
\\
all. It is likely that the normal copying and transcribing of DNA will
10 -
only occur if both the sequence and geometry of the bases are correct. 
Intercalation of a small molecule into the helix can be expected to 
seriously affect these processes and it may prove, less easy for the strands 
to separate* In addition, the side chains of the drug may partially 
block one of the grooves in the helix and prevent enzymes from recognising 
appropriate regions. Drugs may cause mis-translation of the DNA (e.g. 
proflavine) and act as mutagens or carcinogens. Other drugs (e.g. 
daunomycin, adriamycin) are extensively used in the chemotherapeutic 
treatment of acute leukaemia and solid tumours in humans (Tan et al., 1967; 
Bolron et al., 1969).
The three drugs considered in this work are phenanthridines and, in 
common with many other suspected intercalators, they each possess a triple 
aromatic ring (Fig. 1.8). They are trypanocidal, and have been used 
extensively in the treatment both of sleeping sickness in man and nagana 
in cattle. Dimidium bromide was used until 1952 when, in an attempt to 
overcome drug resistance, increased doses were used and found to result in 
high fatility, delayed toxicity and photosensitisation (Burdin and 
Plowright, 1952). The ethyl homologue, ethidium bromide, was found to be 
ten times more active and much less toxic than dimidium and is still usedc
in both East and West Africa. At the pH of the blood, ethidium forms twice 
as much pseudobase as dimidium, and it has been suggested (Watkins, 1952) 
that this may enhance its ability to penetrate cell membranes. A further 
successful modification was achieved in 1956 by attaching the pyrimidyl 
moiety of quinapyramine on to the 8-amino group of the triple ring to 
form prothidiun (di)bromide, which was found to possess prophylactic as 
well as curative activity giving protection to cattle for periods up to 
four months (Robson, 1961). These drugs also have antiviral properties 
and interfere with the synthesis of nucleic acids in- a variety of organisms 
(Kerridge, 1958; Kandaswamy and Henderson, 1962; Tomchik and Mandel, 1964).
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1.3 Outline of the Present Project
This study is aimed at elucidating the mode of attachment of drugs to 
DNA at a molecular level. Information about the binding at this level, 
and in particular the comparison of closely related drugs, is essential 
for the development of new, more specific chemotherapeutic agents with 
reduoed toxic side effects. Moreover, understanding of the way in which 
small molecules modify the structure of DNA may shed light on the inter­
action between DNA and more complex systems, such as enzymes and 
regulatory proteins.
The full chemical nomenclature and structure of the three phenanth— 
ridine drugs used in this work — dimidium bromide, ethidium bromide and 
prothidium (di)bromide - are shown in Fig. 1.8. Previous research on 
DNA-drug interactions has been carried out on complexes either in solution 
or in the solid state. This study has used various physical techniques 
to characterise the interactions in both phases, in an effort to bridge 
the gap between them.
Spectroscopic analysis of the binding (Chapter 4) was used to provide 
information on the common features and differences between the binding of 
the three drugs. Binding parameters, such as the association constants 
and the number of binding sites associated with each base-pair, were 
obtained for the binding to DNA's of differing base-pair content. These 
were used to determine any base-pair or base sequence specificity operating 
in the interactions.
Fibre X-ray diffraction (Chapter 5) was used to monitor the changes in 
helix pitch and intermolecular separation with increased drug content and 
changing humidity. This information was used to determine which binding 
inodes were taking place. Measurement of the arcing of the diffraction 
streaks was used to indicate the probabie disorientation within the DNA- 
drug fibres. \\
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Absorption spectra from fibres were used (Chapter 7) to compare the 
binding modes in the solid state with those in solution. Linear 
dichroism and birefringence measurements, used in conjunction with the 
X-ray diffraction results, can provide information on the orientation of 
the drug chromophores. These measurements were recorded at different 
humidities so that the fraction of free drug and bound drug (whether 
intercalated or externally bound) could be_-followed for different 
environmental conditions.
Preliminary studies with space-filling models (Chapter 8) were under­
taken to investigate the stereochemical feasibility of certain DNA-drug 
models in the light of the accumulated data. A model building study, 
using a computerised linked atom least squares refinement routine, was used 
to compare more precisely idle different models.
' \
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CHAPTER 2
MATERIALS AND EXPERIMENTAL TECHNIQUES
2.1 The Materials
2.1.1 The Nucleic Acids
Some of the more commonly available DNA types are listed belov/ in 
order of descending G-C content:-
G-C {%)
M icrococcus ly s o d e ik tic u s  72
S arcin a lu te a  72
S e r r a t ia  marcescens 58
E sch erich ia  c o l i  50-52
Salmon te s t e s  44
Calf thymus 42
Cytophaga jo h n son ii 33
C lostrid iu m  p erfrin gen s 30
In order to investigate possible base-pair specificity or sequence
specificity in the binding of drugs to DHA, a number of varieties were
required which would adequately cover this range of G-C content and which
would be available in a fairly purified form at reasonable cost. On the
basis of these criteria the varieties shown in Table 2.1 were chosen.
A theoretical paper (Felsenfeld and Hirschmann, 1965) has shown,
usiijg a model in which hypochromism arises from the interaction of base-
pairs along tte helix, that the absorptivity should increase quadratically
with A-T content so long as the base-pair sequence is random. But because✓
their figures and the results from several experimental papers (Schildkraut 
et al., 1962 - buoyant density in Cscl; Gray et al., 1978 - circular
dichroism; Blake and Lefoley, 1978 - spectrophotometry of direct-derivative
- \\
melting curves) do not correspond, and because the experimental values vary
TABLE 2.1
DNA Varities Chosen by the Author for Study-
Species
G-C content 
(%)
Maximum absorptivity 
(M"1 cm“1)
M. lysodeikticus 72 (1,2) 6300 (3)
6400 (2)
6923 (4)
Calf Thymus 42 (5) 6600 16,7)
6412 (4)
Cl. perfringens 30 (5) 6225 (4)
6700 (8)
References
1. Ramstein and Leng, 1975.
2. Kleinw&chter et al., 1959.
3. Vakelin and V/aring, 1976.
4. Miller and Crothers, 1975.
5. Chan and van Winkle, 1959.
6. Pigram, 1968.
7. Plumbridge et al., 1978.
8. Ramstein ct al., 1972
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bo widely amongst themselves, it was decided to adopt the value 6600 M” 1 
cm**'*' as the maximum absorptivity (at 255 - 258nm) for all three samples. 
The three DNA's were purchased from the Sigma Chemical Company -
(i) M. lysodeikticus Type XT (containing approximately 1% protein,
0.2% RNA)
(ii) Calf Thymus Type I (containing less than 1% protein, and
less than 3% RNA)
(iii) Cl. perfringens Type XII(containing less than 2% protein,
0.02% RNA)
The shape of their absorption spectra were similar, though there 
were slight differences in the wavelength at which maximum absorptivity 
was observed (viz. M. lysodeikticus - 255nm, Calf Thymus - 258nm, Cl.
i
perfringens - 256nm).
Several spectrophotometric tests on the purity of a nucleic acid
solution have been cited in the literature. Dalgleish et al. (1973)
considered a sample adequately deproteinized if A2ec/A230 was greater
than 1.85. Goodwin (1977) adopted the criterion that A260^A280 should be
greater them or about 1.90. Groves et al. (1968) have shown that the
absorbance of proteins around 280nm is due primarily to tryptophan and
tyrosine, and that the peptide bond linkage and the other amino-acids are
responsible for the absorbance around 230nm. Marmur (1961) quoted that
A260 ! A230 : A280 = 1 .0  : 0.45 : 0.515, equivalent to A ^ / A ^  =2.12
and A /A„ _ = 1.94, corresponds to an amino-acid content of 0.3 - 0.5%. anu "260 230 *
For solution spectroscopy, values of A260^A230 £rea"ter than 2 «2 811(3 
A26q/A20o Sreaber "than 1.9 were considered acceptable and samples received 
that satisfied both, these conditions were not deproteinized further. On 
the other hand, all the DNA used for fibre-making was routinely purified in 
an effort to improve the quality of the subsequent X-ray diffraction
patterns. Comparisons of the patterns taken using purified DMA have all 
shown a significant improvement in picture quality over earlier patterns
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which were taken using unpurified DMA.
A phenol extraction stage was included in the purification stage since 
phenol has been reported to be effective in removing proteins from DNA 
samples (Massie and Zimin, 1956). Freshly-distilled analar grade phenol 
was used to avoid oxidation products, and the distillate was allowed to 
drip into a 0.1M NaCl solution.
The DNA was shredded gently and dissolved in 0.003M NaCl to give a 
concentration of approximately lmg/ml. This salt concentration is 
sufficient to prevent denaturing of the DNA, but is low enough to allow it 
to dissolve easily. All samples were left for at least six days to 
dissolve completely. Before adding to the phenol, the salt concentration 
of the DNA solution was raised to 0.U1 NaCl by addition of. the appropriate 
volume of 2.0M NaCl,
The DNA solution is added to the same volume of the phenolic (lower) 
layer of the phenol/salt mixture and shaken gently for 20 minutes. The 
resulting mixture is then centrifuged at 3000 r.p.m, for 20 minutes and 
the upper (acqueous) layer is then carefully removed using a hooked Pasteur 
pipette to minimise gathering material from the lower layer. This 
solution is poured on to an equal volume of propanol, and allowed to stand 
for 15 minutes. The precipitated DNA is then wound on to a glass rod and 
washed in 80% ethanol (to remove excess salt), 95% ethanol (to remove water) 
and finally acetone (to remove the ethanol). It can then be cut from the 
rod and stored at 4°C until ready for use. .
purification was found to increase the A260^A230 ra^ °  by between 0.05
and 0.15 relative to the value for unpurified DNA, but had little effect on
*-he a /A ratio. No evidence of - denaturation of the DNA due to the 
vne 260 280
phenol extraction stage has been observed, contrary to the fears of Leng 
et al. (1973).
The DNA samples were dissolved in either 0.01M tris-HCl/O.OLM NaCl
Y\
pH 7.6 (low ionic strength buffer) or 0.01M tris-HCl/O.lM NaCl pH 7.6 
(high ionic strength buffer). Tris is tris-hydroxymethyl
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methylamine. The tris concentration was. kept low so that the main ionic
component of each buffer would be the sodium chloride, but it was sufficient 
to maintain the pH to within Í 0,1.
The pH was measured using a Pye model 79 pH meter using a combined 
glass-and reference electrode, and calibrated using standard buffers.
Checks on the pH of the DNA, the drug and the DNA-drug solutions throughout 
the investigation always resulted in values of 7.6 1 0.1, close to the 
physiological level.
2.1.2 The Drugs
Ethidium bromide was obtained from BDH Chemicals Ltd., and dimidium 
bromide and prothidium di(bromide) were gifts from Dr. T.X. Watkins, The 
Boots Co. Ltd. In the dry state they were stored in a desiccator in the 
dark at 0 - 4°C.
Each was used without further purification, being dissolved in either 
the low or the high ionic strength buffer. Only with prothidium was 
difficulty in dissolving the 'crystals experienced. For the low ionic 
strength solution warming to about 35°C was sufficient to permit dissolving, 
whilst the high ionic strength solution had to be prepared first at low 
ionic concentration and then brought up to the higher value when completely 
dissolved. All solutions were stored at 0 - 4°C, and wrapped in metal 
foil to minimise photolytic degradation.
The structural formulae of the drugs are given in Chapter 1. The 
molecular weight of ethidium bromide was taken as 415.5, and all 
concentrations calculated taking its absorptivity at 480nm to be 5850 M^cm“1 
(Bresloff and Crothers, 1975). This is higher than the 5600 M“*cm“^ figure 
extensively quoted in earlier literature (e.g. Waring, 1965; Pigram, 1968), 
but it takes into account the ethanol impurity (approximately 0.46 mole/mole
ethidium bromide, according to Bresloff and Crothers (1975)) associated
S\
with commercial ethidium and is in good agreement with the figure of
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5900 M^cm"1 used by Wakelin and Waring (1974).
A molecular weight of 380 and absorptivity of 6200 at 480nm
were used for dimidium bromide (Wakelin and Waring, 1974). The 
absorptivities for ethidium and dimidi urn are reliable to 1 100 I>f*cm“*
(M.J. Waring, private communication).
For prothidium (di)bromide a molecular weight of 597.4 was adopted, 
with concentrations calculated assuming a peak absorptivity (at v465nm) of 
7100 M^cra“'*'. This figure was obtained by the author experimentally, and 
because of variations with ionic strength (Chapter 4) is considered precise 
to - 200 M"'1cm“1.
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2.2 Preparation of Complexes and Fibre-making
The required volumes of the stock solutions were separately diluted by 
approximately equal volumes of the appropriate buffer, and the drug solution 
was then slowly added to the DNA, stirring continuously, to give a final 
volume of 14 - 15ml containing approximately 1.5mg DNA. Control samples 
of DNA without drug were also prepared. From each complex, 4ml was 
extracted and used for spectroscopic analysis. The remaining solution 
was sedimented in an MSE ultracentrifuge at 40,000r.p.m. for 12 hours.
The supernatants were carefully removed and their absorption spectra 
recorded; the amounts of free and bound drug in a gel can be calculated 
from subtracting the amounts left in the supernatant from those found 
prior to centrifugation.
A drop of the gel was placed between the rounded tips of two thin 
glass rods about 1mm apart. As the gel dried down the DNA helices tended 
to align along the direction joining the two tips, resulting in an oriented 
fibre about 100 - 150pm in diameter. Orientation is improved if the tips 
are gently separated at stages during the drying, but overstretching must 
be avoided as this will result in "necking" and possible rupture of the 
fibre. Well-oriented fibres of DNA and DNA-drug mixtures containing only 
moderate amounts of drug could be prepared at room temperature. However, 
the more viscous gels associated with high drug content only produced 
suitable fibres when prepared at low temperature (4°C) and high humidity 
(92% R.H.); at higher temperatures the outer surface dries down too quickly 
and the interior is poorly oriented.
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2.3 Methods of Investigating the Binding Process
Detection of a complex between a small molecule and DNA, and ' 
quantifying the parameters of the binding process, often relies on finding 
some physical property of the complex that differs from the sum of the 
properties of the separate species. One of the most convenient tools 
for detecting complex formation is by monitoring the visible absorbance of 
the complex at a range of wavelengths for different drug / DNA ratios, but 
many other methods have been used as well (Chapter 1). In this 
investigation information on the binding process has been collected from 
solution spectroscopy, equilibrium dialysis, fibre X-ray diffraction and 
birefringence and linear dichroism measurements in the fibre state and 
subsequently analysed.
2.3.1 Solution Spectroscopy 
2.3.1(a) Definitions
In this report the binding ratio r will be taken as the number of 
drugs bound per base-pair, which is the system adopted by Muller and 
Crothers (1975). Earlier papers (e.g. Blake and Peacocke, 1968; Waring, 
1965) have taken r to be the number, of drugs bound per phosphate, but the 
definition adopted here is considered preferable since the base-pair is 
the natural unit involved in intercalative binding.
In discussing the results of the X-ray diffraction and model-building 
work, it will prove more convenient to refer to the number of base-pairs 
present for each bound drug; this is just the inverse of r.
2.3.1(b) The Method
The phenanthridines, in common with other drugs that incorporate a 
heterocyclic structure, have characteristic visible absorption spectra,
whereas DNA itself does not absorb light in the visible region. When
V.
mixed with DNA a change in the colour of the drug occurs. More precisely
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as increasing amounts of DNA are added the absorbance maximum shifts towards 
longer wavelengths and reduces in magnitude.
The free drug spectrum (r = 00) and a DM-drug spectrum taken at a low 
value of r (such that further addition of DNA produces no further change in 
the spectrum i.e. all the drug is bound) are considered as the two library 
(or reference) spectra. Spectra of complexes with intermediate values of 
r can be regarded as linear combinations of the two library spectra, and 
the concentrations of the two components may be computed using a least- 
squares minimisation procedure applied to the digitised absorbances (Section 
4.3). From the results of this analysis, binding equilibrium data can be 
determined.
Different mixing schemes have been used in the past to obtain DNA-drug 
complexes in solution with differing binding ratios. These have included 
(i) adding small quantities of a concentrated drug solution sequentially to 
a stock solution of DNA (Waring, 1970; Angerer and Moudrianakis, 1972;
Douthart et al., 1973) (ii) adding aliquots of concentrated DNA to a 
standard drug solution (Krugh et al., 1975; Patel and Shen, 1978; Blakeley, 
1976) (iii) making separate mixtures each with a constant concentration 
of drug but differing concentrations of DNA (Peacocke and Skerrett, 1956;
Porumb, 1976; Plumbridge and Brown, 1977) and (iv) mixing drug and 
DNA stock solutions to form a complex of low binding ratio r, and subsequently 
increasing r by adding appropriate volumes of the original drug stock 
solution (Waring, 1965; Dalgleish et al., 1971).
The first method suffers greatly in that the total drug concentration 
within the various mixtures varies by a factor similar to the range in r 
values required, resulting in vastly different absorbance readings. The 
photodetector of the Cary 118C spectrophotometer has its minimum relative 
error around A = 0.86, with a relative error of about 1% for absorbance
values between 0.5 and 1.5 ("Optimum Spectrophotometer Parameters",
V\
Application Report AR14-2, Varian Instruments, 1970). This method would
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not only result in having to record values outside the optimum range, but 
would involve tald.ng spectra on different absorbance range settings with 
the consequent danger of considerable baseline errors.
The second method involves corrections to the absorbances to allow 
for the increases in volumes of the mixtures, and since it begins at 
large r there it some danger of precipitation. Method (iii) uses 
rather large quantities of both drug and DMA. The fourth method overcomes 
these drawbacks but, like method (i), it involves using a wide range of 
total drug concentration.
By using a constant concentration of drug (method (iii)), not only 
can readings be limited to the optimal range (A = 0.5 to 1.5) but the 
isosbestic behaviour (Section 4.2) can be viewed directly during the 
course of the experiment, if it occurs for that particular complex. A 
method which uses only small quantities of drug and DMA (like method (iv)) 
is also expedient, and a scheme whereby the complex could remain in the 
spectrophotometer and have its binding ratio, r, changed in situ without 
altering the position of the cuvette would have the advantage that 
exactly the same optical path was being sampled for each mixture.
A novel method incorporating all of these advantages has been devised 
by the author. A DNA-drug complex was mixed thoroughly and used to fill 
a cylindrical cuvette of 5cm pathlength and 15ml capacity. The amount of 
drug in the mixture was chosen such that the absorbance maximum would be 
at about A = 1.0, and the binding ratio r was sufficiently low to ensure 
that the ensuing spectrum corresponded to the case in which all the drug 
was bound. Experience indicated that this binding ratio was between 
0.07 and 0.10 for the drugs used, although faring (1965) has used a binding 
ratio of 0.21 (i.e. a pbosphate/drug ratio of 9.6) for his bound spectrum 
for ethidium bromide.
To alter the binding ratio an autopipette (Oxford Laboratories macro-
\ \
pipette, maximum capacity 5ml) was used to withdraw a quantity, x ml, of
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the DNA-drug mixture from the cuvette and replace it with the same volume 
of a solution of the drug alone. The drug in this solution had the same 
concentration as that in the mixture so that the net effect was to leave 
the total amount of drug unaltered but to remove some of the DNA. These 
operations were performed with the cuvette still in position in the 
spectrophotometer, and to ensure adequate mixing a portion of the new 
mixture was repeatedly withdrawn from and returned to the cuvette by 
autopipette« To establish a protocol, this was done ten times and the 
new mixture was allowed to remain in the spectrophotometer for a further 
five minutes before an absorbance trace was taken. This procedure was 
repeated several times, with a spectral trace being obtained for each 
mixture, and the series was completed by removing the cuvette, cleaning 
and drying it, and filling it with the drug stock solution to obtain the 
spectrum of the completely free drug. The spectrophotometer was 
operated in its "auto slit" mode since this provides automatic compensation 
of the changing reference signal and a fixed noise level when scanning 
over an extended wavelength region ("Auto Slit versus Auto Gain", Application 
note UV-73-1, Varian Instruments, 1973).
A similar procedure was carried out in parallel with the reference 
cuvette. Initially it is filled with a DNA solution of the same 
concentration as the DNA in the original mixture* and it is progressively 
diluted by extracting x ml from it and replacing it with x ml. of the 
buffer. This compensates for the effect of light scattering by the D M  in 
the mixture.
With this scheme the binding ratio increases in a geometric 
progression, giving.a convenient spacing of the data in the subsequent 
analysis (Chapters 3, 4) to find the binding site size. The changed 
binding ratio is related to the previous binding ratio by -
changed r V
previous r W  - x (2 . 1 )
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where V is the total volume of the mixture, equal to 15ml in this 
study.
The autopipette was set to extract/deliver a nominal 4ml and was 
calibrated by weighing, on an electronic balance, the amounts of water it 
delivered. At this setting it was found to deliver 3.89ml with a 
precision better than 1% (i.e. x = 3.89 i 0.04ml),
Before each spectral series the cuvettes were cleaned with distilled 
water and rinsed internally with acetone and rubbed carefully on the 
outside with a lens tissue dipped in ethanol to facilitate drying. (V/ith 
this scheme the cuvettes only required cleaning twice - prior to beginning 
the series, and before taking the final free drug spectrum.) The multipots 
on the spectrophotometer were then adjusted to compensate for any cuvette 
mismatching.
To run a spectral series on a particular drug with a specific type of 
DNA and at a given ionic strength requires only a small amount of DNA 
(about 12mM, equivalent to about 6-7mg in its hydrated sodium salt form) 
and even less drug (about 3yM for a drug of maximum absorptivity around 
6000 I-f^cm-1).
At the end of each series, before running the free drug spectrum, the 
cuvette and its contents were weighed and compared with the weight that 
would be expected for a 15ml mixture of that binding ratio. In every 
case, the figures for the mixtures agreed to. within 2-3%. Since each 
series involves about twelve extractions and deliveries of solution, each 
limited to a precision of I/O f there appears to have been no cumulative 
errors within the series.
2.3.1(c) The limitations
The spectrophotometric method can only cover a limited range of 
binding ratios, since at low values of r it is difficult to distinguish 
the mixture spectrum from the completely bound spectrum and at large r
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values the free drug and/or the bound drug may be present at such hi^h 
concentrations that their absorbance contribution is no longer directly 
proportional to their concentration (due to self-aggregation and/or 
instrumental stray light). The mixing scheme adopted by the author 
minimises the dangers at large r values by keeping the total drug 
concentration several times lower than the concentration at which the 
free drug self-aggregates (Chapter 4).
2.3.2 Equilibrium Dialysis 
2.3.2(a) The Method
The equilibrium dialysis method allows investigation of the binding 
over a wider range of binding ratios, and the values obtained require no 
special theoretical assumptions regarding the binding process.
The free drug is allowed to equilibrate across a membrane of 
sufficiently small pore size that it is impermeable to the macromolecule. 
In the scheme considered here, the macromolecule (viz. DNA) is contained 
within dialysis tubing which had previously been boiled in a buffer 
solution for two hours to remove soluble plasticizers. A length of about 
25cm of Visking cellophane tubing, 8mm in diameter, was used to contain 
&nl of solution and was tied at both ends.
With reference to Fig. 2.1, the tubing containing the DNA and a 
similar sac containing 5ml of the appropriate buffer (to act as a control) 
were immersed in a graduated cylinder, of 50ml capacity, containing the 
drug solution at a concentration C, After three days in the dark, 
continuously agitated using a magnetic stirrer, the system was judged to 
have reached equilibrium i.e. the concentration of free drug inside and 
outside the dialysis sacs were the same.
If the total amount of drug is conserved, using the notation of
Fig. 2.1, it follows that ^  •
= CjV + (C2 + C^) v + v+ 2ACV ( 2.2)
Fig» 2 .1 Schematic Representation of the equilibrium dialysis
study
(i)
(ii)
Before dialysis
V + 2v
(iii) Ancillary experiment
to determine A ' Control'
Sac
Where: C = Free drug concentration before dialysis
V *s Volume of drug solution
C., C' = Free drug concentrations inside and outside the 
. sacs after dialysis
C2 = Concentration of drug bomid to DNA
A = The amount of drug adsorbed by th*e membrane
v = Volume of solution vdthin each sac
C", C* = Free drug concentrations inside and outside the 
control sac of (iii)
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The volumes V and v are known (50ml and 5ml respectively), and the 
concentration C will have been determined spectrophotometrically. After 
equilibrating, samples from the control sac and the graduated cylinder are 
removed and their visible spectra recorded to determine and C* . Their 
values were always within 5% of each other, in agreement with work performed 
by Armstrong et al. (1970) using acridine dyes..
The amount of drug adsorbed to the membrane, A, is found from an 
ancillary experiment (Fig. 2.1 (iii)) using the relation
CV - C«V + C"v + A (2.3)
A value for C2 , the bound drug concentration, can then be found from 
equation (2.2). Knowing the DMA concentration, and now the quantities C 
and C2 , a data point on the binding curve can be obtained (Chapter 3).
2.3.2(b) The Limitations
The disadvantages of the method include the long time required to 
achieve equilibrium; the complicating nature of the Donnan effect at low 
ionic strengths (Standke, 1975); the difficulty in determining A precisely; 
the fact that v increases during the course of the experiment due to 
osmotic uptake of water; and the large quantities of materials required.
The maximum accuracy is obtained when V is as small, and both v and 
the DNA concentration are as large as possible. Errors in C2 are 
proportionately greater when C2 is small (Peacocke and Skerrett, 1956).
Values of /G^ and determined by this method have a'precision of 
about - 10% compared with about - 3% for the spectrophotometrically 
determined data. However, the method is useful for providing values in 
a range inaccessible to a spectroscopic study (r $ 0.1), and in providing 
a check on the spectral data in the region where both can be used.
2.3.3 Fibre X-ray Diffraction
2.3.3.1 The Generators and Cameras
X-ray diffraction photographs from DNA-drug fibres were taken using
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nickel filtered copper Ka radiation (A = 1.5418 A) from either a ’Hilger 
and Watts microfocus generator or a Marconi-Elliott.GX6 rotating anode 
generator. Sets were operated at 35kV, with tube currents of 3mA and 
60mA respectively. Exposure times varied with the thickness of the fibre 
(and, to a lesser extent, with its drug content) but.were typically 5-7  
days using the Hilger and Watts generator and 6-8 hours using the 
rotating anode generator.
Pinhole cameras with a specimen-to-film distance of about 3cm were 
used with the microfocus generators. A focussing camera with toroidal 
optics and a specimen-to-film distance of 3.5cm was used with the rotating 
anode generator. The pinhole cameras sample only a small region of a 
fibre, whereas the toroidal arrangement with a beam of annular cross- 
section averages over a larger volume of a fibre.
In order to minimise scattering of the X-rays by air, the cameras 
were continuously flushed at a moderate rate with helium gas. This 
produces relatively little scattering because of the small number of 
electrons in the helium atom compared with the numbers in nitrogen and 
oxygen molecules. In order to control the environment of the fibre, the 
helium was humidified prior to flushing by passing it through water and 
then through a saturated salt solution (Section 2.3.4.2). A pot of the 
appropriate saturated salt solution was also placed inside the camera.
At least one hour was allowed for the fibre to equilibrate to the desired 
humidity before each exposure, and for photographs.taken at 98% R.H. a 
minimum of two hours was allowed. Some difficulty was experienced at 
high humidities (* 92% R.H.) with films exposed in the pinhole cameras.
Due to the long exposure times the backing paper tended to adhere to the 
X-ray film. Soaking of the film in water prior to developing alleviated 
this problem but did not overcome it completely. •
' \
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2.3.3.2 Measurement of Diffraction Patterns
The diffraction photographs were printed on to Kodak KPP positive 
paper, and the positions of reflections on this were digitised using a 
D-Kac pencil follower. Using a computer program based on one developed 
by Dr. W.J. Pigram, the co-ordinates were then converted into reciprocal 
space co-ordinates, from which the pitch, residue repeat distance, and 
the intdsrmolecular separation of the helices were obtained.
In order to obtain an accurate value of the soecimen-to-film distance 
the fibres were sprayed with aragonite powder which produces diffraction 
rings corresponding to spacings of 3.396$ and 3,273$. Calcite impurity 
in the powder also produces a ring corresponding to 3.029$. Digitised 
co-ordinates from one of these rings are used to scale the patterns and 
locate their centres.
Co-ordinates of reflections can be measured much more quickly with 
this method than with the 2-dimensional travelling microscope previously 
employed by this research group. The agreement between the reciprocal 
co-ordinates originating from the four quadrants of a pattern is at least 
as good with this method, indicating that there is no significant loss of 
accuracy incurred through photographic distortion for example.
A Joyce-Loebl recording microdensitometer was used to scan some 
reflections tangentially in order to find the degree of arcing and hence 
an estimate of the disorientation within a fibre.
2 ,3 ,4  Birefringence and Linear Dichroism 
2.3.4.1 The Techniques
Birefringence'measurements on DNA and DMA-drug fibres provide 
information on the orientation of the base-pairs and/or the drug chromophores 
relative to the helix axes, and on the disorientation of the helices within 
the fibre. Dichroic ratio measurements of DMA-drug fibres can indicate
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the fraction of drug chromophores oriented parallel to the base pairs if 
their orientation and the general disorientation within the fibre is hnown 
(from X-ray diffraction and birefringence data).
As with solution spectroscopy, neither of these techniques can show 
that intercalation occurs though the results may be interpreted along these 
lines especially in conjunction with results from the X-ray diffraction 
studies.
2.3.4.2 Birefringence Measurements
Measurements were taken in white light (viz. the internal illumination 
of the Zeiss microscope described in Chapter 7), using a calibrated 
Ehringhaus rotary compensator. The fibres were placed at an angle of 45° 
to the crossed polariser and analyser, and the compensator positioned so 
that its slow axis was aligned with the fast axis of the fibre (Chapter 6).
Interference colours were difficult to distinguish through the colour, 
of a DMA-drug fibre, and in order to ease this problem these readings were 
taken with the microscope illuminator at maximum intensity and the condenser 
aperture (which controls the contrast) fully open. An infra-red filter 
was placed below the condenser to protect the specimen from heating.
The fibre and its glass rod support were enclosed in a 3mm thick 
humidity cell which fitted on the specimen stage of the polarising 
microscope (section 7.-2). The cell was flushed at a moderate rate with air 
which had been humidified by passing through water and then through a 
saturated salt solution. The relative humidity was monitored by paper 
hygrometers placed before and after the humidity cell. The experimental 
readings (at 20 - 22°C) agreed well with each other, but were noticeably 
different to the standard values quoted by O'Brien (1943).
These findings are similar to those reported by \ Porumb (1976),
and are consistent in giving increasing R.H. in the same order as O'Brien 
(1940).
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Nominal R,H. % (O'Brien) Average R.H. % obtained
Dry air . - ' 52
Sodium bromide 57 75
Sodium chlorate 75 84
Potassium chloride 86 90
Sodium tartrate 92 92
Potassium chlorate 98- 95
Each fibre was measured! at a series of increasing humidites, with an: 
equilibration time of at least one hour at each humidity. The fibre 
length and diameter were also recorded at the time of each measurement.
2.3.4.3 Visible Absorption Spectra of Fibres and Linear EAchroism 
Measurements
Visible absorption spectra of DNA-drug fibres were recorded for 
polarised light in the wavelength range 400 to 650nm using a micro­
spectrophotometer system based on a Zeiss Universal microscope and 
described in Chapter 7. The fibre was placed on the rotating stage of 
the microscope between crossed analyser and polariser and oriented for 
complete extinction. The analyser was then removed, and absorption 
spectra taken for polariser orientations perpendicular and parallel to the 
fibre axis under various relative humidity conditions.
The spectra are similar to those obtained from the same complexes in 
solution, and at the low r values used the positions of the absorbance 
maxima indicate that most of the drug is in the bound state.
The dichroic ratio, D, is defined as the ratio of the absorbance 
recorded with light"polarised perpendicular to the fibre axis, A^, to the 
absorbance recorded \vith light polarised parallel to the fibre axis, Aj,
D ■= AX / A | . (2.4)
w  ' •
Due to the large absorbance of the drug component, only the spectra for
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fibres of small binding ratios (r^ 0,1 for ethidium.-DKA and dimidium-DNA) 
could be measured directly. So long as there is only one mode of ' binding 
and the fraction of drug bound is known, this condition need not be too 
restricting. The magnitude of the dichroic ratio does not depend 
necessarily on the amount of drug in the fibre, only on the orientation of 
the drug chromophores (both free and bound) relative to the fibre axis.
By using the values of the dichroic ratio at different humidities in 
conjunction with the X-ray diffraction data,-information on the binding 
mode(s) and the fraction of drug binding intercalatively in the fibre state 
was determined (Chapter 7).
2,3,5 Model Building and Computer Graphics
The quantity and quality of data from X-ray diffraction patterns of 
fibres are often limited due to tko lack of crystallinity within the fibre. 
This often results in patterns which consist largely of diffuse diffraction 
streaks rather than distinct Bragg reflections. With increasing drug 
content the fibres may become so non-crystalline (i.e. the conformation of 
the helices and their packing becomes so irregular) that even the layer 
lines overlap and the resolution deteriorates even further.
Fibre data is so sparse that the structure cannot be solved con -vention- 
ally by the inversion of the observed Fourier transform. Instead, standard 
stereochemical parameters (such as covalent bond lengths and angles) are 
adopted on the basis of the known chemical structure. These are used to 
construct a model that conforms to the gross features indicated by the 
diffraction data - overall diameter, helix pitch, rise per residue, etc,.
The F o u rie r  transform  o f  t h is  model can be computed and compared w ith th e 
observed d i f f r a c t io n  d ata , and th e model can be ad ju sted  u n t i l  agreement 
i s  reached . I n i t i a l  models are u s u a lly  con stru cted  manually but in  la t e r
stages computer model building o^ten takes place, in which case the
\
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conformational energy can be more readily minimised at the same time.
In this work the structure of the undistorted DMA was known and the 
drug binding was presumed to cause perturbations to this structure.
Since there is no adequate Fourier transform theory for the random DNA- 
drug binding situation (Goodwin, 1977) all that could be attempted was to 
build stereochemically satisfactory models that satisfied the gross 
(geometric) features of the diffraction data from the DNA-drug fibres.
Preliminary studies with CPK space-filling models (Koltun, 1965) were - 
made to investigate the stereochemical feasibility of certain models of 
drug binding. A model of the B-DNA double helix had been constructed 
with the central rod supporting the bases divided between two base-pairs 
(Pigram, 1968; N.J. Rhodes and U.J. Pigram, to be published). The two 
sections of the DNA model could be separated and rotated to study inter­
calation models 'with various degrees of unwinding, as well as external 
binding schemes. More accurate skeletal models can then be built from 
which sets of torsion (dihedral) angles can be measured. (In practice 
some intercalation models had been constructed previously (Goodwin, 1977) 
and it was only necessary to adapt these results for the particular drugs 
used in this study.)
These torsion angles were then" refined to give a more favourable 
conformation using a program written by Pigram (1968), which had been 
rewritten by Goodwin (1977) and has recently.been modified by Mr. R.J. 
Greenall of this Department. The program was run on the CDC 7600 Computer 
at the University of Manchester Regional Computer Centre via a link from 
the Keele Computer Centre. Once refined co-ordinates for a model were- 
obtained they were JLnput to a data file at Keele, and then used in a 
graphics program written by the author to display the structure on an 
Imlac refresh display interfaced to the Keele GEC 4082 computer.
Facilities to scale and rotate the drawing, to apply 3-dimensional.
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"windowing" to the data (i.e. isolating and displaying only specially 
desired regions of the model), and to produce perspective views from user, 
nominated positions (using a light-sensitive pen) were included. As 
written the program can be used to produce a drawing of the models on the 
graph-plotter. However, the GINO-F graphics routines referred to in the 
program had not yet been implemented on the graph-plotter at Keele at the 
time of writing and it was necessary to photograph the drawings off the 
Imlac screen for this thesis.
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CHAPTER 3
SPECTROSCOPIC ANALYSIS OF DNA-DRUG BINDING DATA; THEORY
The visible absorption spectra of drugs alter when they are bound to 
DNA. In particular, the bound drug spectrum is shifted to longer 
wavelengths and its maximum absorptivity is reduced in magnitude. There 
may even be more than one type of binding, and the bound species may or may 
not be spectroscopically distinct. The spectra taken at a series of 
binding ratios, r, can be analysed in most instances as a linear combination 
of two library spectra corresponding to the cases of a completely free drug 
and a drug completely bound to the DNA. The analysis gives the 
concentrations of free and bound drug in each of the mixtures comprising 
the series, and is described fully in Section 4.3. This data can then be 
interpreted using a particular binding model to yield the binding parameters 
of the DNA-drug interaction, such as the association constant and the number 
of binding sites associated with each base-pair.
3 ,1  Simple Single-Species Binding
If there is only one bound species the reaction may be described by 
DNA + DRUG -COMPLEX
(free sites) (free drug) (bound drug)
Assuming that the binding sites are independent, the Law of Mass 
Action gives
_ [ bound drug]_____
Ka “ l free sites] [ free drug]
where k is the association constant (an equilibrium constant, not a rateQ,
constant) and the square brackets denote "concentration or'.
D efin in g the fo llo w in g  q u a n t it ie s : '
c «= free drug concentration •
1 • \
c2 *= bound drug concentration
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c = C1 + c2 ” <^ruS concentration
n = number of binding sites per base-pair 
IBP ]= total concentration of DNA base-pairs,
then
k °2 a (n [BP ] - c2 )c1
The bound drug concentration, c2, can be replaced by r(BP), where r 
is the binding ratio defined in Section 2.3.1(a), giving
k = t— r-T - a (n - r ) ^
—  = k (n - r) 
C1
(3.1)
For the evaluation of the parameters n and k , several linear&
transformations of this equation have been used (Klotz and Hunston, 1971;
Scatchard, 1949) and three 6f th ese  are shown in Fig. 3.1. With
transformation (i), — vs. — , the value of - corresponds to the value of ir n r
when — = 0. The extrapolation required is from the largest experimental 
C1
value of c. to c = ", which is a much larger extrapolation than is apparent
1 1  C1 from the graphical plot. Transformation (ii), —  vs c^, has been used
rarely and transformation (iii), — vs. r, leads to the so-called Scatchard
plot which has enjoyed widespread usage.
The association constant, k , is related to the standard free energy
of the binding by the expression
. RTk = e a
where AG is the change in the standard free energy, and is a negative 
quantity for binding 
R is the gas constant
and T is the temperature (in K). •
An energetically strong reaction will therefore result in k being
Y\ a
large, leading to a steep negative gradient on the Scatchard plot, and a
( i )
(iii)
F ig .  3 . 1  G raphical re p resen ta tio n  o f  th ree  p o ssib le  l in e a r
transformations of ^he binding equation for a
A .
single binding model (see Equation 3.1)
- 35 -
weaker reaction will result in a shallow gradient. A typical case of 
strong binding, such as the binding of acridines at low binding ratios to 
DNA, results in a value for AG between -6 and -9 kcal/mole (Blake and 
Peacocke, 1968).
A binding curve (i.e. a plot of r against c^) is another useful plot, 
especially since it presumes no special relationship between r and c^.
For the case of simple single-species binding its form is shown in Fig. 3.2, 
The initial slope is large for a strong binding refection and the value of r 
asymptotically approaches n, the maximum number of binding sites available 
per base-pair, at large values of c^. A similar shape is obtained by 
plotting r against c/[BP], and this has been used as an alternative by 
porumb (1976).
In an experimental situation the Scatchard plot is often curved when 
r is moderately large. The value of n obtained by extrapolation of the 
linear region is frequently less than unity even for homopolymers. This 
cannot be explained in terms of base-pair or base sequence specifity of 
the binding. With DNA containing a, single type of base-pair only, at 
each base-pair either binding (of an integral number of drugs) or no 
binding should occur. For the homopolymers which bind the drug the value 
obtained from the Scatchard plot should be integral. Non-integral values 
of n imply that this simple theory is inadequate in describing the prevailing 
physical situation.
Various, more complex theories have been advanced to account for the 
curvature of experimental Scatchard plots. There may be more than one 
type of binding operating, resulting in more than one bound species. 
Interactions between drugs could be envisaged which could either favour the 
binding of additional drugs or discourage further binding. Binding at a 
particular base-pair might preclude binding at a neighbouring site, perhaps
due to the steric hindrance of a side group of the initially bound drug
\ \
molecule. Binding specificity could operate with a particular drug,
Q  ;
Fifí» 3.2 A schematic binding curve for single-site binding.
r (the no. of drugs bound per base-pair) vs. c^ 
(the free drug concentration); n is the maximum 
number of binding sites per base-pair
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whereby the drug preferentially binds to a particular base-pair or to a 
particular sequence of base-pairs. These possibilities are discussed in 
the following sections.
' \
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3,2 More Than One Independent Bound Species
Equation (3.1) applies for only one species of bound drug and can be 
re-arranged as
r  B
1+kacl
If the drug can bind by m differe.it binding modes at each base-pair 
and the number of binding sites per base-pair for mode i is given by 
with a corresponding association constant k^, then the binding ratio is 
given by
r
= ill 1 + ki°l
(3.2)
The total number of sites per base-pair is then given by 
m
n = j n.
• « «■»
As m increases, the number of binding parameters increases as well. 
Given that the experimental data is not perfect it becomes increasingly 
difficult to obtain precise solutions for these parameters. Considering 
the case where m = 2, a Scatchard plot would result in a shape similar to 
that shorn in Fig. 3.3. This can be treated as being comprised of two 
-.approximately linear regions separated by a curved portion. The data in 
these two linear regions can be analysed to yield two gradients and four 
intercepts, all of which are generally complex functions of n^ and k^.
The only parameter directly obtainable is n( = n^ + n^)» the total number 
of binding sites per base-pair, although experimentally this is often 
difficult to determine accurately. Data at large r is difficult to obtain 
because of aggregation or precipitation of the drug, and in this region 
the plot tends to approach the axis asymptotically.
It should be noted that the apparent intercepts and gradients 
associated with the two linear regions are not what one might expect from 
an intuitive generalisation of the single binding site case. In fact,
Fig» 3.3 Schematic curve of ^ vs. r with intercepts and
limiting slopes, where 2 independent binding modes 
are present
Where: n^,k^ are the maximum number of binding sites and the
association constant for binding by Method I 
ngjkg are the parameters similarly defined, for binding 
by'Method II
r,,c are the total number of bound drugs per base-pair 
and the total free drug concentration
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the two regions are only separable as such when the binding parameters 
involved, kJ_ and k2 , are appreciably different. Consider the case where
ki
nl = ng - 1. If " 10 then an 8% error would result if the slope of
the stronger binding region were taken as -klt- and there would be an error 
of 9% in taking the slope of the weaker binding region as — If
kf = 100» the sl°Pe of the strong binding region could be taken as -kj_ and 
result in only 1% error, but if the slope of the weak binding region were 
taken as -kg a 98% error would result. This latter case would hardly 
arise in practice since if k2 were so small, the analysis would have been 
carried out presuming only single-species binding. The situation is more 
complicated if ^  and are not known explicitly, which is usually the 
case.
Spectroscopic data obtained from proflavine binding to DNA has been 
analysed according to a model assuming two independent bound species 
(Peacocke and Skerrett, 1956). These authors took the gradients of the 
two linear portions as being equal to and -k2 , and obtained values 
corresponding to a AG of between -6 and -9 kcal/mole for the strong binding 
mode, and between -2 and -3 kcal/mole for the weak binding mode. The 
stronger binding was later associated (Blake and Peacocke, 1968) with 
intercalation in conjunction with results obtained from X-ray diffraction 
studies. The weaker binding was considered to be an external binding 
scheme with a strong electrostatic character’, since it was found to be more 
dependent on the ionic concentration of the complex.
In a .particular analysis if the intercept, zn^ is less than m, and 
the individual values do not seem to correlate with any structural ’ 
features of possible'DNA-drug models, then an alternative binding model may 
have to be considered. The binding curve, r vs. c, is often helpful in 
deciding whether or not a model with more than one bound species is 
appropriate. For the case of two bound species, in which ^  and kg are 
well separated, the binding curve will exhibit the characteristic shape 
illustrated in Fig. 3.4.
Fig, 3.4 Binding curve, where 2 independent binding modes are present
0
Fig, 3,5 Theoretical plots of - - vs, 0 for several values of 
w a 1
i^Te (after Steiner and Beer, 1961)
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3.3 Co-operatlvity and Anti-Co-operativity
Electrostatic interactions between bound cationic drug molecules may 
have the effect of discouraging further binding at nearby sites (anti- 
co-operativity). However, in some cases it seems that attractive Van der 
Vaal's forces may overshadow electrostatic effects and favour the 
attachment of further drug molecules av. adjacent sites (co-operativity).
For the very simple case in which interactions of bound drugs involving 
only nearest neighbours are considered, and neither the co-operativity nor 
the binding constant is affected by any change in the DNA secondary 
structure caused by the binding of the drugs, the following relationship 
has been proposed (after Fowler and Guggenheim, 1952),
U_
 ^ ,6 - 1 + 2Q%.KTAx s lo , i oo)® (3.3)
+  1 - 20'
rdiere X = the absolute activity of the drug
x = the partition function for a molecule of bound drug,
0 s the fraction of occupied sites (i.e. — )n
W = the free energy of interaction of a nearest neighbour
pair of bound drug molecules
k = Boltzmann’s constant ' '
vr V
and B = {1 - 40(1 - 0)(1 - e )}'*
For dilute solutions the left hand side of Equation (3.3) can be 
replaced by k&c^ to give
W_
t j _  O f t  \ S V
(3.4)
If nearest neighbour interactions are negligible (W % 0) this reduces 
simply to Equation (3.1).
If the forces of interaction are puibly electrostatic in origin, 
further simplifications to Equation (3.4) lead to a binding equation of 
the form ■ ^
k c, e r£-r 1 + 2fl ■ kT a 1 T V  l - ¿Q)e
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— = k'k (n - r) 
C1
(3.5)
k* is an interaction coefficient which is related to the ionic 
charges and the dielectric constant of the medium, but it can be more 
conveniently treated as an adjustable empirical parameter. For instance,
if _ AG°(r)
RTk' = e
then AG°(r) can be taken as an electrostatic free energy term which depends
on the binding ratio, r (Ramstein and Leng, 1975).
In cases where non-electrostatic interactions may be important, the
more exact approach of Equation (3.3) is preferable. A theoretical plot 
0
of against 0 (equivalent to a Scatchard plot with both k& and n
normalised to unity) for several values of e ^  , as computed from Equation 
(3.3), is shown in Fig. 3.5»
When W is non-zero, pronounced curvature is obtained. For positive 
values of W (i.e. anti-co-operativity, due to a repulsive interaction) the 
plots are curved downwards below the simple linear case, and for negative 
values of W (i.e. co-operativity, resulting from attractive forces) the 
curvature is opposite and the plot lies above the classical Scatchard line. 
It will be noticed that the anti-co-operative case could be difficult to 
distinguish from the curvature arising from the two independent binding 
species model. Co-operative binding is easier to recognise;because of the 
characteristic direction of the curvature of the Scatchard plot, and the 
sigmoidal nature of the binding curves as shown in Fig. 3.6.
The acridines, being simple planar molecules, exhibit a strong tendency 
to aggregate by stacking in concentrated solutions and the aggregate 
spectrum is blue-shifted relative to that of the free monomer. A similar 
co-operative effect has been found amongst acridine molecules, thought to 
be externally bound to DMA, at r values close to unity (Peacocks and 
Skerrett, 1956; Bradley and Felsenfeld, 1959). This stacking behaviour
rCi
Fin. 3.6 Schematic binding curves to illustrate the difference 
in shape between data for non-co-operative and co­
operative binding
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along the DNA is not observed with ethidium bromide because the phenyl 
side group prevents close contact, but anti-co-operativity could operate 
either because of this steric restriction or because of changes in the 
DNA secondary structure due to local distortion at the strong binding 
sites (now believed to be intercalative),
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3.4 The Excluded Site Model 
3 .4 , 1 The Rationale
It is possible to conceive of a situation where a bound drug occupies 
more than one binding site. The drug does not need to physically cover 
more than one site: all that is required is that binding at a particular 
site precludes binding at neighbouring sites. This could arise fiom
(i) Steric hindrance. For example, the phenyl substituent on ethidium 
and dimiditun, and the phenyl group and the pyrimidine moiety on 
prothidium, could prevent the approach of another potential binding 
drug.
(ii) An anti-co-operative effect, e.g. due to the local electrostatic 
shielding of the lattice phosphate by a bound drug. It will be seen 
later in this section that this anti-co-operative character which we 
already have considered separately In Section 3.3 can be conveniently 
included in the excluded site model. Indeed it is difficult to 
separate it out as a term independent from the steric hindrance and 
secondary distortion effects.
(iii) Distortion of the DNA secondary structure. Binding of a drug could 
cause stereo-modification of the DNA at or near a binding site. If 
its effect spreads to adjacent sites then it may not prove feasible to 
implement the same modification at the neighbouring sites. According 
to the intercalative binding model of Sobell et al. (1977), DNA kinks 
or bends prior to accepting an intercalative drug. This is made 
possible by altering the normal C2' endo sugar ring puckering in B 
DNA to a mixed puckering pattern of the type C2' endo (5•—3 *) C3‘ 
endo and partially unstacking the bases. This mixed pucker system 
necessarily limits intercalation to every other.base-pair (i.e. nearest 
neighbour exclusion).
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3,4,2 The Binding Analysis
In the treatment of the excluded site model by McGhee and von
*
Hippel (1974) the drug covers n base-pairs on a DNA molecule N base- 
pairs in length (Fig, 3.7),
At any degree of binding the number of free binding sites depends not
only on the number of drug molecules already bound, but also on thr.ir
distribution along the DNA lattice. This is a major departure from the
classical Scatchard analysis of Section 3,1. Fig. 3,8 shows some of the
Nimmediate differences. At complete saturation, — drug molecules are
bound. The classical analysis presumes that at any degree of saturation,
the numbers of bound and free sites should add up to this number. Fig,
3.8(i) shows that this is not the case. For this particular example,
although the lattice is not completely saturated, there are no acceptable
vacant binding sites because the bound drugs had not been constrained to
bind n base-pairs apart. Fig. 3.8(ii) shows that the number of binding
sites on a naked lattice is (N - n + IX A consequence at low binding ratios
(Fig. 3,8(iii)) is that the classical analysis would underestimate the
number of free sites (in this instance, as four instead of seven) and thus
overestimate k (see Table 3.1), cL
By incorporating these features and using simple conditional 
probabilities, McGhee and von Hippie were able to begin with the Law of 
Mass Action and develop it to obtain an equation analagous to Equation (3.1),
r
C1
k(l - nr) ( 1 - nr ' 1 - (n-l)r
n-1 (3.6)
where n, ^  and r have been previously defined, and k is the association 
✓ '
constant of an isolated site.
When n = 1 the last factor in this expression becomes equal to unity, *
* Note that this differs from the n defined in Section 4,1 and used up 
until now. The current n is 'the number of base-pairs occluded per 
bound drug molecule, whereas the previous n was the number of binding 
sites per base-pair. They are related by their inverses.
n= 3
DRLJG
• I
N= 10 
DNA
Fig, 3,7 An example to illustrate the terms n (the number of 
base-pairs covered by a drug molecule) and N (the 
number of base-pairs in the DNA molecule) for the 
excluded site model
Fig, 3.8 Diagrams to illustrate some of the special features, 
described in the text, of the excluded site model 
of McGhee and von Hippel (1974),
For these examples, n = 2 and N = 10
• No, of bound sites = 3 
No, of free sites = 0
*: 9, in this 
instance
In this example of low binding density, the number
• %
of free sites is 7 ,
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and the equation reduces to 
| = k(l - r)
This is identical to the classical equation (3.1), except for the 
"one" inside the brackets. Its appearance, rather than Scatchard's n, 
results from the assumption in this treatment that every base-pair is a 
potential binding site for a single drug. If the bound drug molecule 
occupies more than one base-pair on the DNA, the last factor in Equation 
(3.6) is less than unity and is a function of n and r. The resulting 
Scatchard plot is curved and'falls below the classical straight line plot 
(Fig. 3.9).
The intercept on the abscissa is ^ as required for complete 
saturation, though the plots become-very shallow at large r for even 
moderately sized drug molecules. Crothers (1968) noted that this implied 
a reluctance of the drugs to bind, and resulted from the accumulation of 
gaps smaller than n base-pairs in length.
The slope of Equation (3.6) at low r is -k(2n - 1) so that extrapolation 
of data from this portion of the curve leads to an intercept of about ♦
This results in an overestimation of the binding site size (see Table 3.1). 
Many earlier DNA-drug binding studies have produced extrapolated intercepts 
of around 0.3 drugs per base-pair, which was difficult to explain in terms 
of the classical analysis. It can now be seen that these values are 
consistent with an exclusion site model in which n = 2 (viz. nearest neigh­
bour exclusion)•
Equation (3.6) is the most convenient but not the sole formulation of 
the solution for the excluded site model. The results of Zasedatelev '¿t 
al. (1971)» obtained by a combinatorial method, can be arranged to give 
this expression; and both Crothers (1968), using a Monte Carlo method, and
Schellman (1974), using sequence generating functions, have proposed
\\
similar equations. In addition, there have been a number of more 
restricted analyses which have produced less general solutions (Hill, 1957;
Fig. 3.9
binding of drugs ranging in size from n=l to n=20, for
ks=l M"1 (after McGhee and von Hippel , 1974). ,
1
The 'absicca is scaled in units of and the dashed 
line represents the limiting slope of the n=20 curve 
(see text)
Theoretical plots calculated from.Equation (3.6) for the
Fig. 3.10 Theoretical plots for the co-operative binding of a 
ligand of n=l (for k= 1 M- )^ with w ranging from 
0 to 5 (after McGhee and von Hippel, 197 4)
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Schwarz, 1970; Bauer and Vinograd, 1970; Armstrong et al., 1970),
Recently, good quality X-ray diffraction patterns (Bond ct al,, 1975)
from a platinum-substituted ethidium-DNA complex have strongly supported
the nearest neighbour exclusion theory by demonstrating a 10.2A periodicity
along the helix axis. Unfortunately, however, no estimate of the pitch
owas made from the diffraction data and because the 10.2A meridional is
o
considerably less intense than that corresponding to the 3.4A base-pair 
repeat, there are doubts (Goodwin, 1977) as to whether saturation of the 
binding had been reached,
Ethiduim bromide binding to DNA is a particularly difficult case to 
analyse spectroscopically. If an external binding mode is present, it is 
likely that it causes a similar shift to the free drug spectrum as is caused 
by intercalative binding ( Porumb, 1976). Previously the curved 
Scatchard plot had been analysed according to a two binding mode scheme 
(YJaring, 1965), but more recently the data has been shown to fit accurately 
a single binding species model in which nearest neighbour exclusion effects 
are operating (Bresloff and Crothers, 1975),
Theoretical calculations have been quoted (Gale et al., 1972; Cairns, 
1962) to support a saturation of binding at less than r = 0.5 for the 
nearest neighbour exclusion model. It has been suggested that the maximum
occupancy under this scheme would be (1 - e ) _ Q ^  The original paper
(Page, 1959) considered the random selection of adjacent pairs of points 
from a line of N points, but the theory is inapplicable to drug binding.
Once pairs of points had been selected they were not considered again, 
whereas in drug binding a dynamic situation prevails in which a rearrange- 
ment of drugs along the DNA is continuously occurring.
The excluded site model can be generalised further to include more 
than one binding species and/or to include drug interactions, but in most 
such extensions the number of unknown parameters proliferates at a greater
46 -
rate than do the experimental means of distinguishing the different effects. 
The introduction of a drug interaction parameter w (McGhee and von .Hi ppel, 
1974), for instance, modifies the theory to produce the plots of Fig. 3.10. 
Values of w greater than unity correspond to co-operativity, and values 
less than unity to anti-co-operativity. Anti-oó-operativity and binding
site overlap are seen to result in the same effect on the plot (viz. a 
curving below the classical straight line), and for most applications it 
will suffice to absorb the interaction term within the largely steric 
overlap factor to produce an "apparent site size" which includes both 
effects.
3 .4 .3  The Cbmputer Programs
A computer program, "SCATCH", written by Dr. James McGhee (to be 
discussed fully in a publication in preparation) uses the Regula falsi 
iterative method to minimise (with respect to n and k) the sum of the 
squares of the differences between the two sides of Equation (3.6), in order 
to fit experimental binding data to that expression. A listing kindly 
supplied by Dr. McGhee has been modified so that the program would run on 
the link to the CDC 7600 computer at Manchester.
Convergence to the best fitting values can be accelerated using a 
quadratic convergence scheme and the author has developed independently a 
program, "SCATFIT", which uses the Simplex method (Nelder and Mead, 1965). 
This program also outputs graphically the curve generated by Equation (3.6) 
using the best-fit values of n and k, and superimposes it on the data
points. '
Both programs were tested using previously published data for ethidium 
bromide (Bresloff and Crothers, 1975) and actinomycin C3 (Muller and 
Crothers, 1968). The values obtained for n and k are compared with those 
quoted in the original papers in\Table 3.1. As previously noted, use of
TABLE 3.1
Comparison of Binding Parameters Using Different Analyses
Original Value s Values using 'SCATCH' Values using 'SCATFIT'
n k n k n k
\
Ethidium bromide 2.76
(2.00
5.03 x 104 (1) 
1.83 X 104) (2)
2.02 1.836 x 104 2.923 1.838 x 104
Actinomycin C3 (low salt) 11.11 2.4 x 106 (3) 6.388 - (4) 6.230 2.003 x 105
Actinomycin C3 (high salt) 12.50 1.2 x 107 (3) .. 7.662 (4) 7.349 8.055 x 105
1. Values obtained from the classical' Scatchard analysis (Equation (3.1), applied to the linear portion of the data of 
Muller and Crothers (1975)).
2. Values obtained by Bresloff and Crothers (1975) using the analysis of Crothers (1968), which is equivalent to 
Equation (3.6), with n constrained to equal two.
3. Values obtained by Muller and Crothers (1968) applying Equation (3.1) to their data.
4. Program failed to converge with the starting parameters chosen (n = 7 and k = 2.0 x 105).
5. Program failed to converge with the starting parameters chosen (n = 7 and k = 8.0 x 105). .
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Equation (3.1) (applicable to the simple single binding species model) 
rather than Equation (3.6) (resulting from the excluded site theory) leads 
to an overestimation of both n and k.
Figs. 3.11 and 3.12 show the results from "SCATFIT" for these sets of 
data. Each figure shows the generated best fit curve, and two other 
curves generated by talcing values of n 5% lower and k 5% higher than the 
best-fit values (the upper dotted curve), and then n 5% higher and k 5% 
lower than the best values (the lower dotted curve). This is used to 
give an idea of how well the best-fit curve fits the experimental data.
The ethidium data is seen to be well described by Equation (3.6), but the 
actinomycin data deviates markedly from the theoretical fitted curve at 
large r (as previously noted by McGhee and von Hippel (1974)). This 
implies that an additional complication is operating in the actinomycin 
binding, and this is probably that actinomycin C3 prefers to bind to a 
G(5* - 3')C sequence (Sobell, 1973). Equation (3.6) is sufficiently 
inflexible that variations from it due to binding site heterogeneity 
(discussed fully in the following section) can be detected by a poor fitting 
of the generated curve to the data.
"SCATFIT" was used in preference to "SCATCH" for analysing the data 
presented in Chapter 4, because of its more rapid convergence and its 
improved robustness (i.e. its ability to cope with somewhat poorer starting 
values of n .and k). A further advantage of "SCATFIT" is the ability to 
specif^, prior to minimisation, the error tolerable in the final result.
A surface plotting program, "SURFPLOT" was developed with the 
assistance of Dr. P. Collis of the Keele University Computer Centre. The 
log of the sum of ;fche residuals from Equation (3.6) is plotted against a 
range of values of n and k enabling the region where the minimum occurs to 
be located, and hence starting values of n and k to.be obtained for use in
"SCATFIT". Figs. 3.13 and 3.14 show these plots for the ethidium and
\\
actinomycin data. The steps at the right hand side of the plots show 
regions in which a minimum will not be found. The absence of readily
r/Clxio‘5
Fig, 3,11 Ethidiura bromide - DMA binding data (from Bresloff 
and Crothers, 1975) fitted to Equation (3,6) using 
the i5rogram 'SCATFIT'. The dotted lines indicate 
the goodness of fit (see text)
Fig. 3.12 Actinomycin C3 - DMA binding data (from Muller and Crothers,
k=2-0x10i
k=1-6x 10
n=2 l,
( i i)
Figure 3.13 Surface plots produced by "SURFPLOT" from BMA-ethidium 
bromide data (from Bresloff and Crothers, 1975). The 
dotted portion of diagram (i) is-shown, increased in 
scale, as diagram (ii).
Fin, 3.14 Surface plots produced by "SURFPLOT" from DMA- 
actinomycin C3 binding data at (i) low ionic 
concentration and (ii) high ionic concentration
\\
\
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identifiable minima in Fig. 3.15 for actinomycin indicates that Equation
(3.6) may be a poor description of the experimental situation. "SURFPLOT" 
has been designed to be used either with a Tektronix graphical display unit 
(for interactive use) or with a digital plotter (to produce permanent 
copied such as those shown in Figs. 3.13 and 3.14).
s\
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3.5 Heterogeneous Binding Sites 
3.5.1 Base-pair Specificity
A curved Scatchard plot could result from either base-pair or base 
sequence specificity in the binding reaction. Present knowledge of the 
existence of base-pair specificities is restricted largely to the 
actinomycin-DNA system (Muller and Crothers, 1963; Sobell et al., 1971), to 
the interaction of several acridine dyes (Ranstein et al., 1972) and 
analogues (Muller and Crothers, 1975), and to the antibiotic netropsin 
(Wartell et al., 1974).
Crothers (1963) produced a non-linear Scatchard plot for a heterogeneous 
polynucleotide using a Monte Carlo method. For a drug which can bind 
between two base-pairs (Fig. 3.15) in which at least one member is G-C, and 
for which n = 4, he obtained the plots shown in Fig. 3.16. Crothers 
considered the binding to be intercalative, but this is not necessary for 
the theory. All that is required is that the drug show this preference 
for a G-C base-pair.
For this simulation Crothers considered a DNA molecule comprising 
5000 base-pairs, a value which permitted advance specification of the base- 
pair composition of the random sequence to within roughly 2%, If f is 
the fractional G-C content, then the probability of one base-pair chosen 
at random being G-C is f. The probability of choosing two adjacent base- 
pairs with at least one of them being G-C is (l - (1 - f) \ that is,
(2f _ f2). This probability holds no matter what the binding site size, n, 
of the drug, so long as the identifying site (Fig. 3.17) on the drug (i.e. 
the chemical group^which actually binds) is fixed in a certain position.
This would be the case for most binding schemes, although an exceptibn 
would be the bifunctional intercalators. (e.g. echinomycin - Uakelin and
Waring, 1976). ■ ^ ■
In the simpler case of a homogeneous lattice the intercept on the —Cl
Fig» 3.15 A schematic representation of the conditions applicable 
to the plots of Fig. 3.20
0 ---------
1  --------------
2 — J--
Identifying -------------
S i te  ________
' 3 — i ------
. 5 — -  —
- n = y>
Either 2 or 3 is G-C, or both of them are G-C's
Fi^. 3.16 Theoretical Scatchard plot for a model in which a drug 
(n=4) binds between two base-pairs when at least one 
of them is G-C (P=2f-f2), (After Crothers, 1968)
■ k has been set to III“1.
F x g i 3»17 Two different identifying sites for the case 
where n = 4
( i ) (ii)
Identifying site is 2 • Identifying site is 1
(or 3) (or 4)
v\
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axis of the Scatchard plot is k, the intrinsic association constant of each
binding site. Because of the need to satisfy the base-pair preference in
a heterogeneous lattice system, the level of binding v/ill always be less
for a given total drug concentration. The - intercept will be reduced
C1
by the probability factor, P, to Pk. P depends on the fractional G-C 
content, f, according to the details of the binding preference. For the 
scheme considered by Crothers, the dependence of P on f is shown below -
If binding were to occur exclusively on only one particular side of
a G-C pair then the probability factor would equal the fractional G-C content
(i.e. P = f), and if it required two adjacent G-C pairs then the probability\
P, would be equal to f2. Thus a plot of the £ intercept (called the
C1
affinity, a, by Muller and Crothers (1975)), determined for a variety of 
DNA’s, against a specific expression for P in terms of f, the G-C content, 
could be useful in testing different models for the binding site specificity 
requirements. Fig. 3.18 shows the theoretically expected variation of the 
affinity, a, with the fractional G-C content, f, for the cases where 
P = 2f - f2, P = f and P = f2 ,
These relationships hold only for a heteropolymer with random base-pair 
sequence, whereas in DNA the sequence is generally non-random. Josse et al. 
(1961) showed that the base-pair sequence in DNA from odd numbered type T 
phages is close to random if sufficiently long segments of DNA are examined, 
whilst in thymal and bacterial DNA there is a correlation in the arrangement 
of immediate neighbours. Shugalin et al. (1971) have concluded that these 
latter types can be considered as blocks of quasirandom sequence, although
Fig» 3.18 The theoretical variation of the affinity, a , 
(normalised to unity) with the fractional 
G-C content, f.
Case (i) P = 2f - f2
(ii) P » f
.(iii) P = f2, where P is the probability factor (see text for
details)
' \  '
i
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each block contains a differing G-C content. For calf thymus DNA the mean 
molecular weight of the block is 10 - 15 million with a mean square 
deviation of the content of the blocks from the average of an entire genome 
as 9.5%, and for E. coli the respective figures are 5 - 1 0  million and 4%. 
However, Gurskii et al. (1972) using these values for thymal DNA, have 
shown that the resulting value of the binding site size,n,for actimomycin 
binding to DNA is only about 5% away from the estimate made on the 
assumption of a completely random heteropolymer. This deviation is lower 
than the normal experimental error in these investigations. In any case, 
the molecular weights of the DNA fragments used in the experiments 
described in this work are likely to be less than the mean value of a 
block so that the sequence within each fragment can be taken as being 
completely random.
For the situation where n > 2 the concept of an identifying site 
(Gurskii et al., 1972) becomes important. The affinity is independent of 
the position of the identifying site with the drug, hut the saturation 
value of r, r , for a random heteropolymer does depend on the position 
of this site. For the case where binding requires a G-C pair adjacent to . 
the identifying site, r ^  is given by
______________ f_______________ _
rmax = 1 + f(n - 1) + (l - f) [l - (1 - f)*"1} (3,7)
where t denotes the position of the identifying site. In Fig.
3^17(i) t could be taken as either 2 or 3, and in Fig. 3.17(ii) it could 
be taken as either 1 or 4. For use with Equation (3.7) t should be taken 
such that 1 $ t $ ~.
The equation can be generalised by replacing f by the probability 
factor P, so that it will describe other base-pair specificity schemes -
max 1 + P(n - 1^+ (1 - P) jl - (1 - P j ^ j (3.8)
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For n=2, when the position of the identifying site is unimportant, 
this reduces to
P
max 1 + P (3.9)
Table 3.2 illustrates the dependence of r on f for random-sequencemax
DMA samples of differing G-C content. The relationship between r andmax
f is shown fully in Fig. 3.19, for the three different probability factors 
considered previously.
For n=4, the case considered by Crothers, Equation (3.8) reduces to
P
and
max
max
1 + 3P for t = 1.
1 + 4P - P£ for t = 2
(3.10)
(3.11)
The intercepts, r , for these two distinct cases are tabulated in max
Table 3.3 for the G-C contents considered by Crothers, and the relationships
between r and f are plotted in Fig. 3.20. max
Crothers considered the case where the identifying site requires at 
least one G-C pair (i.e. P = 2f - f2). However, it is difficult to tell 
from -his results whether his example corresponded to having the identifying 
site at t = 1 or t = 2,
i
Because of reduced binding due to base-pair specificities, the intercept
r is less than the value expected for that.particular binding site size, 
max
n. It is the inverse of the intercept which gives a measure of the binding 
site size. If the values of r ^  are smaller due to base-*pair specificities, 
inverting them will result in values for the apparent binding site size,
napp
(-: i ), which are larger than the actual site size, n. This is
max
illustrated, for the different types of specificity considered, in Fig. 
3.21 for an actual site size of two (n = 2) and in Fig. 3.22 for an actual 
site size of four (n = 4).
To recap on the significance of the intercepts measured from the 
Scatchard plots -
Fig. 3.19 The r intercept, r^. , from a Scat chard plot bhown as 
a function of the G-C content f, for n=2
Fig. 3.20 The r intercept, r^^, as a function of G-C content 
f , for n=4
TABLE 3.2
The Intercept, r for various f Values when n=2 ' max
DNA type f
rmax
P = 2f - f2 P = f P = f2
Poly dG - poly dC 1.00 0.50 0.50 0.50
M. lyso 0.72 0.48 0.42 0»34
Calf thymus 0.42 0.40 0.30 0.15
Cl. perfringens 0.30 0.34 0.23- 0.08
TABLE 3.3
The Intercept, r , for various f Values when rt=4 max
f
r for t=lmax r for t=2max
P = 2f - f2 P = f • P = 2f - f2 P = f
1.00 0.250 0.250 0.250 0.250
0.50 0.231 0.201 0.219 0.183
0.257 0.191 0.145 .0.173 0.131
' \
Fig. 3,21 Apparent binding site size, n , as a function ofaPP
the fractional G-C content f for n=2
8 -
6 -
4-
2 -
0 1 T" . ..
ao  0.2 a i
• f
05 08 iTo
Fig. 3.22 Apparent binding site size, napp, as a function of 
the fractional G-C content f for rt=4
(i) the ^ intercept (the affinity, a) is independent of the size of the 
binding site and of the position of the identifying site within a 
drug molecule. Its variation with the fractional G-C content 
depends on the particular type of base-pair specificity operating,
&nd its value is always less than in the case where there is no 
specificity in the binding (Fig. 3.18).
(ii) the r intercept (r ) depends both on the binding site size and,
when n >2, on the position of the identifying site (Figs. 3.19 and
3.20). Its value is always smaller than the expected value when no
base-pair specificity is present. Although it depends on more
variables than does the affinity, it may prove useful to consider its
variation with G-C content if r , is known more reliably than a.max
A further complication would be that binding occurs to both A-T and 
G-C pairs but with differing affinities (k^T and kGC), a circumstance that 
could hardly be detected by these methods.
Muller and Crothers (1975) studied the base-pair specificities of a 
series of proflavine and acridine orange analogues by differential dialysis 
of the drugs against DNA samples of differing G-C content. For the bis 
(dimethyl-amino) phenazoxonium ion, the results fitted closely a linear, 
relationship between the affinity, o, and the fractional G-C content 
indicating that binding requires one G-C pair.
3,5.2 Ease Sequence Specificity
Analysing the dependence of ° and r ^ ^  on the G-C content, as described 
in the previous section, may provide information on the preference of a 
drug for a particular sequence of bases. The situation where a drug is 
found to prefer binding to a site containing two adjacent G-C's (i.e. 
p _ f2) is equivalent to a sequence specificity for GpG (or CpC).
It can be shown that, as a consequence of the right-handed nature of •: 
the Watson-Crick DNA double helix with its strands of opposite polarity .
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(Fig. 1.2), there are ten distinctly different binding sites (Fig. 3.23). 
Although the experimental evidence is conflicting (Chan and van Winkle, 
1969; Gersch and Jordan, 1965; Kleinwachter et al., 1969; Bidet et al., 
1971), each of these sites could theoretically possess a different 
association constant (k^, k2 ,<k^.••••...k^) and the differences amongst 
them would be more apparent at low binding ratios. These ten sites could 
be built into a double-helical model of eleven base-pairs, or into a 
circular double helix of ten base-pairs, for inspection purposes (Fig. 
3.24). It is clear, for example, that sites 1, 2 and 3 in Fig. 3.24 are 
not equivalent and that they present different environments to a binding 
drug molecule.
In a random arrangement of base-pairs in a DNA molecule, the frequency 
of any nearest neighbour pair (viz. a sequence of two) should be 
predictable as the product of the frequencies of its constituent monomers 
(e.g. F(ApT) = F(TpA) = F(Ap) x F(Tp), where F indicates "frequency of"). 
Josse et al. (1961) observed that whilst most sequence frequencies fell 
within these predictions, for several DNA's they differed sharply. In 
particular, the sequence C(5' - 3')G seems to occur with a frequency which 
is invariably less than the random value in animal and plant cells (0.016 
in calf thymus, instead of an expected 0.21 x 0.21 = 0.044); and, by 
contrast, its isomeric sequence G(5' x3')C differs little from the random 
expectation (in calf thymus, 0.044 experimentally). In bacteria, the 
reverse of this tendency appears to be the case. Some of the results of 
josse et al. zre reproduced in Table 3.4, togetlfer with the corresponding 
expected (random) frequencies.
Base-pair specificity can be determined through binding experiments 
using DNA samples of varying base-pair composition (Uartell et al., 1974 - 
netropsin; V/akelin and Waring, 1976 - echinomycin). Direct determination 
of sequence specificity (Muller et al., 1973) is facilitated by using 
synthetic double helical polynucleotides, but these are limited in their
Fig. 3.23 Schematic drawing of the possible intercalating sites 
in DNA. A degeneracy exists so that of the 16 
possibilities, only 10 are distinctly different
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Fig. 3.24 The 10 distinguishable sites may be built into a DNA
model-11 base-pair^ long, or into a circular DNA
\
model 10 base-pairs long with 5 G-C*s and 5 A-T*s
TABLE 3.4
Nearest Neighbour Frequencies for some Common DNA Types 
(Experimental data from Josse et al., 1961)
Nearest Neighbour 
Sequence
(5* - 3')
Cl. perfringens Calf thymus M. lysodeikticus
Theoretical Theoretical Experimental Theoretical Experimental
ApA, TpT 0.123 0.034 0.089, 0.087 0.020 0.019, 0.017
CpAf TpG 0.053 0.061 0.030, 0.076 0.050 0.052, 0.054
^  GpA, TpC 0.053 0.061 0.064, 0.067 0.050 0.065, 0.063
CpT, ApG 0.053 0.061 0.067, 0.072 0.050 0.050, 0.049
GpT9 ApC 0.053 0.061 0.056, 0.052 0.050 0.056, 0.057
GpG, CpC 0.023 0.044 0.050, 0.054- 0.130 0.112, 0.113
TpA *■ 0.123 . 0.084 0.053 0.020 0.011
ApT 0.323 0.034 0.073 0.020 0.022
CpG 0.023 0.044 0.016 0.130 0.139
GpC 0.023 0.044 0.044 0.130 0.121
Theoretical values using: fc G = 0.15 and fA, T = 0.35 (Cl. perfs.)f
fc; G =
0.21 and ÇA, T = 0.29 (Calf thymus)
rz ~ 0.36 and fA, T - 0.14 (II. lyso.)C, G
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availabi I'.ty.
Kriigh et al* (1975) have investigated the strong (intercalative) 
binding of ethidium bromide to dinucleotides using visible spectrophotometry, 
circular dicbroism and MMR techniques and have reported a base sequence 
specificity. A definite preference for binding to a purine (5< - 3 «) 
pyrimidine sequence (GpC) compared with the isomeric pyrimidine (5 • — 3') 
purine sequence (CpG) has been detected. They predict the existence of 
different equilibrium constants for the ten different intercalation sites 
based on the importance of stabilising stacking interactions between the 
base-pair and the intercalated phenanthridium ring. Patel and Canuel 
(1976) have extended sequence studies to the tetranucleotide level, and 
have observed stronger binding of ethidium to the self-complementary 
GpCpGpC (i.e. two GpC intercalation sites) and GpGpCpC (i.e. one GpC 
site) duplexes compared to the CpCpGpG (i.e. no GpC sites) by monitoring 
the UV absorbance at 480nm of various mixtures.
A recent theoretical analysis (Pack and Loew, 1978) of the origins 
of the base sequence specificity in the intercalative binding of ethidium 
to DNA has considered the binding in two stages. In the first stage, 
the double helix changes conformation (unwinds) to accept the intercalating 
molecule; and in the second stage, the drug is bound and its interaction 
energy (primarily with the bases) compensates for the energy required for 
.unwinding. They conclude that the sequence'specificity of ethidium is 
more readily explained in terms of the conformational energy changes than 
by preferential stacking interactions. NMR studies (Patel and Canuel,
1977) of the binding of proflavine and propidium diiodide have shown that 
both exhibit a specificity for G(5* - 3')C sites, similar to that shown by 
ethidium, and it is probable (Pack and Loew, 1978) that all drugs which 
unwind DNA in the same manner as ethidium would exhibit this particular
\\
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sequence specificity *
9-amino acridine (Seeman et al., 1975) shows a sequence preference for 
a pyrimidine (5» - 3«) purine sequence, ApU, but it is a non f
intercalator, Actinomycin D shows a strong specificity for G?5* 
sequences, but this has been explained in terms of specific h y d r i n
m t I)“ laCt°ne ^  XMuUer 311,3 Crot^ .  1368,- Jain and
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3 ,6  Concluding Remarks
• The change in the free energy when drugs bind to DNA results from a 
complex mixture of electrostatic effects, ir-electron interactions, 
hydrophobic bonding and dipole/polarisability factors, all constrained 
by steric considerations. Estimation of the relative importance of each 
of these effects v/ould not be easy even with detailed thermodynamic and 
kinetic studies. Free energy calculations (e.g. Gersch and Jordan, 1965, 
on the aminoacridines) remain at a formative stage and, because of the 
complexity of the situation, must continue to function only in a supporting 
capacity, to empirical observations.
Useful information can be obtained from a careful interpretation of 
a Scatchard plot of the binding parameters. It is important to realise 
that much (if not all) of the non-linearity in such a plot can be 
attributed to a binding overlap effect (i.e. an exclusion site model). 
Experimental data should be first analysed according to this model, and 
only if this proves inadequate should one consider a multi-binding species 
or a co-operativity treatment. Analysis using DMA samples of different 
G-C content will reveal any base-pair specificity of a drug, and may 
indicate a base sequence specificity in its binding.
The presence of different binding sites may prove to be of great 
importance in the recognition process involved in protein-nucleic acid 
interactions and in DNA replication and transcription. Simple 
electrostatic and hydrogen bonding interactions cannot by themselves be 
very selective since there are many such sites on the helix, but 
selectivity due to stacking/steric/electrcnic/unwinding factors would allow 
a sequence within the DNA to be recognised. Highly specific antibiotic 
and anti-tumour drugs could then be designed to Bind at or adjacent to 
these sequences. If a correspondence were established between the unwinding 
an^le of DNA and the helical conformation of the intercalative complex,
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specifici es could be predicted directly from measured unwinding angles and 
this would greatly facilitate the design of sequence-specific intercalators.
' \
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CHAPTER 4
Spectroscopic Analysis of DNA—Drug 
Binding Data : Experimental
4.1 The Absorption Spectra of the Drupg
The three phenanthridine drugs under investigation possess the 
characteristic planar phenanthridiniurn ring, the electronic structure of 
which is little affected by the methyl or ethyl substituents of dimidium 
and ethidium bromide (Giacomoni and Le Bret, 1973). Fig. 4.1 shows the 
geometry of the main ring and the ^-electron distribution. Theoretical 
calculations (Giacomoni and Le Bret, 1973) on this structure have predicted 
an absorbance spectrum with a strong visible component around 445nm. The 
red shifting of the peak to 480nm for dimidium and ethidium, observed 
experimentally, is due to the bathochromic effect of alkyl groups (Jones, 
1945).
The absorbance of ethidium bromide obeys Beer's Law (i.e, the 
absorbance increases linearly with the concentration of the solution) up 
to concentrations of about l.OmM (Taring, 1965) above which departures 
occur due to aggregation of the drug molecules (Thomas and Roques, 1972).
The author has found that dimidium obeys Beer's Law up to a similar 
concentration, and that prothidium obeys it up to at least O.lOmM (which is 
lower than the free drug concentration C  0.02mM) used in the spectroscopic 
series). Above these concentrations the drugs can form antisymmetric 
dimers causing the spectra to become red-shifted and hypochromic (Fig. 4.2). 
The proposed structure of the ethidium dimor is shown in Fig. 4.3. In 
this configuration both the steric hindrance, due to the phenyl groups, 
and the electrostatic repulsion of the charged nitrogens are minimised, and
the large surface areas in contact maximise the hydrophobic effect. A
\
similar stacking geometry applies to the acridines (Zanker et al., 1959),
Figure 4.1 The planar geometry and charge distribution of the 
ethidium chromophore. The numbers refer to the 
net electronic distribution on single atoms.
The arrow shows the direction of the first 
transition moment (after Giacomoni and Le Bret, 1973).
Figure 4.2 Absorption spectra of ethidium bromide in acqueous 
solution. The concentrations are (1) 10”%  t 
(2) 2 x 10“3M; (3) 5 x 10“% ,  (4) 10“2M,
(5) 10”%  (after Thomas and Roques, 1972).
Figure 4.3 (i) Possible structure of a stacked complex between
two ethidium bromide molecules (after Ihomas and Roques, 
1972).
(ii) Electrostatic attraction (A) and repulsion (R) 
sites in this stacking model (after Giacomoni and Be 
Bret, 1973)
\
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The exciton interaction theory (Philpott, 1970) has been used to 
explain the spectral changes in dimérisation. The electronic transitions 
in the neighbouring chromophores are assumed to be coupled by Coulombic 
interactions, and the transition dipoles are approximated to point dipoles. 
For a stacked aggregate the energy of interaction is largest when the 
transition dipoles are parallel or antiparallel, and it becomes zero when 
they are mutually perpendicular. The original energy of the transition is 
split into two transitions, with a transfer of intensity (i.e. a higher 
oscillator strength) to the idgher energy transition, and the resulting 
spectrum is thus blue shifted.
The theory is successful in explaining the blue shift displayed on 
stacking by the acridines (whose dipoles are arranged antiparailei to each 
other in the dimer) but it cannot explain the red shift shown by the 
phenanthridines. In fact,.the transition dipole of the visible transition 
of the ring in ethidium bromide has been calculated (Giacomoni and Le 
Bret, 1973) to make an angle of 34° with the line joining the amino groups 
(Fig, 4.1) and in the antisymmetric geometry of the dimer the dipoles 
would be nearly perpendicular, so that the exciton interaction would be 
very small. The observed red shift may be due to the bromide ion,
(Porumb, 1976), freely dissociated in a monomeric drug solution, attaching 
itself to a specific site in the dimer and acting as an auxochrome (i.e. an 
electron-donator). This would enlarge the territory available to the 
-electron system and consequently increase the wavelength of (i,e, »red 
shift») the electronic transition. It is suggested that the bromine ion 
would attach to one of the chromophores in the positively charged area of the 
N5 and C6 atons» a site protected from the acqueous environment and not 
available in the monomer. An increase in the ionic strength of the solution 
is expected to facilitate dimérisation since the anions of the salt will 
electrostatically shield the charged nitrogens of each ring. Although no 
significant effect was detected for diraidium (compare the free drug spectra
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in Figi 4,18(i) with that of Fig. 4.21(i)) and for ethidium (compare 
Fig. 4.9(i) with Fig. 4.13(i)) a small shift was noticed for prothidium 
(di)bromide, which is doubly charged in solution (compare Fig. 4.24 with 
Fig. 4.26(i)) .
w
\
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4,2 The Absorption Spectra of the DNA-Drug Compleyjes
Acridines and phenanthridines bind readily to DNA in vitro. • The 
complexes formed are metachromatic viz. the absorption spectrum of the 
drug is shifted to longer wavelengths (bathochromism) and the maximum 
absorptivity is depressed (hypochromism). These spectral changes provide 
a convenient means of studying the parameters of the binding process, 
according to the analysis described in Chapter 3. The spectral changes 
can be explained on the basis of exciton interaction between the transition 
dipole corresponding to the visible band of the drug and That associated 
with the UV band of a DNA base (Philpott, 1970), According to this 
theory, the shifted transition energies will diverge - in particular, that 
associated with the visible band of the drug will be red shifted.
Spectral series were taken, as described in Section 2.3.1(b), for 
the three drugs complexed with different DNA types. Within each series 
there is a progressive shift in the absorbance maximum to longer wave­
lengths with increasing DNA content. For the three drugs considered 
here (with the exception of prothidium at low ionic concentration and 
low binding ratios) all the spectra in a series pass through a common 
point, called an isosbestic point. The most common circumstance under 
which this obtains is when there are only two forms of the drug, in 
this case "free" and "bound" components. If these have the same 
absorptivity at some wavelength, then shifts in the relative proportions 
of each will produce no change in absorbance, for a constant total drug 
concentration, at that wavelength (if the DNA has negligible absorptivity
in this wavelength region). However, the existence of isosbestism is 
✓
not proof that only two forms are present. There could be more than
one form of bound drug (e.g. intercalated and externally bound) having
different spectra, but if these are always present in the same ratio an
\
isosbestic point will be observed. Alternatively, two bound species 
may be present each producing shifted spectra so similar that they are
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indistinguishable within experimental error.
The converse behaviour allows a more definite conclusion. If there 
is not an isosbestic point,even though the spectra of complex and free 
drug cross, then there must be more than one form of binding. This is 
the case for proflavine (Blake and Peacocke, 1963), where it is interpreted 
as demonstrating intercalative binding at low binding ratios and additional 
external stacking on the surar-phosphaue backbone when the drug concentration 
is high.
\\
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4.3 Theory of the Spectroscopic Analysis
Fig, 4,4 shows schematically a two-component case (i.e. a free and a 
single bound species) in which the free drug spectrum is denoted 
"library 1", the bound spectrum (Section 2.3.1(b)) is called "library 2", 
and spectra taken at intermediate values of r are the "mixture" soectra.
At any wavelength A,
A = alCl + a2°2 (4.1)
where A is the absorbance of the mixture, a^, a2 are the absorptivities of 
the free and bound drugs and c , c2 are the concentrations of free and 
bound components in the mixture. The concentrations c^ and c2 can be 
found by considering the spectra at any one wavelength, A (Peacocke and 
Skerrett, 1956), since the total drug concentrations, c, is constant and 
known.
By proportions,
the fraction bound (= £|.) = j^ L-" ^   ^ (4.2)
where A^, A2 and A are the absorbances of library 1, library 2 and the 
mixture spectrum respectively, at that wavelength. The best wavelength 
at which to perform these measurements would be where A^ and A2 differ by 
the greatest amount, since this will minimise the effect'of experimental 
error. The computation will be most reliable for the mixture that is 
located midway between the two library spectra, since in that case the 
numerator and denominator of Equation (4.2) v/ill be of similar magnitude.
An extension of this analysis would be Lo use the entire spectra, 
rather than readings at just one wavelength, to improve the precision of 
the values of and c ^ .
Thus, using m wavelengths,*
* Note that a reaaing at the isosbestic wavelength gives no information
2 since
a2i 'ali "
> N & 11 aU (°l + °2>
= ali°
Fig. 4.4 Schematic representation of a mixture spectrum in 
terms of two library_ spectra
V
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0(V  “ all°l+ a 21°2+
= ai2°i + a22°2 + s2
A°( V  “ alm°l + a2nc2 + {n> (4.3)
where? g.... n are "fc5le experimental errors and the superscript "0"
denotes "observed" (i.e. experimental) absorbances. The problem becomes 
one of selecting the best values for and c , and the criterion adopted
is to minimise
m m
♦ = l à ;
J
j=l
l  (A °; - AC .)' 
J J 
j=l
(4.4)
where the superscript "c" refers to "calculated" absorbances («sin? the
formula A . = a  .c  + ap .c ).J ij i ‘-J  c.
As mentioned previously, values of and derived at wavelengths 
where the two library spectra are different by a large amount will be more 
reliable so that, in this generalised scheme, it is judicious to weight 
contributions to the final solution by a term proportional to the magnitude 
of this difference,
Wj  ^alj “ a2j I (4.5)
A firs«*—order dependence was considered appropriate i.e.
Wj = K j ~ a2j | (4.5a)
because of the form of the dependence of the concentrations on the 
absorptivities (Equation 4.2), and because’there is an approximately 
constant random erro/ associated with each observed absorbance.
A standard least-squares minimisation treatment results in the 
following solution
*
This is a combination of the precision of measurement of the Carv U8C 
r.nectrophotometer and the resolution (0.02mm) of the D-mac nencil 
•llower used in digitising the plots. 1 A
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A (4.6)
(4.7)
A
2
A computer program "SOLVE" was used to find c and c2 , with the 
libraries and the mixture spectra (labelled 1, 2, ...H) digitised by a 
D-mac pencil follower. The program is an extension of one used by Porumb 
(1976), with added options including weighting of the data and computer 
graphic output.
4.3,1 The Program "SOLVE"
. The input data to the program consists of the digitised spectra, 
values for the total drug concentration (a constant for each spectrum 
(Section 2 .3.1(b)) obtained from the free drug spectrum) and the DMA 
concentration appropriate to each spectrum. The program plots the 
digitised spectra (e.g. Figs, 4.6, 4.7 and 4.8), and determines the 
concentrations, c^ and c2 , for each mixture. An option is available to 
tveight the equations comprising Equation (4.3) according to the weighting 
scheme of Equation (4.5), where N is an integer. Results can be obtained 
by utilising the entire wavelength range, or a selected part of it. The 
difference between the total drug concentration, c, and the sum of the 
computed concentrations, c^ + c2, will reflect the total experimental
errors. The discrepancies, AA( = A . — A .), for each mixture spectrum 
are plotted against wavelength. Inspection of these plots can be used to
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detect the presence of a base-line shift (i.e. a systematic error) in the
mixture spectra (Ellis and Duggleby, 1973). The presence of an additional
species in the system (either a second bound mode, or a contribution from
DMA absorption) would be evident from persistent systematic effects in a
spectral series in the wavelength region where this species absorbs.
Several other graphs are produced by the program. A plot of r vs. c^
will typically liave the form of Fig. 3.2, with r increasing to a maximum
(in the case of a single binding mode) approaching ^ (Section 3.4.2), and
the free drug concentration, c^, increasing as the mixtures 1 to M are
considered sequentially. The quantity r rises as the bound drug occupies
sites on the DNA (whose concentration is decreasing due to the pipetting
scheme (Section 2.3.1(b)). Eventually this increase slows up and
approaches a limit, as all the available binding sites on the DMA become
filled. The estimation of c^ will tend to be inaccurate when it is small
i.e. for mixture spectra which are difficult to differentiate from library
2 (viz. at small II). Similarly c^ (and hence r) is more inaccurate for
mixtures that are close to library 1 (viz. at large M).
A Scatchard plot is produced, and this would typically be of the form
depicted in Fig. 4.3. Both r and c^ increase progressively through the
mixtures 1 to 15, but r increases at a slower rate than c-^ (due to the
kinetics of binding) so that the quotient —  fulls as the mixtures 1 to MC1
are considered. According to the model of McGhee and Von Hippie 1 (Section
3 .4 ), the binding ratio r would increase to a saturation value equivalent
to - where n is the binding site size. At low binding, errors in - in 11 n c]
be prominent and at high binding errors in r are more important. 
Experimentally, a lot of points are required at the extremities of the pilot 
if accurate values of the association constant, k, and the site size, n, 
are to lie determined.
V
Fig. 4.5 Schematic Scatchard plot, showing the typical error 
bars (exaggerated in length) arising at the 
extremities of the ranges
r
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4.3.2 •Testing the Program
An additional subroutine was used to generate too gaussian library 
spectra, and.three mixture spectra by combining the library spectra in 
the ratios % : %, : V?. and % : V3 such that the total drug concentration
was unity. Baseline errors and random noise (using a random number 
generating subroutine) were added to the mixtures to simulate experimental 
conditions, and their effects were monitored.
Five cases were considered 
(.i) no random or baseline errors.
(ii) a 5% random error (i.e. at each wavelength of each mixture spectrum 
an amount of up to 5 of that particular absorbance reading way 
either added or subtracted), and no baseline error,,
(i.ii)no random errors, but baseline shifts of +5%, -5% and +10% of the 
respective peak absorbances were added to the mi:cture spectra.
(iv) a 5% random error, plus baseline shifts of +5%, -5% and +10%,
(v) a 1% random error, plus baseline shifts of +5%, -5% and +10%.
The graphs generated for examples (i), (ii) and (v), together with a 
typical discrepancy plot for each, are shown in Figs. 4.6, 4.7 and 4.3.
In the cases where a large portion of the error was systematic the Aa 
plot approximates to the shape of the original spectrum (Fig. 4.8(ii)).
Where the error is largely random, A\ fluctuates randomly about zero 
(Figs. 4.6(ii) and 4.7(ii)). Thus, discrepancy plots are useful in 
distinguishing base-line errors in an experimental situation.
The values calculated for c^ and cQ and their sum (c^ + c2) (which 
should equal unity for the test curves), and the root - mean - square 
discrepancy (averaged over the mixtures for the complete wavelength range) 
in each of the cases (i) to (v) - for both an unweighted scheme, and one 
which weights according to |a - A g . | - are shown in Table 4.1. Although 
the differences are small toe weighted scheme appears to deal with random 
errors slightly better, and baseline (systematic) errors a little worse than
described in Section 4.3.2 (Case (i))
Fig. 4.6 (i) Generatedgaussian library and mixture spectra as
(ii) A discrepancy plot, A A vs. X, obtained for the 
spectra shown above
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Fig. 4.7 (i) Generated gaussian library and mixture spectra
(ii) A discrepancy plot, Aa v s . 1; for the spectra 
shown above
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Fig. 4.8 (i) Generated gaussian and mixture spectra (Case (v) in
(ii) A discrepancy plot, AA v s . X , for the spectra shown above
TABLE 4.1
Results Obtained in Testing "SOLVE" (see Section 4.3.2)
No Weighting Weighting cc A1 ’ - A2
m s rms
C1 C2 (C1+C2} discrepancy C1 C2 ( c 1 + c 2 ) discrepancy
-13 -14Case (i) MIX 1 0.333 0.667 1.000 0.140 x 10 A 0.333 0.667 .1.000 0.874 x 10
'MIX 2 0.500 0.500 1.000 0.117 x 10-13 0.500 0.500 1.000 0.635 X 10“14
„ _14 -13 iMIX 3 0.667 0.333 1.000 0.913 x 10 0.667 0.333 1.000 0.135 x 10
Case (ii) MIX 1 0.31S 0.676 0.994 0.125 x 10~4 0.317 0.681 0.993 0.126 x 10"4
MIX 2 0.4S2 0.508 1.000 0.117 x 10“4 0.494 0.510 1.004 0.113 X 10
. ^ MIX 3 0.671 0.320 0.991 0.977 x 10“5 0.669 0.322 0.991 0.979 x 10"5
Case (iii) MIX 1 0.378 0.099 1.077 0.210 x 10-4 0.376 0.706 1.032 0.212 x 10-4
r i x  2 0.455 0.468 0.923 0.210 X 10-4 0.457 0.461 0.913 0.212 x 10”4
MIX 3 0.757 * 0.398 1.155 0.421 x 10“4 0.752 0.411 1.163 0.423 x 10“4
Case (iv) MIX 1 0.334 0.639 1.083 0.232 x 10“4 0.372 0.710 1.082 0.240 x 10“4
MIX 2 0.452 0.473 0.925 0.245 x 10"4 0.460 0.441 0.901 0.236 x 10
MIX 3 0.759 0.403 1.162 0.432 x 10”4 0.759 0.400 1.159 0.457 X 10-4
Case (v) MIX 1 0.376 0.701 1.077 0.217 x 10-4 0.376 0.705 1.031 0.213 x 10"4
MIX 2 0.453 0.469 0.722 0.212 X 10"4 0.457 0.461 0.918 0.214 x 10“4
MIX 3 0.753 0.395 1.153 0.423 x 10-4 0.750 0.411 1.161 0.431 x 10-4
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tine unweighted scheme. Since baseline errors can he recognised fror. 
the discrepancy plots mid compensated for if necessary, the weighted 
program v/as adopted in all further v;ork.
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4.4 Tile Spectra for the D'lA-Phenanthririine Comdexes
The absorption spectra of the three phenanthridine drugs under 
consideration v;ere measured v/hen bound to three naturally occurring DMA 
types of differing G-C content (Section 2.1.1), and these results were 
repeated using lov/ and high ionic concentrations (Section 2.1.2).
Although binding studies of DNA-ethidium complexes have been reported 
previously (e.g. Waring, 1965; Paoletti and be Pecq, 1971; Plumbridge and 
Brown, 1977), none of these have investigated the binding in such detail. 
The scheme adopted here ensures a large number of data jxeints on the 
Scat chard plot for each spectral series. Analysis vising the excluded 
site model of McGhee and Von Hippel (1974) is shown to provide a better 
fit to the data than the classical analysis used in the earlier studies, 
and a detailed consideration of the binding specificity has boen made 
possible by analysing the binding to several DITA types. The binding of 
dimidium and prothidium has not been reported previously, and a similarly 
detailed analysis has been performed for these drugs.
The mixing scheme employed (Section 2.3.1(b)) ensured that the 
results within each spectral series were self-consistent. Several of the 
series vrere repeated to check on the reproducibility of the results. In 
all cases, the values of the binding parameters obtained from the Scatchard 
plot with the repeated series agreed to within 2% of the values obtained 
with the corresponding initial series.
The spectroscopic results (marked with a '+') are displayed as a
Scatchard plot for each spectral series, and they are supplemented by
results obtained from equilibrium dialysis (marked with a *X'),
✓ ’
4 .4 , 1 Ethidiun Bromide 
4.4.1(a) The Results
\
The metachronatic shift of the absorption spectrum of ethidiun bromide 
in the presence of DMA is shown in Figs. 4.9(i) and 4,l3(i), for a. series
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of. binding ratios r. Minor differences were evident between the shifts 
produced by the different DNA's, but the general effect was the same.
The absorption spectrum was shifted from 478nm to 519nm with calf thyir.al 
DNA, and to 5l5-6nn for Cl. perfringens and M. lysodeikticus DM's, Good 
isosbestic points were obtained for all three DHA types - at 510m for 
calf thymal DHA, and at 506nm for the other two DNA * s, suggesting the 
existence of only one (spectroscopically distinct) bound mode. The 
effect of binding was visible as a change in colour, from yellow-orange 
(free drug) to bright pink (bound drug). The binding appeared to be 
almost instantaneous, as judged from the change in colour. Nevertheless, 
the protocol described in Section 2.3.1(b) was adhered to,so as to put all 
the readings on the same basis.
Similar spectral series were obtained at both low and high ionic
concentration; good isosbestism was evident in both instances, and at the
same wavelength, for the same variety of DNA. At low binding ratios the
absorption spectra for the two cases are identical, but at a high degree
of binding (r % 0.2) the spectra at high ionic concentration are shifted
towards the blue and are more intense than those taken at low salt
concentration. This effect will be apparent as giving rise to smaller
values of , the saturation binding level, and consequently to larger
values of n , the apparent binding site size, app
Each spectral series was analysed to determine the concentrations of 
the free and bound components at each binding ratio. The analysis in 
terms of one bound species, instead of two, was justified by the existence 
of a well-defined isosbestic point in each case. Examples of the binding 
curves (r vs. c) are'shown in Figs. 4.9(ii) and 4.13(ii). In each case, 
the value of r rises sharply with c, and then assumes a steady value within
The lower wavelength values for the shifted library 2 spectra and for 
the isosbestic points, for Cl,\ perfringens and M. lysodeikticus, may 
reflect the lower wavelength at which maximum absorbance was found to 
occur for these DNA types (Section 2.1.1).
Fig. 4.9 (i) Absorption spectra for ethidium bromide binding to calf
(ii) The binding curve, r vs. c, for the spectra shown abovo
CU H
02 H
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k ~  8 -5 * 1 0
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experimental error. There is no indication of a secondary binding mode 
which would have been evident from an increase in r at large drug 
concentrations, c, provided that its n, k values were reasonable different 
from those of the primary binding mode.
The Scatchard plots for the interaction of ethidium with the different 
DMA types are shown in Figs. 4.10, 4.11 and 4.12 (low ionic concentration) 
and Figs. 4.14 and 4.15 (high ionic concentration). The results from the 
equilibrium dialysis investigations are marked on «ach graph. They are 
useful in confirming the spectroscopic results in the range where they 
overlap, and in verifying the extrapolation at low values of r and c to 
obtain the affinity, a. They were not, however, used in the actud curve­
fitting because they are subject to larger experimental error than the 
spectros copi c data (Me ction 2.3.2(b)).
It is immediately apparenc tnaw tne plots are non**linear. The 
interpretation of suc.i daca depends on the theoretical model used, and the 
author has argued (Chapter 3) that the initial stage should be to try and 
fit the data to an excluded site model using Equation (3.5). The full 
lines superimposed on each plot represent the best-fitting of the data to 
t/iis model, and the dashed lines represent the effect of 5% deviations in 
tile corresponding value.,? ox n and k (as described in Section 3.4.3). All 
of the plots, except that for binding to Cl. perfringens at low ionic 
concentration indicate a good fitting of the results to the theoretical
model. The poor fitting at large r for the low ionic concentration 
Cl. perfringens data (Fig. 4.1l(ii)) may indicate an additional anti- 
co-operative character to the binding in this case.
The values obtained from the program 'SCATFIT* (Section 3,4.3) for 
the parameters n p, the apparent site sine, a, the affinity of an isolated 
site (Section 3.5.1) and a goodness-of-fit parameter -are listed for the 
various DUA’s used in Table 4.2 (for low ionic concentration) and Table 4.3 
(for M g h  ionic concentration). If the actual binding site is determined
Fig. 4.13 (i) Absorption spectra for ethidiflm bromide binding
• =1 Absorptivity caIf thymal DNA at ^  lonic concentration'
7000 J  r  *
to

r ig .  4.15 (i) Scatchard plat for-ethidium bromide binding to Cl. perfringens DMA at high ionic concentration
r/C l xlO'6
M, lysodcikticur: DNA at high ionic concentration
TABLE 4 .2
Best-Fit Parameters for Ethidium Bromide 
binding to DMA at low ionic concentration: 
f is the fractional G-C content
DMA type napp Affinity,a 
(= P.k)
Goodness-of-fit
parameter
Cl. perfringens (f=0.30) 3.86 1.33 x 106 0.325
Calf thymus (f=0.42) 2.13 2.20 x 106 0.010
M. lysodeikticus (f=0.72) 2.97 7.SO x 106 0.049
TABLE 4.3
Best-Fit Parameters for Ethidium Bromide 
binding to DIIA at high ionic concentration
DMA type °app Affinity,a 
(= P.k)
Goodness-of-fit
parameter
Cl. perfringens (f=0.30) 4.33 4.54 x 105 0.007
Calf thymus (f=0.42) 2.74 4.77 X 105 0.170
M. lysodeikticus (f=0.72) 4.64 5.10 x 105 0.001
\\
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by a number of specific bases then, in a heteropolymer such as DMA r.* c.pp
(the apparent size of a binding site) will be larger than n (the actual 
site size) si nee it will also account for the bases to which the drug does 
not bind. For example, if a drug were to show an outright specificity 
for a G-C base-pair n ^  would be much larger than two for Cl. perfringens 
DNA since there is a 40% likelihood that a second G-C base-pair will be 
located farther than two base-pairs away from the first G-C. in fact, 
application of Equation (3.9) would indicate a value of about four for
n in this exanole.app .
4.4.1(b) Discussion of Results
The values for “ are in agreement with those of the previous, more
limited binding studi.es of baring (1965), Paoletti and Le Pecq (1957) and
Plunbridge and Brown (1977). The n values are generally lower than
those obtained previously, but this reflects the method of analysis used
here. If an attempt was made to fit data presented here to the classical
analysis, by fitting a straight line to the data at low r, a lower
intercept (r ) and hence a larger value for n  would result. TheaPP
values obtained for na^  end a are mean binding parameters, averaged over 
the microscopic binding constants for all possible sites, since Equation
(3.6) considers tne DNA as a homogemus one-dimensional lattice of possible 
binding sites. The values for xi and a may be expected to reflect, albeit 
crudely, the relative abundances of the ten different binding sites available 
in an heterogeneous PNA molecule (Section 3.5),
The values of the affinity a, show a correlation with G-C content.
In particular, the binding appears to be tighter (i.e. the association 
constant is larger) with species rich in G-C. This specificity is much more 
marked at low ionic strength, where there is a factor of nearly 6 between 
the values for M. lysodeickticus and those for Cl. perfringens. At high 
ionic strength, this factor is only 1.12, and the association constants are 
all lower than those obtained at low ionic strength.
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At high ionic strength the binding saturates at a lower binding level 
e.g. with calf thymal DMA, binding saturates at r 0.3 at high ionic 
concentration, whereas it continues to r  S i 0.45 at low ionic concentration. 
This reduction in binding with increased ionic strength hars been reported 
previously ('daring, 1965; Le Pecq and Paoletti, 1967; Porumb, 1976), and 
can be explained in terms of the positive charge on ethidiun at this pH 
due to its quaternised nitrogen at position 5 (Fig. 1.3). If the binding 
has an electrostatic character (i.e. there is either a distinct electro­
statically bound species, or there is an electrostatically bound stage en 
route to the finally bound species), competition with the sodium cations 
of the buffer will affect the drug binding. In particular, at high ionic 
concentration more phosphate anions will be screened by the sodium cations 
and binding of the charged drug will be inhibited. The lower values of 
lc at high ionic concentration indicate a less stable DNA-drug complex at 
high salt content.
The nature of the G-C preference can be investigated by plotting the
affinities for various DKA types as a function of the fractional G-C
content (Fig. 4.16). At low ionic strength, the variation of a with f is
2
faster than linear and resembles an f variation (Fig. 3.13). The ratios 
of the experimental affinities oorrelate best with the theoretical ratios
Oassuming an f variation (Table 4.4). A plot of log “ against log f 
(Fig. 4.17) shows that the data could be fitted to a straight line of 
gradient 2.03 i 0.05, which is a strong indication of the f dependence. 
Thus it appears that ethidium prefers to bind at low ionic strength to a 
sequence of two G-C pairs, although the precise nature of this sequence 
specificity cannot be ascertained (viz, whether GpC, CpG, GpG or CpC).
At high ionic strength, the results are more difficult to interpret. 
Fig. 4.16 indicates that the variation of a with f may be according to 
(2f - f2), but Table 4.4 indicates that the variation in a is much less 
than required for this model. It would appear that the specificity for
Figure 4.16 The affinity, a, as a function of the fractional G-C
content, f, for ethidium bromide binding to DNA. The 
full curve indicates the results at high ionic concentration 
and the broken curve shows the results at low ionic cone.
F igu re  4.17 a v s .  f  p lo tte d  on a lo garith m ic s c a le ,  fo r  ethidium  
binding to  DNA a t  high io n ic  concen tration
TABLE 4.4
A Comparison of the Ratios of the Theoretical Affinities for Binding to Different DNA 
Types with those Obtained Experimentally using Ethidium Bromide
\ Theoretical Experimental
2 At low salt At high salt
P=f P=f2 P=2f-f Concentration Concentration
M .lysodeikticus/Calf thymus 1.71 2.94 1.39 3.59 1.07
M.lysodeikticus/Cl. perfringens . 2.40 5.76 1.31 5.94 1.12
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G-C base-pairs at this ionic concentration is only slight, and that binding 
probably occurs to both G-C and A-T pairs with only marginally differing 
association constants. It could be that at low ionic strengths, when 
competition with the sodium ions for binding is not so severe, ethidium lias 
sufficient binding sites available (at least at low binding ratios) for 
it to exercise its sequence specificity for two G-C pairs; but at higher 
ionic strengths, so many phosphate groups are screened by sodium cations 
that the drug cannot find its preferred binding site (viz. two G-C's) and 
binds to those which it finds a little less favourable.
The variation of the experimentally•determined values of n with theapp
fractional G-C content should reflect this specificity, although the
relationship is more complicated especially when n (the value of n forapp
f = 1.0) is more than two (Section 3.5.1). The fact that n does notapp
vary monotonically with f at either low or high salt concentration is of 
some concern, although similar variations to those obtained here have been 
reported for the binding of the peptide antibiotic echinomycin (V/alcelin and
Waring, 1976). The variation inn amongst the DUA varietiesapp
considered here is much less than the variation in k within the group, and
values for the intercept f 1 (from which then values have been obtained)
are notoriously inaccurate even when a large number of data points are
taken at high values of r, because of the curvature of the Scatchard plot in
this region. The value for Cl. perfringens at low ionic strength may also
be affected by additional anti-co-operative effects, which could be due to
repulsion between a bound drug molecule and a prospective binding molecule.
Another factor to be taken into accounc is the values taken for the
- 1 - 1maximum absorptive.ties of the three DIIA types. A value of 660(21 cm 
has been assumed by the author for all three varieties. Various studi.es 
have reported a difference in absorptivity amongst DIIA's of different type, 
but unfortunately there is no unanimity in their findings (Table 2.1.1). 
Muller and Crothers (1975) leave suggested that the value should be higher
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for M. lysodeilcticus and lower for Cl. oerfringens. If this were the 
case, the values of r (and therefore ~ )  would be systematically shifted
leadinr to an error in the determination of napp (The effect on k is
not so great, since both r and —^ values on the Scatchard plot are 
systematically shifted). However, the changes in the absorotivities 
suggested by Iluller and Crothers (1975), if implemented, are only about 555 
resulting in a shift of around 555 in n . This would not account for thectpp
strange variation in n with f reported here. It seems likely that,
because the binding is more complicated than merely an absolute specificity
for G-C, the theory adopted to explain the variation of n (or r ) with
f is inadequate. The more straightforward theoretical fluctuation of the
affinity, a, with f, and the ability to determine a more accurately than
n . would point towards the variation of a with f being a more reliableapp
indicator of the binding specificity. The observation that n isapp
appreciably increased, for all DNA types, at higher ionic concentration 
indicates an increased exclusion effect. This is probably due to the 
sodium cations occupying more of the phosphate sites and precluding binding 
at these sites, although it may also reflect conformational changes in the 
DMA at high ionic concentration v/hich make the binding sterically less
favourable. '
4.4.2 Dimidium Bromide 
4.4.2(a) The Results
The spectra obtained with dimidiun bromide (e.g. Figs. 4.18(i) and 
4.21(i)) are very similar to those recorded for ethidium bromide, as 
expected from their"very similar chemical structures. Good isosbestic 
behaviour was observed, with the isosbestic points occuring at similar 
wavelengths (508 - 5l2nm) to those for ethidium. A similar trend to that 
obtained with ethidium was observed as the ionic concentration was increased. 
T h e spectra for large values of r at high ionic concentration were noticeably
o
r
4 20 (i) Sca-tchard plot for dimidium bromide binding to
Cl. perfringens DNA at low ionic concentration
(ii) Scatchard plot for dimidium bromide binding to 
-M* lysodcikticus DNA at low ionic concentration
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blue-shifted and more intense than those at low ionic concentration, 
indicatins reduced binding with increased salt content.
The spectral series were analysed in terms of a free and a single 
bound drug species, and examples of the binding curves axe shown in Figs. 
4.l8(ii) and 4.2l(ii). Except for the case of binding to calf thynal 
DNA at low salt concentration, the binding level increased sharply to a 
steady value, providing no evidence of the existence of a second binding 
species. For the low salt binding to calf thymal D M  there was evidence 
of some secondary (weaker) binding for free drug concentrations above 
about 17}Jll. The levels of saturation binding were higher than those 
obtained for ethidium (leading to smaller values of 41 ) except for
M. lysodeikticus at low ionic concentration which displayed a similar 
level of binding as \ith ethidium.
The Scatchaxd plots are shorn in Figs. 4.l9(ii), 4.20, 4.22(ii) and 
4.23, and the parameters n and «obtained from data-fitting to the 
excluded site model described by Equation (3.6) are listed in Tables 4.5 
and 4.6. The experimental results were a good fit to the theoretical 
expression, except for binding to calf thymal DNA at low ionic concentration 
(Fig. 4.19(ii)) but even in this case all the data points fell within the 5% 
limits on either side of the best-fit line.
4.4.2(b) Discussion of results
The binding of dimidium to DNA is not so tight as the binding of 
ethidium. The association constants are appreciably lower than those 
obtained with ethidium, especially at low ionic strength. However, the 
affinity of dimidium for calf thymal DNA at high ionic concentration is 
larger than that for ethidium, and slightly,larger even than its affinity 
for calf thymal DNA at low ionic strength. This later point is 
particularly puzzling especially since the goodness-of-fit parameter at 
high ionic strength is very low, Indicating that the results fit the 
theoretical excluded site model well. It is probable that the value at
Fig* 4*21 (i) Absorption spectra for dimidium bromide binding to calf thymal DNA at high ionic concentration
U i )  The binding curve, r vs. c, for the spectra shown above
Fig. 4 .2 2
(i) A surface plot for dimidium binding to calf thymal DNA a t  high ionic concentration
(ii) Scatchard plot of the
same data
r7
(ii) Scatchard plot for diraidium bromide binding to DMA 
fiom M. lysodeikticus at high ionic concentration
TABLE 4 .5
Best-Fit Parameters for Dimidium Br-onide 
binding to DNA at low ionic concentration
DNA type napp Affinity, a 
(=» P.k)
Goodness-of-fit
parameter
Cl. perfringens (f=0.30) 3.59 0.36 x 106 0.033
Calf thymus (f=0.42) 1.7S 0.79 x 106 0.016
M. lysodeikticus (f=0.72) 3.00 2.65 x 106 0.001
TABLE 4.6
Best-Fit Parameters for Dimidium Bromide 
binding to DNA at high ionic concentration
DNA type napp Affinity, a 
(= P.k)
Goodness-of-fit
parameter
Cl. perfringens (f=0.30) 3.99 2.4 x 105 0.014
Calf thymus (f=0.42) 2.41 3.8 x 105 0.005
M. lysodeikticus (f=0.72j 4.57 4.3 x 105 0.001
\\
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low ionic strength is a little low, since its goodness-of-fit parameter is 
higher, and that there is no statistical difference between the two 
association constants for calf thymal DNA. Apart from this one result, 
the overall trend for dimidium is for lower association constants than 
ethidiun, indicating a less stable complex with DNA.
The specificity for G-C base-pairs appears less marked, with the 
difference in affinities at lov/ salt concentration between Cl. perfringens 
and M. lysodcikticus DNA indicating a probable preference for a single 
G-C pair (i.e. a is proportional to f). At high ionic strength the 
difference between the affinities for Cl. perfringens and M. lysodeilrticus 
is less significant, indicating that the specificity for G-C is only 
slight. It is probable that at higher ionic concentrations, relatively 
more binding takes place to A-T pairs since many of the sites will be
screened to some degree by the additional sodium ions present.
The values for n , the anoarent binding site size, arc lower than app • ''
-those obtained with ethidium, indicating that dimidium molecules can be 
bound more closely together along a DNA helix. It is unlikely that the 
significantly smaller values obtained with dimidiun reflect the slightly 
smaller overall dimensions of the drug (which contains a -CH group in 
place of a -CgH^ . S^up in ethidium). It is probable that dimidium shows 
a relatively hifdier affinity for A-T pairs than does ethidium, so that 
binding is not limited to the presence of C— C base-pairs to such a degree. 
It is possible that the binding of ethidiun and dimidiun distorts the DNA 
secondary structure and tils tends to inhibit further binding, but that tue 
effect of dimidium is smaller and so binding continues to a higher level. 
There was some evidence at lov/ ionic concentration that a secondary binding 
mode nay operate in the dimidium binding at larger binding ratios. Binding 
could continue to high binding levels if it were to bind by a mechanism 
wh/ch caused Very little disturbance of the DNA secondary structure, and 
this would account for the lower values for n  ^obtained with dimidiun.
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ïhe variation of trtth G-C content is similar to the variation 
observed in ethidium. Since the variation is not nonotonic.it is 
difficult to fit tiie findings to one of the specificity models considered 
in Section 3.5. I n  any case, consideration of the affinities for dini.Uum 
has indicated that simple specificity for a G-C base-pair is scarcely 
adequate to explain those resulte. It is more likely that the binding 
scheme is more complicated, v.-ith association constants for binding to both 
G—C and A—i base—pairs wnich fire not far removed from each other in 
magnitudo.
The values of n ^ ^  for calx thymal DMA are significantly lov;er than 
for 'Che otner DMA types for both dimidi urn and ethidium binding, at the two 
ionic concentrations considered here. It is likely that this reflects 
small conformational differences in the native DIIA's. Bran and Toward 
(1972; have claimed two new conformations, the P and T forms, for Cl. 
perfringens DMA in the fibre state, based on fibre X-ray diffraction patterns 
A later paper (Bran, 1973) has reported a progressive decrease in the 
intensity of the second layer line as the fractional G-C content decreases, 
with an approximately three fold decrease being observed between diffraction 
patterns from Sarcina lútea DNA (f = 0.72) and those from yeast 
mitochondrial DMA (f = 0.18). Whether the same conformational differences 
with varying G-C content are present in solution is more difficult to 
ascertain, since solutions are more disordered than fibres and this disorder 
degrades the difinaction data. Bran (1972) has reported that hteh-an^le 
X-ray diffraction data from Cl. perfringens DMA in solution suggests that 
tlie structure is not tint of the B form and is different from DMA’s having 
a higher G-C content (f ^ 0.4). The change is relatively slight, and at 
present has not been fully explained in terms of a modification to the DMA 
structure. It appears possible, however, that conformations observed in 
solution may vary at least in the turn angle per residue, and that this 
variation may be dependent upon baso composition. Calculations by Levitt
-  so-
(1973) have s u i t e d  that In solution complementary bases in DMA are not 
coplanar, each beins propellor-tvdstad with rospoot to the other by about 
35° to give a DBA structure with an average bass twist of 17°. Th<3se 
variations in the DIJA conformation v/ith ionic concentration, and 
c o n f o r m a t i o n a l changes induced by drug binding, may account for the
variation of napp ;
4.4,3 Prothidium ( Di ) bror,il de 
4.4.3(a) Results
Prothidiun (di) bromide appears to form staohed-natregates in solution, 
as evidenced by a red shifting of its spectrum with increasing drug 
concentrations, at lower concentrations than for ethidium and diraidium.
There is little doubc that the large hydrophobic ring surfaces are the main 
cause of tnis slacking. Solutions of around O.OSnfl concentration have a 
maximum absorptivity at 460nm, and at a concentration of 0,25mM the 
maximum has shifted to around 465nm. Increasing ionic strength appears to 
cause slight red shifting of the spectrum as well, though this effect is 
slight ( ^ l~2nm). By analogy with ethidium bromide, the red shifting - 
may be explained by the bromine ions acting as auxochromes at specific 
sites on the asymmetric dimer when the concentration is raised. The most 
probable sites for attachment would be in the positively charged areas 
around the N* of the chromophore and the IJ* of the pyrimidyl moiety. The 
N3 nitrogen of the pyrimidyl ring has a lone pair of electrons. It could 
either act as a H-bond acceptor or it could be protonated and electrostatically 
attract a bromine anion. The observation that red shifting of the 
prothidium spectrum-becomes evident at lower concentrations than for 
ethidium and dimidi urn may be related to the fact that there are two 
bromine ions for every drug molecule. Increased ionic strength is 
expected to facilitate dimérisation, resulting in the observed shift of the 
spectrum to longer wavelengths at high ionic concentration.
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The spectra for the binding of prothidium to DNA (Figs. 4.24, 4.25 
and 4,26) differ from those for ethidium and dimidium providing a direct 
indication that the type of binding may be significantly different. At 
low ionic strength, for each DNA type, the spectra show a red shift from 
the free drug spectrum for all mixtures, but at lower drug/base-pair 
values 1.0) a hyperchrornic effect is evident accompanied by a slight 
blue shifting. In fact each spectral series can be split into two sub­
series-one (series E) consisting of the spectra with drug/base-pair 
ratios greater than or about unity, and the other (series A) comprising 
the spectra v/ith drug/base-pair values less than or about unity. Each 
series shows isosbestic behaviour within itself. Series A has' isosbestic 
points at about 455nm and around 520nm, and series D has isosbestic points 
at 4 1 0-4 1 5 nm and 485-490nm. At high ionic strength, this rather complicated 
behaviour is less apparent and all the spectra appear to belong to a single 
series, with isosbestic behaviour at 400-405nm arid 435nm, It seems likely 
that the binding operating at high salt concentration is similar to the 
type predominating at large drug/base-pair ratios (viz. series B) when the 
salt concentration is low. There is little variation in the spectra when 
different DMA types are used.
Since fairly good isosbestism was obtained at high ionic strength 
these results were analysed in terms of a single binding species using the 
excluded site model. , Binding curves and Scatchard plots are shown in 
Figs. 4.26 to 4.29. This analysis was.not carried out on the binding 
spectra obtained at low salt concentration, since it is inappropriate to a 
case that does not show a single isosbestism throughout the range of 
mixing ratios. ^
4.4.3(b) Discussion of Results
The library '1' spectra corresponds to a drug concentration of about
V
go iH which is below the concentration at which stacking of the free drug
Fig. 4.24 Absorption spectra for prothidium (di)bromide binding 
to calf thymal DNA at low ionic concentration
\ .
fig* 4.25 ( i )  Absorption spectra for prothldlura (d l) bromide
binding to Cl« perfringens DMA at low ionic 
concentration
(11) Absorption spectra for prothidium (di)bromide 
binding to H* lysodeikticua DNA at low ionic 
concentration
Fig. 4.26 (i) Absorption spectra for prothidium (ai)bromide
binding to calf thymal DNA at high ionic
concentration
(ii) The binding curve, r vs. c, for the spectra shown above
G2
occurs. The binding curves at high ionic strength for Cl. perfringens 
and calf thymus DMA rise steeply at low values of r and c, indicating 
tight binding (mode I binding), and then they rise less steeply at 
around 0.4 — 0,5 (node II binding). Tho transition between the two 
regions is gradual, but a change in the slope of the binding curve is
apparent, xne appscrexnce ox one c,'/o regions mdxcatss that there nx'e 
at least two binding species. The observation that they arc not well 
separated may be due to the two species having similar association 
constants, so that they both occur together in significant proportions 
at all binding ratios, or, indeed, there may be moro than two bindin 
species. For binding to M. lysodeikticus DMA, the landing curve, approache 
asyrapotically the value r = 0.45 at large values and there is no further 
increase in r, This shows either that there .is only one binding species 
in this instance or, more likely, that the two (or more) binding species 
are so similar spectroscopically and have so similar n and k values that 
their effects are indistinguishable. It may be tliat these species 
correspond to binding to A-T and G-C pairs by a similar mechanism, although 
if this is the case it is difficult to explain why binding does not 
continue above an r value of 0,45.
The Scatchord plots show that‘the data for binding to M. lysodeikticus 
DMA can be fitted fairly well to the single binding species, excluded site 
model. For binding to Cl. perfringens and calf thymus DMA the fitting 
is inadequate at large values of r, find this is probably uue to the effects 
of other modes of binding. The binding constants to M. lysodeikticus DMA, 
and the constants fox’ the binding at low r values (mode I binding) to the 
Cl. perfriugens and calf thym.-.l DMA, are listed in Table 4.7. There is no
evidence of G-C specificity in the binding. The values for n areapp
similar for the three types, and there is very little variation amongst the
affinity values.
\ .
The binding constants are all significantly higher than those obtained 
with ethidiun bromide, indicating that the interaction with the DMA's is
r/qxlO7
Figure 4.27 Scatchard plot for the binding of prothidiura 
di(bromide) to calf thymal DNA at high ionic
V
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Fig. 4.28 (i) The binding curve, r vs. c, for prothidium (di)
bromide binding to-Cl. perfringens DNA at high 
. ' ionic concentration
(Ü) Scatchard plot of the data shown above
Fig. 4.29 (i) The binding curve r vs. c, for prothidium (di)bromide
. . binding to M. lysodeil'.ticus DMA at high ionic
concentration “
: r
0-4- ♦
♦ ♦ ♦ ♦
(ii) Scatchard plot of the data shown above
TABLE 4.7
Best-Fit Parameters for Prothidium (EL)bromide
• binding to DMA at high ionic concentration
DMA type napp Affinity, a 
(= P.k)
Coodness-of-fit
parameter
Cl. perfringons (f=0.30) 2.03 6.06 x 105 0.60S
Calf thymus (f=0.42) 2.11 9.72 x 105 1.503
H. lysodeikticus (f=0,72) 2,01 7.24 x 105 0.059
V
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stronger. This cou.U be related to the doubly-charged nature of 
prothidium, which renders it strongly attracted to the negative phosphate 
ions of the DNA backbone. The charge separation in prothidium is 3.0?
(Oam et al., 1009), which .is the approximate distance separating phosphate 
groups along cither strand of the D M  double helix. Each prothidium 
molecule M s  tnree a m  no groups and a lone-pair nitrogen, all of which are 
likely to form hydrogen bonds - the anino groups as donors, and the i t  of 
the pyrimidyl moiety as an acceptor. The distance between the amino 
groups are such that hydrogen bonds could be formed to phosphate oxygens 
located either along the same strand, or on opposite strands (across either 
a narrow or a wide groove). The hydrogen binding would be expected to bo 
less strong than the electrostatic binding, although it may be mediated 
by a strong electrostatic character due to charge delocalisation around 
the aromatic rings.
Since prothidium possesses so many groups capable of providing strong 
interactions, in several different ways, with DNA it is likely that
some or all of these binding types will be present simultaneously. The 
spectra of the drugs bound by these different mechanisms may be very similar, 
and the binding parameters describing the different species may not be 
very different. This would account for the fairly good isosbestism 
observed, and the findings that the binding curves each show two rather 
poorly separated regions and the Scatchard plots indicate more than one 
binding species.
Binding mode I appears to saturate, to some extent at least, at a 
binding ratio of atout 0.5 i.e. at one bound drug molecule for every two 
base-pairs. This,results in nftpp values of around 2.0, and these are
insensitive to the G-C content. Further binding to Cl. perfringens and 
calf thymus DNA can occur, approaching r values of unity with calf thymal 
DM. The saturation of the initial stronger binding occurs at around the 
value for total binding saturation for ethidium and dimidium. Prothidiun 
is a significantly larger molecule tlian ethidium and dimidium. J.t seems
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likely that binding mode I in prothidiw differs in type from the binding 
operating with the other two drugs. if ethidiura and dimidiun bind 
primarily by intercalation and this mode were considered for prothidium, 
the increased steric hindrance (Chapter 8) due to its larger size would be 
expected to result in a lower value for binding saturation and therefore in 
a larger value for napp for mode I binding. In addition, the fact that 
further binding can continue past this level suggests that the initial mode 
I binding has not markedly changed the DMA conformation by, for example 
unwinding the helix.
High k values are a perennial source of problems with the analysis of 
DNA-phenanthridine spectra since they mean that data at low free drug 
concentrations, arc difficult to obtain. At low ionic strength the 
association constants are even larger, because of the reduced competition 
v/ith Na ions, and the analysis is even more difficult than for the series 
at high ionic concentration. At moderate to high ionic concentrations, 
results from equilibrium dialysis may be used to supplement the spectro- 
photometrically determined data but at low ionic concentration these too 
become suspect (Section 2.3.2(a)). For prothidium at low salt concentration 
it is thought that the same binding schemes are operating as at high salt 
concentration,although the electrostatic character to the binding will be 
enhanced because the phosphates will not be shielded by the sodium cations
to any great extent.
A plausible rationale for the anomalous shifting of the spectra at low 
ionic strengths is that, at low binding ratios, initial binding (proposed as 
being strongly electrostatic) causes a red shifting relative to the free 
drug spectrum. By-analogy with the formation of dimers in a free drug 
solution at high concentrations, as more drug is bound some of it may form 
antisymmetric dimers with the already bound drug to cause a further shift 
towards long wavelengths. At still higher drug/base-pair ratios some drug 
will remain unbound in solution causing the spectra to shift towards the
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spectrum rf the completely free drug. It is not clear, however, why the 
formation of bound dimers would be inhibited at high ionic concentration.
The spectra at low ionic concentration have not been analysed 
according to a single species, excluded site binding model since it is 
obviously inadequate to describe the observed spectral data. The author 
has decided not to analyse the results according to a different scheme 
because of the computational difficulties, and because of the uncertainties 
in the interpretation of the binding modes in operation. Careful equilibrium 
dialysis measurements in the future at moderate ionic strengths may 
elucidate the nature of the binding interactions, • For the present, however, 
only the data at high ionic strength appears amenable to quantifying the 
nature of the binding.
Y\
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4.5 ■ A Summary
The binding of dimidium is very similar to that of ethidium, as is 
expected from their similar chemical structures. The electron-donating 
power of the methyl group to the triple aromatic ring is greater than that 
of an ethyl group. This difference can be expected to affect the electron 
density and hence the dipole moment cf the chromophore. If the binding 
were primarily intercalative, a strong base-pair specificity in the binding 
would require that the dipole moment of the preferred base-pair should match 
that of the bound drug. Charge displacement would result in changes in
the direction of the transition dipole moment in the drug and may result in 
a less favourable alignment of the drug and base-pair dipole moments, 
resulting in tlie reduced specificity observed for dimidium bromide. More 
information on the precise nature of the specificity could be obtained with 
synthetic polynucleotides of known sequence, especially if the snail
conformational changes thought to occur with different base sequences were 
known more quantitatively.
The binding of both of these drugs appears to be mainly by a single 
mode, although this does not rule out the possibility tiiat the binding may 
occur via several stages. Any model proposed for this binding mode must 
be able to explain satisfactorily the observed saturation of the binding 
at around one bound drug for every two base-pairs (see Chapter 8).
The spectral series for prothidium binding is very different to those 
for ethidium and dimidium, indicating that a different binding mechanism 
may be operating. In particular, the binding cannot be successfully 
explained in terms of a single bound species. The higher levels of 
binding observed is further evidence that there is a different binding 
scheme than for ethidiun and dimidium. Prothidium has been observed to 
remove and reverse the supercoiling of closed circular duplex DMA (Uakelin 
and Waring, 1974), indicating that some unwinding of the helix must occur 
on binding. However the result is not diagnostic for intercalative binding,
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since known non-intercalators, such as the steroidal diamines, are lo->own 
to unwind closed circular DNA. Binding models will be discussed in 
detail in Chapter 8 but the differences in the spectroscopic behaviour 
of prothidium compared to ethidium and dimidium suggest that more than one 
binding mechanism is involved, and that probably none of them 
correspond to the mechanism operating with ethidium and dimidium. The 
presence of a double positive charge and the three amino groups in 
prothidium suggest that electrostatic and hydrogen-bonding interactions 
are prominent in its binding to DKA, and steric hindrance due to the 
P5'rimidyl moiety can be expected to be a .important. f actor in any binding 
scheme.
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CHAPTER 5
X-Ray Diffraction from DNA-Drug Fibres
5.1 Introduction
The scattering of X-rays by a molecule is described by its Fourier 
transform and this in turn depends on the positions of the constituent 
atoms and on their Fourier transforms, known as atomic scattering factors. 
If the molecule is pare of a regular crystalline lattice then diffraction 
will occur only at specific angles which are related to the size and shape 
of the unit cell of the crystal. The Fourier transform of the molecule 
is ‘sampled' by the reciprocal lattice of the crystal and the diffraction 
pattern shows discrete spots, or reflections, instead of a continuous 
variation in intensity. The spacings of reflections in a diffraction 
pattex'n bear a reciprocal relation to spacings in the real structure.
In a non-crystalline D M  fibre, although there is normally some 
degree of regular often hexagonal packing, there is no azimuthal correlation 
between the molecules. Such fibres give diffraction patterns consisting 
of continuous intensity streaks along each layer line, which essentially 
represent the diffraction from a single molecule. In principle such data 
allows more information to be obtained from the diffraction pattern along 
each layer line since, unlike the case of a crystalline fibre, the intensity 
is not merely sampled at discrete points. However, because the diffracted 
intensities from each molecule are spread out over a large sampling 
region, they are less easy to distinguish from the background (due to 
diffraction from va ter and amorphous DM) and accurate measurements are 
more difficult. An intermediate situation occurs for semi-crystalline 
fibres. If the molecules are considered as smooth helices then they are 
packed in a crystalline lattice, but if the atomic detail is considered 
then the molecules have a random screw displacement. This gives rise to
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fairly.sharp crystalline reflections in the centre of the pattern, but a 
non-crystalline pattern at higher angles.
Cochran et al. (1952) have shorn that the Fourier transform of a 
right handed, infinitely long, helical molecule is given by -
F(S,\|>,C) = l I f. J (2irSr ) exp iln('J'-<f ,+J) + 2*CZ 1 ^ J J ** *1 J ^ J (5.1)
t/here
and
r .,^ . ,Z . = the real space cylindrical polar co-ordinates of the
J J v
.thj atom.
C, V', S = the reciprocal space cylindrical polar co-ordinates 
(Fig. 5.1).
J = a Bessel function of the first kind of order n. n
thf . = the atomic scattering factor of the j atom,0
This describes a three dimensional transform which is observed on a 
two dimensional plane. It is zero everywhere except on a series of planec 
observed as layer lines. On any particular layer line, 1, the orders of 
Bessel functions contributing to the resulting transform are given by 
the following selection rule -
n = 1 - mN K (5.2)
where
and
n = Bessel function order 
m = an integer
K is the minimum number of complete turns of the helix
necessary to incorporate an integral number of residues,
N is the number of residues in this repeat distance.
The first maxima of Bessel functions occur at increasing values of the
argument as n increases, and only a zeroth order Bessel function has a
non-zero value when the argument is zero (Fig. 5.2). _ If the helix is
’ , thintegral (K =1)* then n = 1 when m = 0 so that an 1 order Bessel function 
occurs on the 1th layer line (Fig. 5.3). This arrangement, repeated in
the four quadrants of a diffraction pattern, produces the cross-like pattern
>
 N
Figure 5.1 The real-space and reciprocal space co-ordinates used 
to define a helix.
Figure 5.2 Bessel functions, Jn(x), from zeroth to third order.
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Figure 5.3 Calculated diffraction pattern for a discontinuous 
• helix with 5 residues per turn (after Wilson (1965))
Figure 5.4 Diffraction pattern from a continuous helix
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characteristic of diffraction from a helix (Fig. 5.4).
The DNA molecule has two periodicities along its length - the pitch,
and the translation per residue. The C spacing of the layer lines depends
on the helix pitch and whether or not the helix is integral. The layer
line with 1 = 0 is known as the equator and the line perpendicular to it
and passing through the centre of the pattern is known as the meridian.
The magnitude of the Fourier transform at ? = 0 must be zero except when 
*thzero order Bessel functions occur on a particular layer line. For
B-DNA (N=10, K = 1) Equation (5.2) predicts that a zero order Bessel
tillfunction will occur on the 10 layer line when m = 1. Because the base 
pairs are approximately perpendicular to the helix axis, diffraction is 
observed as a very strong meridional corresponding to a 3.4a residue 
repeat distance. Equatorial reflections (1 = 0, m = 0) correspond to a 
projection along the helix axis, and provide information on the packing of 
the helices. For a diffraction pattern from A-DNA the resulting 
crystalline reflections can be indexed enabling the unit cell dimensions to 
be calculated. For semi-crystalline B-DNA patterns the equatorial 
reflection enables the intermolecular separation, BIS, of the helices to 
be obtained.
If there is a distribution in the orientation of the helix axes 
within a fibre, the observed pattern is a convolution of the molecular 
intensity transform and the orientation probability function P(6^, <J>^) 
defined in Section 6.3.1. This has the effect of spreading out the 
diffracted intensity along an arc centred on the centre of the diffraction 
pattern (Fig. 5.5(i)). A simple geometric explanation of this is 
illustrated in Fig.-5.5(ii)). Holmes and Earrington-Leigh (1974) have 
shown that for a gaussian disorientation function the intensity is gaussian 
along the arc, provided the arc is not close to the meridian. Deconvolution 
schemes have been proposed by which the molecular transform itself may be 
extracted from such diffraction patterns (Celia et al,, 1970; Holmes and
Figure 5.5 (i) The arcing of reflections on a diffraction pattern
due to disorientation.
(ii) The disorientation along a layer line is approximately
proportional to the distance from the meridian. The axes
of three helices a, b and c are shorn together v:ith-the
. disorientated layer lines (1=0,1,2,3) they produce.
(After Holmes and Barrington;Leigh, 1974)
j t i i i i i_i_i_i_i_i_|
6 5 4 3 2 1 0 1  2 3 4 5 6  
order of Bessel function
Figure 5.6 Calculated diffraction pattern from a discontinuous 
non-integral helix (after Wilson (1966))
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Barrington-Leigh, 1974; Stubbs, 1974).
The situation is further complicated in the case of DMA molecules 
possessing a non-integral number of residues per turn (e.g. C-DNA N = 23,
K = 3) as this results in splitting of the layer lines (Fig. 5.6). This 
causes an increase in the apparent angular half-width of reflections if the 
split layer lines are not resolved (Franklin and Klug, 1955). In DNA-drug 
fibres the regularity of the molecule is itself disturbed by the random 
attachment of drug molecules along the helix. At low drug content the 
complex can be considered as a more-or-less regular backbone structure with 
a non-integral number of residues per turn, so long as the drug molecule 
resembles a base-pair in its scattering characteristics. The X-ray beam 
will impinge on an area corresponding to many repeats of the helical 
complex, and the diffraction pattern will show new, average helix parameters. 
As the proportion of drug is raised the increased disorder results in a 
deterioration of the pattern and a consequent loss of readily interpretable 
information.
V,
\
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5.2 Previous X-ray Diffraction Studies
X-ray diffraction experiments on oriented DNA-drug fibres have been 
reported for the drugs proflavine (Leman, 1361; Neville and Davies, 1SC6), 
ethidium bromide (Fuller and Waring, 1364), daunonycin (Piyram i960,
Pi gram et al., 1972), adriamycin (Porunb, 1976)end sfceffLmycin (Al-Jubory, 
1978). The results of these studies have varied in their details but, in 
general, the binding of the drug to DNA resulted in a disordered pattern 
as seen by the diffuseness of the layer lines. The amount of disorder 
was seen to depend on the nature of the drug, the drug content within the 
fibre and the relative humidity. An increase in the observed pitch with 
increasing drug content, together with a retention of the 3,4^ meridional, 
was interpreted as indicating intercalative binding.
Neville and Davies (1966) reported a systematic examination of the 
diffraction patterns observed for DNA-acridine fibres. At high humidity 
the patterns revealed a significant increase in the pitch of the fibres 
compared to the pitch of B-DNA. This increase could arise from an 
unwinding of the helix either by intercalation or by an external binding 
mode. However, external binding models could not successfully explain 
the length increases found by a number of measurements on solutions of the 
complex (Luzzati et al., 1961; Cairns, 1962). Consequently, Neville and 
Davies proposed that the acridines bound to DNA primarily by intercalation, 
although some of it was in an externally bound state. A variation in the 
eauilibrium between these two binding modes would explain the observed 
change in layer line spacing as the relative humidity was changed.
A similar X-ray fibre diffraction study was performed on the interaction 
between daunomycin and DMA (Pigram, 1968; Pigram et al., 1972). These 
authors observed a pitch increase and a reduction in the intermolecular 
separation of adjacent DNA molecules. The observed changes in DNA 
parameters at 92% and 98% R.H., in combination with computer model building 
studies, supported an intercalation model. Experimental data suggested
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agreement with the earlier result for ethidium (Fuller and V/aring, J954), so 
that the DNA helix untwists locally by 12° in order to intercalate one 
daunomycin mole cule•
Porumb (1976) has reported a significant difference in the binding 
of the anthracyclines adriamycin and daunomycin to DNA as the humidity 
is lowered. This has direct relevance to the understanding of the 
difference in their biological activity. Both drugs are characterised 
by a marked antitumour activity, and from the chemotherapeutic point of 
view adriamycin appears to be more effective than daunomycin. In living 
cells, the presence of nucleoprotein and-enzyme systems complexed with DNA 
is likely to create an environment devoid of water, similar to the 
environment existing in fibres at low relative humidity. It appears that 
adriamycin is a more effective drug because of its ability to remain 
intercalated even under conditions of low humidity.
The interpretation of DNA-drug diffraction results is difficult 
because of the uncertainty of the unwinding caused by intercalation, and 
because the fraction of drugs intercalated at a given humidity is generally 
unknown. Controversy still surrounds the value for the unwinding angle. 
The value of 12° for etliidium (Fuller and V/aring, 1964) has been challenged 
and a value of 26° has been proposed (Wang, 1974). The chemical and 
enzymatic studies of Pulleyblank and Morgan (1975) have also predicted 
that the untwisting angle is between two and three times as high as the 
previously accepted value of 12°, and experiments using electron microscopy 
(Liu and Wang, 1975) and gel electrophoresis (Keller, 1975) have supported 
the 26° estimate. Tsai et al. (1977) have co-crystallised ethidium vath 
both the dinucleoside monophosphates adenosine (5' - 3') 5-iodouridylyl 
and guanosine (5* - 3') 5-iodocytidylyl, and have solved the crystal 
structures to atomic resolution. The phenyl and ethyl groups of the 
intercalated ethidium molecule lie in the narrow groove of the miniature 
double-helices, and there is an unwinding of the helices by 28°. It
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should be noted, however, that there is no evidence for the intercalative 
binding of ethidium to double-helical RNA. The fact that intercalation 
has been visualised in an RNA fragment (A (5' - 3') iodoU) may illustrate 
the limitation of studying the intercalative binding of drugs to nucleic 
acid duplexes by extrapolation from data obtained from binding to 
oligonucleotides. In principle, with DNA-drug patterns it should be 
possible to identify a peak on the equator, the position of which is 
independent of the DNA/drug ratio, from which the degree of untwisting at 
the intercalation site could be determined (Goodwin, 3.977). Unfortunately, 
such a peak would correspond to a Bessel function of very high order 
(n = 30 if the untwisting angle were 12°). Such peaks occur far out in 
reciprocal space and are not easily recorded.
Relaxation kinetic measurements (L.i and Crothers, 1959) show that even 
in solution, several percent of the bound proflavine is attached externally 
to DMA. The balance between intercalation and external binding is a 
delicate one, readily influenced by environmental conditions. The 
interpretation of X-ray results has been limited due to a lack of knowledge 
of the fraction of bound drug actually intercalated in a fibre, under given 
ionic and humidity conditions and for a certain drug loading in the fibre. 
Measurements of the dichroic ratio, taken in parallel with the X-ray 
diffraction measurements, can help to resolve this difficulty and the two 
sets of data will be discussed together in Chapter 7 with a view to 
clarifying this situation.
The question of the biological significance of intercalation remains 
open. The diverse biological activities which have been attributed to 
intercalative modes of binding may be due to differences in tlie stereo­
chemistry of intercalation for different drugs, and to differences in the 
equilibrium between intercalative and external binding.
\
5.3 The Program 'FI-XL:I'
The program 'FFILM' performs three basics - 
(i) It finds the centre of the diffraction pattern and scales the 
pattern. Diffraction from the aragonite powder (Section 
2.3,3,?.), with which each fibre had been sprayed, produces a 
ring centred on the centre of the pattern. If the corresponding 
spacing in real space is known, then the ring may be used to 
find the centre of the pattern and the specircien-to-film 
distance, D. The best; values of these quantities may be 
obtained by application of the formula
- = - si n { y 2 tan -) (b.3 )
where  ^is 1.541sR, the wavelength of the copper KQ radiation used 
in this work, F, is the radius of the ring and d is the corresponding 
distance in real space.
The program incorporates a subroutine 'CENTRE ' , written by Dr.
W.J. Pigram, which obtains the best values of the centre co­
ordinates and specimen-to-fiIn distance by using a least-squares 
minimisation algorithm.
(ii) It obtains the reciprocal space co-ordinates (and the corresponding 
real space values) for points in a diffraction pattern. The 
measured film co-ordinates (X, Y) of an elongated spot on the 
pattern are converted to (cylindrical) reciprocal space co-ordinates, 
using the relations
$
_______Y ____
A(D2 V X2 + Y2!^ (5.4)
e
0  0 / 2
2(1-A £ ) D ] 
(D2+X2) 2
2 r2 C + 5
(5.5)
(5.6)
where the quantitiesp  , i  and £ are defined in Fig. 5.1. The 
reciprocal of S is also given, except for points on the equator,
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since this value is usually equal, or proportional, to either 
the helix pitch or the translation per residue along the helix 
axis.
For B-DNA and complexes of DNA with an intercalated drug the 
packing of the helices usually conforms to a hexagonal pattern. 
In this case, the intermolccular separation, IMS, is given by
M S  =
2 1
S u o
(5.7)
where ^ is the value calculated for the strong (innermost) 
equatorial spot, talcen as the (1 1 0 ) reflection.
(iii)It calculates a value for the disorientation, of the molecules 
within the fibre.
Fox' spots remote from the meridian, Fraser ct al. (1976) have 
shown tlxat the following formula holds t/ell.
Q =
where Q =
2V2 
irp X
(A ct)2
+ 26" (5.3)
In 2
Aa = the angular« half-width of the spot on the photograph, 
taken ns the angular distance between the peak 
intensity point and a half-intensity point, 
p = the coherent particle length, which determines the 
sharpness of the layer linos in the ^-direction.
X = the X co-ordinate of the spot.
and  ^ = the half-angle of the gaussian disorientation
(defined in Section 6.3.1).
*i 2
The intercept of a plot of Q against ^  w i l 1  ^ive 2(5 .
The half-width of a reflection is measured from a microdensitometer 
trace tangential to the ai'c (Fig. 5.7). The program calculates the 
cox'responding angular half-width, Aa, given the pantograph ratio of the 
microdensitometer arm and the distance of the reflection from the centre of
(i) From an A-DNA pattern
(ii) From
Figure 5.7 Typical densitometer traces used to test the program
(see text for details)'FFILM'
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the pattern. The angular half-width in 3-dinensional reciprocal space, 
is output, along with values for Q and from which 5 may be 
obtained. A facility exists to input uncertainties in the microdensito­
meter half-widths and obtain corresponding uncertainties in Q.
The parameter p, determined from the gradient, will not have as much 
significance for a DNA-drug fibre as for a pure DNA fibre because the 
helices are irregular, but it should still give some idea of the distance 
over which a semblance of regularity persists. Its value would be 
expected to decrease as the proportion of drug in a fibre is increased. 
The value of <5 obtained will be an overestimate of the gaussian 
disorientation since other factors (such as the limited crystallinity of 
the fibre, lack of collimation of the X-ray beam and, in the case of a 
non-integral helix, layer line splitting) will have contributed to the 
arcing of the spots.
The program was tested on an A-DNA pattern supplied by Dr. C. Nave, 
and on a DIlA-daunomycin (M = 2.5) pattern supplied by Dr. W.J. Pigram.
The results are tabulated in Table 5.1.
TABLE 5,1
Disorientation Parameters from the Program ♦FFIL'i1
La La 6 ,P(X)
A-DNA (1) 3.6° 3.6° 3.1° 1000
(2) 3.6° 3.6°
°o•CO 500
DNA-daunomycin (1) 11.7° 11.5° 7.7° 91
(2)
/ *
11.2° 11.0° 8.4° 167
The readings marked (1) were obtained using a 2-dimensional travelling 
microscope to measure the reflection co-ordinates; those marked (2) 
employed a DMac digitiser. The good agreement for corresponding cases .
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indicates that both methods are equally reliable.
The large values obtained for the coherence length of A-DNA indicate 
that regularity persists over a considerable distance. The values 
themselves, hov/ever, are imprecise because the gradient of the graph of 
Q vs. *s so small that it is almost horizontal. Relatively small 
uncertainties in the densitometer half-widths result in large uncertainties 
in the slope, of the best-fitted lines, and hence in the value of p. For 
the DNA-daunomycin fibre at M =2.5 regularity seems to persist over 3 
to 5 base-pairs which is comparable to or slightly more than the distance 
between the dru^ if they had been bound .regularly.
The values of 5 are slightly lower than those for Aa and Ao, although 
they correlate well. The disorientation half-angle, 5, is expected to 
show this trend since the total arcing, described by the half-angles Aa and 
Aof will be due to other factors in addition to the disorientation of the 
helices. For the further work in this Chapter, the disorientation A has 
either been computed using measurements from a tangential microdensitometer 
trace, or it has been assigned a value equal to 70% of the value of Aa 
estimated geometrically from a diffraction photograph.
\\
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5.4 Aims of the Diffraction Study
The details of fibre making eire given in Section 2.2. All the fibres 
used in this study were made using the low ionic concentration buffer 
(Section 2.1). At this ionic, strength, a DNA fibre would normally 
undergo a transition from the B form to the A form at about 30?$ R.H.. For 
some of the discussion of the experimental results of this chapter, it 
will be more convenient to specify the bound drug content of a fibre by 
its base-pair/bound drug ratio, M, This is obtained by measuring both 
the UV and visible absorbances of the complex in solution and its 
corresponding supernatant after centrifugition. Subtraction of the 
values obtained will give the concentrations of bound drug and DNA in the 
gel, and hence in the fibre, assuming that all the drug molecules bound 
to the DNA in solution remain bound during sedimentation and the subsequent 
drying down of the gel to form a fibre. The ratio M is equivalent to the 
inverse of the binding ratio, r, which has been used exclusively up until 
this chapter as a measure of the proportion of bound drug. For each of 
the three drugs considered in this thesis, an extensive set of fibres 
(together with control DNA fibres) was prepared with M values in the range 
2.0 to 19.
The purpose of this study was to determine accurately the modified 
DNA helix parameters from the diffraction patterns of a series of fibres as 
a function of the drug content and the hydration of the complexes. These 
parameters indicate whether or not intercalatxve binding takes place, and, 
if so, to what extent. Since intercalation is a largely hydrophobic 
mechanism it was anticipated that the relative humidity would affect the 
amount of intercalatively bound drug. An estimate of the gaussian 
disorientation can he obtained from the arcing of the diffraction spots.
Apnlication of some of this information is reserved for Chapter 7, where it 
.is interpreted in conjunction with the diohroism and W.re fringe nee
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measurements. These latter measurements provide information on the 
orientation of the clrirj diromophores in the fibres, and may be used to 
estimate the proportions of interc .latively and externally bound druij 
molecules for a particular set of environmental conditions.
\
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5.5 Ethldlum Bro ini de 
5.5.1 Experimental Results
Typical X-ray diffraction patterns from the control DNA are shown
in Fig. 5,3. The pattern obtained at 75% R.H. is that of file crystalline
A form, and the pattern at 93% R.H. shows the semi-crystalline 3 form.
The quality of the patterns does not match the best of the previously
published DNA patterns (Langridge et al., 1960; Fuller et al,, 1965;
Fuller, 1961), but the previously published patterns were obtained from
fibres which were formed by dissolving DMA in a droplet of water between
two glass rods whereas the fibres used here were made by drying down a
centrifuged gel. The patterns in Fig, 5.8 are sufficient to show that the
control D M  is neither degraded nor denatured and that it is extensively
free from impurities. The quality of trio patterns depends on the
disoi'ientation within the fibre, and this is related to the conditions
under which the fibre was pulled. From the layer line spacings the helix
o 0pitch of the B form is calculated to be 33.8A at 92% R.H. and 34.2A at 98%
R.H,, and the equatorial reflections give intermolecular separations of
25.8$ and 26. 2$ respectively. The layer line spacing of the A pattern
corresponds to a pitch of 28.1A, and the spot positions agree with those of
Fuller (1961) indicating that the DMA crystals are monoclinic with unit
cell dimensions a = 22.24a, b = 40.62$, c (=Pitch) = 23.15$ and 3, the
oangle between the a and c axes, = 97.0 .
Typical X-ray diffraction photographs from DNA-ethidium fibres are 
shown in Figs. 5.9 and 5.10. Those taken at 92% R.H, are all of the 
semi-crystalline B type, as shown by the strong meridional reflections and 
the distinctive intensity distribution on the layer lines. The retention 
of the strong 3.4$ meridional at all M values indicates that the bound 
drug molecules must be attached such that the 3.4$ repeat distance along 
the helix axis is preserved. The layer lines become more diffuse for
(i) A conformation, 75% R.H.
(ii) B conformation, 98% R.H.
Fi re 5 ,8  X -ray diffraction patterns from a I'ri/V fibre (O.OLM MaCl)
- -llr0 X_r0y dlrrroCtlon P»tt«r™ fro™ »UUathldiu. fll.ro« ot
92X R.H. (O.OLM HnCl)
(i) H = 4.0
(ii) M = 5.5
( i i i )  M = S.O (iv) M = 19.0
Fi lire 5.10
.-.-ray d iffra ctio n  patterns from DNA-ethidium fib re s at
•H. (0.01 M HaCl)
(iii) M = 8.0, 92« R.H. ( i v )  M = 1 9 . 0 ,  92% R.H.
Fipure 5.11 X-rav diffraction patterns fron DKA-dimidium fibres
(0.01M I.'aCl)
-  102
fibres of larger drug content as expected from the increased disorder 
caused by binding, and reflections on tiie layer lines are not resolved as 
spots. Only the second layer line is resolvable in Fig. 5 ,9 (i) and (ij) 
The first layer line is never as clear as the second layer line in B-DIIA 
patterns, but as fibres of increasing drug content are considered the 
first layer line becomes more obscured by the equatorial streaks (ripr. 
5 .0(i), (1 1 ) and (iix)). Repeated measurements along the second layer lino 
produced an estimate of the pitch which agreed with estimates from the 
other three quadrants of the pattern to about t  2% for most fibres.
Measurements made on the patterns showed that, at 92% R.H., ethidium 
causes an increase in the helix pitch from the 33.a? value obtained with 
the control DMA fibres, and this increase is a monotonic function of the 
fractional drug content (Fig. 5 .1 2 ). The intermolecular separation 
appears to decrease slightly when ethidium is bound in moderate proportions, 
but at large drug binding ratios it increases again to about the value for 
the control DNA (Fig. 5.13).
At 75% R.H, (Fig. 5.10) fibres of high drug content (e.g. M - 4 and 
M — 5.5) show a vaguely 3-type pattern, whereas fibres containing onlv a 
small amount of ethidium (e.g. M = 19) exhibit an A-type pattern. Both 
Fig. 5.10(i) and (ii) show the very strong 3.4.? meridional, with that of 
Fig. 5 .1 0 (i) being arced to a large degree indicating poor orientation 
within the corresponding fibre. At intermediate values, sometimes an A 
and sometimes a B type pattern was obtained with different fibres of the 
same M value. In this range of M values, the variability in the conditions 
under which the fibre was made seems to be a greater determining factor es 
regards the conformation than does the actual drug proportion within the 
fibre. The A-type patterns all show a pitch of around 28.1?, the pitch 
of the control fibre at this humidity. The measured pitches for the 
B-type patterns appearing at 75% R.H. are larger than 28.1? and they 
increase over the range of M values as the drug content is increased. For
Figure 5.12 The pitch of DNA-ethidium fibres at 92% R.H. a function 
*
of the binding ratio, r. (0.01M NaCl)
Figure 5.33 The intermolecular separation, IMS, at 92% R.H. for
DNA-ethidium and DNA-dimidium fibres as a function of 
the binding ratio, r. (0.C1M NaCl)
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large M values (M = 4 and M = 5.5) the pitch has risen to around 3 3. 
comparable v/ith the pitch of B-DNA at 92% R.H. The B-type drug patterns 
at 75% R.H. would appear to result from binding to a low-pitch form of 
B-DNA, similar to that obtained by Porumb (1976). The exact mechanism 
by which the low-pitch conformation arises is not known. It may be 
regarded as a helix containing alternating regions of A and B type DNA 
resulting from an indecisive B to A transition in the fibre. Pigram 
(1968) obtained a diffraction pattern of mixed A and B character from a 
DNA-ethidium fibre (M = 12.5) at 92% R.H. The two phases could be clearly 
identified from the low angle diffraction spots.
5.5.2 Discussion of ResuJ ts
Fig. 5.12 shows a progressive increase in the pitch of the fibres at 
92% R.H. with increasing proportions of bound ethidium. The increase in 
pitch becomes more gradual at high drug contents, and appears to approach 
a limit of about 47& at M % 2.5 (i.e. r = 0.4). This is similar to the 
saturation binding level deduced from the spectroscopic measurements in 
Section 4.4.1, and could be due to an exclusion site effect.
An increase in helix pitch with increased drug binding is not absolute 
proof of interealative binding, since an external binding mechanism could 
be envisaged which would cause an unwinding of the helix. A larger 
unwinding angle per drug would be required to account for a certain increased 
pitch for an externally bound drug, than if the increase were due to 
intercalation. This is because intercalation increases the pitch by 
insertion of a drug molecule into the helix as well as by the consequent 
unwinding of the helix to relieve the tension in the sugar-phosphate backbone.
External binding of a large amount of drug would probably tend to 
increase the intermolecular separation of the hélices since the added 
volume of the drugs would tend toxkeep the helices well separated.
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Intercalation could successfully explain the observed reduction in 
intermolecular separation (Fig. 5.13), since intercalative drug molecules 
are inserted into the centre of the double helices and so there is less 
material to block the close approach of the helices. The unwinding of 
the helix by intercalation would result in the molecule becoming thinner, 
and hence in a reduced intermolecular spacing. However, the interpretation 
of the Ciiange in invermolecular separation with M is very difficult For 
instance, the externally bound drug molecules would be expected to cause 
considerable screening of the electrostatic repulsion between the DMA 
helices, thus allowing the helices to pack closer together.
Intercalative binding seems to be the only realistic way to explain all 
the observations, and account for the retention of the 3.4$ repeat alon- 
the helix axis. An intercalated chromophore would scatter X-rays in much 
the same way as a base-pair and since the ethidium chromophore is about 
3 .4$ thick the meridionial would be almost unaltered.
The relationship between the increased pitch, P. and the amount ofi n v
intercalated drug (of 3,4$ thickness) into a B-type structure is given 
(after Fuller, 1966) by -
int
P(1 + Fr) (5.9)
where P is the original pitch, before intercalation, F is the fraction of 
bound drug; which is intercalated, $ is the unwinding anJLe at the inter­
calation site and r is the binding ratio as previously defined (Section
2.3,1 (a)). This relationship is shown in Fig. 5,14 with P = 34$ for 
various unwinding angles in the range 6° and 36°, and F values of 0.5,
0 . 7  and 1 .0 .
A corresponding formula for the increased pitch due to external
binding P is given by ex»
\
Figure 5.14
/contd.
Figure 5.14 Variation of pitch with the binding ratio, r, and the
unwinding angle, , for intercalative binding (Equation 
,5 .9 ). The values of F are ‘narked on each graph.
\
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P = ----1____ext 1 (5.10)
360
where F* is the fraction of bound drug which is externally bound, ia 
the unending angle at the site of external binding and the other symbols 
are defined as for Equation 5.9. This equation is shown plotted in 
Fig. 5.15 with P = 34^ for various unwinding angles in the range 6° to 36° 
and F values of 0.7 and 1.0. A scheme whereby both binding modes
existed simultaneously would result in an equation for the increased pitch 
which v/ould be a combination of Equations 5.9 and 5.10.
We can consider which of these schemes is more likely to result in a 
pitch of ^47% at r % 0.4. If intercalation is considered, it is unlikely 
that all the drug in the fibre is intercalated since if F = 1 no unwinding 
would be required in Equation 5.9 to give the experimental pitch value. 
Stereochemically this is unreasonable; model building studies (Pigram,
1968) have shown that intercalation must-necessarily be accompanied by an 
unwinding of the helix. If an unwinding angle of 12° were assumed (as 
proposed by Fuller and Waring, 1964), then 67% of the drug in the fibre 
would need to‘be intercalated. If a higher unwinding is proposed, say 
26° (as suggested by Wang (1974)) then a smaller fraction of the drug is 
required to be intercalated - in this instance, 49%. Considering an 
external binding mode, even if all the drug in the fibre was bound 
externally, Equation 5.10 v/ould require an unwinding of 25 to account for 
the observed pitch of the fibres at high drug content. If all of the 
drug is not bound, higher unwinding angles would be required. For example 
if 70% of tlie drug in a fibre is externally bound then an unwinding of 36° 
would be required at each binding site. This latter value is unacceptably 
large since it would cause a very large disruption of the DMA helix, and 
even at fairly low drug content the diffraction patterns would lose their 
B-type character. Such a large unwinding angle cannot be accommodated readily 
into models of the DNA-drug structure (Pigram, 1968). It is difficult to
Figure 5.15 Variation of pitch with the binding ratio, r, and
unwinding angle, , for external binding (Equation 
(5.10)). Values for F' are marked on each graph.
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conceive of an external binding scheme that would result in unwinding 
angles as large as, say, 25° and it is unlikely that at 92% R.H. all the 
bound drug would attach externally to the DHA. It is much more probable 
that the observed unwinding is due to intercalation of a fraction of the 
bound drug, and that the remainder is bound externally without altering 
tlie DI'IA helix.
The experimental results do not fit closely, over the full ran^e of 
binding ratios, any of the theoretical plots of Fig. 5,14 but there are 
several other factors that would explain this. The results at low 
binding ratios cause only small changes in the pitch from the control value 
of 33.i$, and so they are difficult to determine accurately. At larger
drug content exclusion effects will become important and the drug will find 
it increasingly difficult to find suitable binding sites. Table 5.2 
shows the fraction of intercalutive binding, F, required to explain the 
measured pitch values if intercalation is assumed to cause unwindings of 
1 2 ° and 26° respectively.
The observed pitch measurements can be explained successfully either 
in terms of 9Oh of the drug binding intercalatevely with a 1 2° unwinding,
or in terms of about 65-70% of the drug binding intercalatively with a 26° 
unwinding. For unwinding angles between 12° and 26°, values for F between 
90% and 65-70% would account for the results. At large drug loadings, 
these figures drop to about 75% and about 55% respectively for unwinding 
angles of 12° and 26° due to the exclusion effect. The remainder of the 
drug is presumably bound by some external binding mechanism in such a way 
that it causes no unwinding of the helix. This mode is not evident in 
the spectresconic analysis of the complexes in solution, because presumably 
at full hydration only intercalation takes place. With the reduced 
h\tlqjtrric drive to intercalation at 92% R.H. in a fibre, some of the drug
slims out from its intercalation site and binds externally,
V
As the humidity is lowered the DNA-ethidium fibres adopt a conformation
TABLE 5.2
The Pitch of DNA-sthldiuni Fibres, P, at Various r 
Values, and the Fractions of Intercalatlvely Bound 
Drug Needed to Explain these Pitch Values 
According; to Equation (5.9)
p r F (if <t> = 12°) F (if <> = 25°)
33.8 0 - -
35.4 0.080 0.44 0.34
36.4 0.125 0.45 0.35
37.5 0.160 0.50 0.38
38.'7 0.166 0.63 0.43
39.5 0.182 0.67 0.50
42.5 0.200 0.91 0.67
43.6 0.220 0.92 0.68
45.0 0.260 0.83 0.65
46.0 0.318 0.78 0.57
46.5 0.356 0.72 0.53
Note; The values of F for r  4 , 0.16 are less reliable since the 
corresponding pitch values are close to the control DNA 
value.
\
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of lower helix pitch. Intercalation is known to stabilise the B-form 
of DMA (Bloomfield et al., 1974 - melting temperature measurements).
For fibres with a low proportion of drug (e.g. M - 19), it appears that 
all the intercalated drug slips out at 75" R.H. allowing the helix to 
adopt an A-typs conformation. The drug molecules, now either externally 
bound or free in the fibre, arc randomly orientated within the fibre and 
cause a degradation in the resolution of the pattern. At high drug 
content (M = 4 and M = 5.5) sufficient drug remains intercalated to 
stabilise a B-type pattern. The pitch of these patterns is around 33.5a 
indicating that these complexes do not represent an unwinding of the 
control B-DNA appearing at 9 2 % , but rather an unwinding of a lower pitch 
conformation of DMA which is similar to the B-conformation (Porumb, 1976; 
Goodwin, 1977). At intermediate values of II the situation is more 
complex, and regions of A-type and B-type DNA probably exist together within 
a particular fibre. For a particular value of M, the pitch at 92% R.H, 
is always greater than that obtained at 75" R.H., so that there is little 
doubt tliat intercalatively bound ethidium slips out of the helix as the 
humidity is lowered. It is not possible to assess the extent of this 
behaviour since patterns from the low-pitch B-type DBA, occurring at 75" 
R.H., have not been obtained by the'author.
The patterns are generally very similar to ethidium patterns of the 
same drug content that have been reported previously (Digram, 1968; Porumb, 
1976). The disorientation half-angle, <$, for all the patterns is between 
4° and 9°. There may be some correlation between the disorientation and 
the drug content, but it was difficult to recognise. Variations within 
the range 4° - 9° were observed with different fibres of the same M values, 
so it seems that the conditions operating whilst pulling an individual 
fibre are of prime importance. It is unlikely that variations in the
disorientation within this range would have much effect on the results for
\
the pitch and intermolecular separation, even if intercalation were to
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increase the disorientation to some extent by kinking the helices 
(Chanter 0). Although the disorientation measurements have not been used 
in this discussion, they will be of value when considering the dichroic 
ratio values in Chapter 7.
Y\
5.6 Dimidium Bromide
5.6.1 Experimental Results
The diffraction patterns obtained with dimidium arc very similar to 
those obtained with ethidium. A selection of them is shown in Fig. 5.11. 
The same features are present as with ethidium - in particular, the 
retention of the 3.4$ meridional and the reduction in layer line spacing* 
indicating an increase in pitch with increasing drug content. Generally, 
the patterns obtained were not as good as those obtained with ethidium, 
though most of the loss in detail may be attributed to a poorer 
orientation of the helices within the dimidium fibres (compare Fig.
5.1l(i), (iii) wttli Fig. 5.9(i), (ii) and (iii)). By analogy with 
ethidium, there is no doubt that dimidium binds intercalatively. The 
variation of pitch with drug content at 92% R.II. is shown in Fig. 5.16, 
and the values for intermolecular separation are shown in Fig. 5.13 
together with the results for ethidium. The values obtained for the 
intermolecular separation do not show clearly the drop in BIS at moderate 
r values, and the subsequent increase at large r values to the control 
value for B-DNA, that was observed with ethidium. Instead they are 
more-or-less randomly distributed within the range 24$ to 26$ for M values 
between 4 and 19.
5.6.2 Discussion of Results
The variation of helix pitch wdth drug content is identical to that 
for ethidium, at r values up to about 0.20. At higher r values, the 
pitch is slighter higher than for ethidium. It appears to approach a 
constant value of about 49$ at r = 0.4. This asymptotic behaviour at 
high drug content again probably reflects the exclusion character of the
binding. The higher observed pitch values at large r values suggest
\
that either exclusion effects are less prominent than with ethidium, or that
oFigure 5.16 The pitch of DNA-dimidium fibres at 92% R.H, as a function 
of^the binding ratio, r. (0.01M NaCl)
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the hydccjjWic drive toirards intercalation is greater. This is in 
agreement with the findings of Chapter 4, where it was noted that the 
binding site size was smaller for dimidium than ethidium. A pitch of 
4sS at r = 0.4 could be due to 76% of the drug in the fibre binding 
intercalatively with a 12° unwinding at each intercalation site. 
Alternatively, it could be accounted for by 55% binding with an unwinding 
of 25°. These values are slightly higher than the values derived for 
ethidium binding at high r by the same mechanisms (viz. 67% and 49% 
respectively), and are consistent with the smaller apparent binding site 
size of dimidium compered with ethidium (2.41 compared with 2.74 for 
binding in solution at this ionic concentration).
It is very likely that dimidium unwinds the helix by the same angle
as ethidium since they are very similar molecules. This would explain
the close similarity in Figs. 5.16 and 5.12 at low binding ratios. The
same unwinding angle can account for the results at large r, and the
higher pitch values can be explained in terms of higher fractions of
intercalative binding. l.'akelin and Waring (1974) estimate the unwinding
' o oangle for dimidium to be 11.5 , if a 12 unwinding is assumed for 
ethidium, from unwinding studies of supercoiled DNA in solution. They 
assumed that all the drug molecules, detected as bound by solvent 
partition, were actually intercalated. In the fibre state, there appears 
to be slightly more intercalatively bound dimidium than ethidium for a 
given (large) r value and this would result in the unwinding angle for 
dimidium appealing to be slightly lower still than for ethidium. The 
effect is small, however, and using the values just calculated ¿he 
unwinding of dimidium would appear to be about 10.6° if the value for 
ethidiun were 12°, and 23° if the ethidium value were 26°.
It is possible, however, that the stereochemistry of intercalation 
into DNA in solution is somewhat different than in the fibre state and 
care must be exercised in comparing the values of parameters obtained in
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the two states. Hogan et al., (1979) have proposed a model for the 
intercalation of ethidiura into a DMA molecule in solution in which the 
base-pairs are related to each other in a propellor-like fashion as 
suggested by Levitt (1978). In this scheme the complementary bases in 
DMA are not coplanar. Instead they are twisted with respect to each 
other by about 35° to give an average base twist of 17°. Hogan et al. 
(1979) suggest that an intercalated drug molecule unstanks the 5’ 
pyrimidines on either side of the binding site, and that the intercalated 
drug is tilted by an angle between 17° and 28° from being perpendicular 
to the helix axis. Consequently tlie lengthening of the helix would be 
2 ,7 ? i for each intercalated ethidium chromophore rather than 3.4a . This 
scheme could not describe the situation in a fibre, since the strong 
meridional intensity in X-ray fibre diffraction patterns indicates that 
the base-pairs are nearly perpendicular to the helix axis.
There appears to be little systematic variation in the intermolecular 
separation of the helices with changing dimidium content (Fig. 5.13).
The interraolecular separation is difficult to measure precisely on some of 
the patterns. The uncertainty due to the width of the equatorial spots 
in these patterns results in an error of up to i 1a , and there were 
less dimidium patterns measured than ethidium patterns. A large 
proportion of the uncertainty in the intermolecular separation may be 
ascribed to the variability in the drying-dom of complexes involving an 
ionic drug (unpublished results of this research group).
Y\
112 _
5.7 Prothidium Di(bromide)
5.7.1 Experimental Results
The X-ray patterns from DNA-prothidium fibres (Fig. 5.17)are noticeably 
poorer in quality than those from fibres containing eitner ethidium or 
dimidium at corresponding DNA/drug ratios (e.g. compare Fig. 5.17(ii) with 
Fig. 5.£(iv)). A 3.4& meridional v;as observed in all the patterns, 
indicating that at least some B-type character was retained even at 7 5%
R.H., For fibres of high drug content (U  v 8), the centres of the corresponds 
diffraction patterns were very vague and they were no resolvable layer 
lines. This is evidence of a very irregular structure, but the gross 
features of the patterns indicate that they are based on the B-confôrmation. 
The patterns display significantly more detail as the proportion of drug 
is reduced. A fibre with M = 12 is show in Fig. 5.17(i) and (ii). At 
75% R.H. it exhibits a mixture of A and B-type conformations, whilst at 
92% R.H. it shows the B-conformation only. Fibres of very low drug content 
(M ^ 17) often retained some A-type conformation at humidités of 92% and 
above.
Patterns taken from different prothidium fibres of the same drug content 
were often variable in quality. This is thought to be largely due to the 
variability in the drying down of the gel. • Some fibres may dry down 
quickly on the outside to form a skin containing a less orientated interior. 
Prothidium gels are very viscious, and the proportion of fibres which 
collapsed on drying down was much larger than with ethidium and dimidium.
On occasions, particular fibres did not display reversible conformational 
changes as the humidity was changed.
5.7,2 Discussion of Results
The generally poor resolution of the DNA-prothidium patterns compared 
with patterns using the other two drugs is an early indication that the
(i) M = 12.0, 75% R.H. (U) M « 12.0, 92% R.H.
Fi;ure 5.17 X-ray diffraction patterns from DtiA-prothldium fibres 
(0.01M Hr,Cl)
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D M  is more seriously interfered v/ith by binding prothidiun to the helix, 
although some of the loss in detail is due to the poor orientation of many 
of the prothidium fibres. Some loss of'resolution may be expected due to 
the greater size of prothidium resulting in a larger perturbation of the 
DMA, but the rather drastic worsening of the patterns compared with those 
from ethidium and dimidium suggests a much less regular character to the 
binding, or indeed a different mode of binding,than that operating v/ith 
the other two drugs. The patterns which showed a significant proportion 
of A-type diffraction showed less distinct reflections than obtained in 
the control A-DNA patterns at singles corresponding to distances in real 
space of 15? and above. This indicates a limited crystallinity within the 
DMA-drug structure, probably due to an increase in screw disorder as more 
drug is bound. There is very little detail remaining in these patterns 
at 3 - 10? resolution, indicating a severe loss of regularity in the 
molecules at the nucleotide level.
The B-type patterns all give rise to pitch values less than or about 
34? at 7 5 % K.H. and about 34?. at 92% R.H., which indicates no unwinding of 
the helix compared with the control B-DNA pattern. Porumb (1976) has 
obtained B-type patterns with a pitch less than 34? using daunonycin and 
adriamycin at humidities around 83£RJi. This is consistent with the belief 
that low-pitch B-type DMA conformations may be'stabilised at low humidities. 
The author has not obtained any low-pitch B-type DMA patterns using the 
control DNA fibres, v/ith which to compare the DNA-prothidium patterns. 
However, the appearance of low-pitch D M  seems to require a rather delicate 
balance of ionic and humidity conditions (Porumb, 1976).
The intermolecular separation measured from the B-type patterns ✓
increases by 2-3? as prothidium is bound up to M = 12, after which it is 
difficult to resolve the B equatorial spot. The increase indicates that 
binding by prothidium may result in a builder structure, and this could be 
accounted for by an external mode 'of binding - either along a strand of the
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double helix, or across from one strand to the next. Both of these 
binding schemes could occur to binding levels greater than one drug for 
every two base-pairs (c.f. the spectroscopic results of Section 4.4.3).
If both of these binding mechanisms were operating simultaneously a 
substantial degradation in the regularity of the structure, as revealed by 
X—ray diffraction, would result even at much lower binding levels. This 
is because the electron density of the drug, in an external binding mode, 
is at a radius equal to or greater than that of the sugar-phosphate backbone. 
The most reasonable interpretation of the B-type drug patterns is that 
prothidium binds to DMA by a mechanism that does not involve a substantial 
pitch increase, and this precludes intercalation as the major binding mode. 
The increased intermolecular separation at high levels of binding suggests 
that the mode of binding is an external attachment to the su^r-phosphate 
backbone *
All the vaguely A-type patterns exhibit a pitch close to 28.lR, the 
pitch of the control A-DNA fibre, irrespective of the humidity at which the 
patterns were taken. Some patterns in which there was a substantial 
proportion of B-type conformation gave a slightly higher pitch value than 
this, but this was probably due to the interference between the two 
simultaneously present patterns malting it difficult to measure the layer 
lines of the A conformation accurately. It is improbable that intercalation 
would occur with the A-like conformation since it was not found to occur in 
the B-like patterns, in which the DMA offers a stereochemically more 
favourable conformation. The positions of the equatorial spots on an 
A-DNA pattern provide information on the size of the lattice parameters a 
and b, and may be used to describe the separation of the helices analogous 
to the intermolecular separation used in discussing B-type patterns. Only 
one equatorial spot could be identified on the DNA-prothidium mixed A/b
patterns' as arising from the A-lih-e conformation. Measurement of it
Y-
indicated that there was no significant change in its position compared with
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the corresponding reflection in A-DM. The observation that an A-type 
character may persist even when the humidity is raised to 92% R.H., may be 
due to drug binding across the strands holding them rigidly in their 
A-conformation and resisting a conformational change to the B-type structure.
Wakelin and Waring (1974) have reported that prothidium uncoils closed 
circular DNA, indicating that its binding unwinds the helix. However, 
their results have not been quoted in detail so it is not possible to assess 
the magnitude of this effect. The X-ray diffraction results quoted here 
rule out the possibility of substantial intercalation in the fibre stat«. 
Differences in the D M  structure in solution compared with its structure 
in the fibre state would undoubtedly modify the binding schemes present in 
the two forms, and may account for the apparent change in the binding 
priorities. Neville and Davies (1966) have reported that in order to 
investigate the diffraction patterns of DNA-acridine fibres at liigh 
hydrations, it was insufficient simply to raise the humidity in the X-ray 
camera to 100% R.H.; the fibres had to be actually wetted. (This was in 
contrast to NaDM fibres at 100% R.H., which swelled continuously without 
coming into direct contact with liquid water). They found that the 
wetting could be accompanied by exposing the fibres to a mist of water, 
and that the degree of hydration obtained depended on the time for which 
the fibre was exposed. If these considerations apply to prothidium, it 
is likely that the conformation of the DNA before binding is substantially 
different in the fibre state at 92% R.H, than it would be in solution, so 
that different binding mechanisms may operate in the two cases. It is 
possible that prothidium might intercalate in a fihre of very high humidity, 
but will not intercalate at 92% R.H. — a similar behaviour to the acridines
The study of the interaction of prothidium with D M  is generally 
rendered very difficult because of its high binding affinity (Section 4.4.3) 
and the multiplity of possible binding modes (Chapter 8). The binding 
constant of doubly charged drugs binding electrostatically is strongly
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dependent on the ionic concentration. Duane (1972) and Record et al. 
(1976) have shown that a straight line is obtained when the logaritlim of 
the binding constant is plotted against the logarithm of the ionic 
concentration. According to Record et al. (1976) the slope of this line 
is m»ip, where m' is the number of ion pairs formed in the interaction and 
^ is a parameter equal to 0.S3 for double-stranded DMA. Local variations
in the ionic concentration within a DM-prothidium fibre will greatly 
affect the association constants of the drug for electrostatic attachment 
to DMA, and would therefore affect the delicate balance between the bindin 
modes in operation. This may be part of the reason for the greater 
variability in the prothidium patterns, for a particular drug content and 
humidity, than was observed with the singly-charged dimidiun and ethidiun.
-  117 -
5 . 8  Summary
The results of this chapter are best explained by intercalative 
mechanisms being the major binding mode to DNA for both dimidium and 
ethidium. It is not possible to specify the unwinding angle caused by 
intercalation because the fraction of bound drug actually intercalated is 
not known. The results are consistent with unwinding angles in the 
range 1 2 to 26 , if the corresponding fractions of intercalated drug are 
between about 90% and 70% respectively. No evidence of prothidium 
intercalating into DNA has been obtained. Some unwinding of the helix 
at 7 5 % R.Ii. by an external binding mode cannot be precluded but since 
there is usually some B-type structure present as well it is more likely 
that the small measured pitch increase above 2 8 % is due to interference 
with the B-pattern. The doubly'charged prothidium appears to bind so 
strongly either along the phosphate chain or between the two chains, that 
it is reluctant to leave this site and slip into an intercalation position 
even at high humidity. The optical data presented in Chapter 7 will be 
analysed with a view to elucidating the orientation of the bound drug 
molecules at their binding sites, and model-building studies in Chapter 8 
will attempt to explain the differences in the binding mechanisms amongst 
these phenanthridines in terms of their structural features.
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CHAPTER 6
Linear Dichroism and Birefringence - 
A Theoretical Treatment
6.1 • Linear Dichroism
The absorption of visible light by a DNA-drug fibre depends on the
*
nature of the visible absorption bands of the drug, and on the changes in 
these induced by binding to DNA. The DNA base-pairs do not absorb in the 
visible region of the spectrum. The visible absorption bands of the 
drug chromophores are due to ir - ir* transitions (Ingraham and Johansen, 
1969; Giacomoni and Le Bret, 1973) which take place within the plane of 
the drug.
The phenomenon of linear dichroism is the result of the preferential 
absorption of light plane-polarised in a particular direction. As 
mentioned in Chapter 2, the dichroic ratio, D, can be defined as
D = f t  <6,l)
where A± , A ft are the absorbances for light polarised perpendicular and
parallel (respectively) to the fibre axis. The absorption of polarised
light depends on the square of the scalar product of the transition
moment vector of the chromophore and the electric field vector of the
propagating light. Therefore by making absorbance measurements with
light polarised perpendicular and then parallel to the fibre axis some
information will be obtained regarding the orientation of the drug
chromophores. For a fibre in which the drugs are bound such that the
plane of the drug chromophore is perpendicular to the DNA helix axis and
in which the DNA molecules are aligned along the fibre axis, A^ will be
larger than A^ and the dichroic ratio will be greater than unity.
The measured dichroic ratio will reflect the anisotropy of the drug
V #
and all "the factors which affect the inclination of the drug chromophore
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to the fibre axis. These will include the amount of free (randomly 
oriented) drug in the fibre, the amounts of intercalated and externally 
bound drug and their respective inclinations to the helix axis, and the 
distribution of the helix orientations about the fibre axis.
W
\
6.2 Dichroism of Perfectly Orienta t M  Fibres
Expressions for the diohroio ratio can be obtained either in terns of 
a, the ansie between the transition dipole moment and the plane 
perpendicular to the helix axis or 0, the angle between the plane of the 
drug and the plane perpendicular to the helix axis. For an arbltary 
orientation of the transition dipole within the chronopher., a will ^  
smaller than 6 (Fig. 6.1).
Using the notation of Fig. 6.2 and considering light incident along 
the x-diraction,
D = <(EJ- COS ^)2 » '
<E n cos (90-a)2>
where E^, E(, are the magnitudes of the electric field vector for the 
appropriate directions, and "< >« denotes an average taken over the 
azimuthal angle, For light polarised at 45° to the fibre axis (assumed 
coincident with the helix axes), E„ and therefore
D » —V
- <c°s2
“ 2 <sin a>
.2
I f  2 2cos a cos <{. d (J>
o
. . 2ir " “
gj- / sin2 a d <f> 
o
= % cot2 a (6.2)
This relationship, for a perfectly orientated fibre, is illustrated 
in Fig. 6.3. D varies from zero to infinity, and has a value of unity 
when a - 35°16'. This result is in agreement with that of Fraser (1953), 
although he worked in terms of the complement of the angle a .
The relationship between 9 and a.
The arrowed line indicates the direction of the 
transition dipole moment
Fibre axis
Definition of the angles used in Section 6.2
Fig. 6.3 The variation of the dichroic ratio, D, with the tilt of
the transition dipole moment, a (Equation 6.2)
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The disadvantage of this treatment is that information regarding the 
directions of transition dipole moments in drug molecules is very limited. 
In the absence of information regarding its precise orientation, the 
transition dipole moment may be considered as pointing isotropically 
within the drug chromophore. It will be seen below tnat for small angles 
of tilt of the chromophore this is a reasonable approximation.
Using the notation of Fig. 6.4,
n KD - r—A ï .
< (Er cos - 90))^»
<(E, cos (90 - ntt))2>
< sin 
. 2< s m  0„>
since Ex = E #
For a perfectly orientated fibre, = 0 , and since cos 0X = sin 6sin <j>
then
2ir
~  J ( 1 - sin2 0 sin ) d{>
o___________________ __
2it
/ sin26 d<f>
o
“ COt2 * * 4 (6.3)
This is equivalent to both the expression produced by Seeds (19 5 1), 
«ho considered the dipole as being equivalent to two mutually perpendicular 
dipoles at any arbitrary orientation within the plane of the drug, and to
the computer-simulated studies of Porumb (1976).
The variation of D with 0 is stown in Fig. 6.5. The dichroic ratio 
varies from 0.5 to infinity, and takes the value unity when 6 = 54044,#
The dichroic ratio does not fall to aero when 0 = 90°, because (unlike the 
situation when a „ 90°) this does not correspond to zero absorbance in a 
plane perpendicular to the helix axis. The transition dipole is 
considered as isotropic in the plane of the chromophore in this case so 
that even when the chromophore is aligned parallel to the helix axis a
Fig. 6.4 A trigonometric system attached to a DNA fibre
Fip. 6.5 The Variation of tho dichroic ratio, D, v;ith tho
Chromophore tilt, 0 (Equation (6.3))
D
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component of the isotropic dipole will contribute to absorption 
perpendicular to this direction. The values for D predicted on the basis 
of these two models are similar for small angles. In practice Equation 
(6.2) is less useful than Equation (6.3) since there is normally little 
information on the direction of the transition dipole. The angle 0, as 
used in Equation (6.3), can be taken as equal to the base tilt for 
intercalative binding and is readily obtained from X-ray diffraction 
patterns with reasonable accuracy. Equations (6.2) and (6.3) are 
identical if = 45 (Fig, 6,2), This reflects the situation that 
the isotropic dipole moment can be considered as two mutually perpendicular 
dipoles, or as their resultant (viz. one dipole at 45° to them).
\\V
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6.3 Disorientated Fibres
A fibre can be considered as being comprised of a fraction of the 
DNA helices completely aligned to the fibre axis, with the remainder 
being randomly orientated (Fraser, 1953 and 1955; Pilot and Brahms, 1972 
and 1973). A more realistic model is that adopted by Porumb (1976), in 
which the disorientation within the fibre is assumed to take the form of 
a gaussian spread of the helix axes about the fibre axis. The probability 
of a DNA helix lying along the surface of a ccne of semi-angle 3 is 
proportional to exp ( X j ) ,  „here t is the half-width of the distribution.
A computer program (porumb and Slade, 1976a, 1976b and 1976c) was 
used to simulate this situation and gave a series of plots (Fig. 6.6 and 
6.7) of the dichroic ratio against either 6 or a for different 
disorientation half-widths, 5.
It is possible, however, to adopt the same model for the d? ^ orientation 
and obtain analytical expressions for the dichroic ratio, rather than 
resorting to the computer simulation techniques of Porumb and Slade (1976a) 
or the numerical integration methods of Libertini at al. (1974). These
expressions, and the methods used to obtain them, are described in the 
following sections.
6.3.1 . The Dichroic Ratio in Terms of the Chromophore Tilt
It is convenient to use the formalism of Van et al. (1974) and
introduce three Cartesian frames of reference - the fibre axes (X , Y Z )1 1 1 ^
the DNA molecular helix axes (x,, y2 , z2) and axes attached to the bound 
drug (x, y, z).
The transformation from a given Cartesian system to another can be 
effected by means of three successive rotations performed in a specific 
sequence. These angles of rotation are called the Eulerian angles, 6,
$ and 4», and are defined in Figi 6.8 using the notation* of Goldstein (1964).
* Unfortunately there is no unanimity-in the literature reaardin«» the 
definition of Eulerian angles; the definition adopted here is one of 
several.
disorientation half-widths S, (The computer simulation
results of Porumb, 197G)
The dichroic ra tio , D, as a function of 9 for various
Fig. 6.7 Tho dichroic ratio, D, as*a function of a for various 
disorientation half-widths, <5. (The computer simulation
Fig. 6.8 Eulerian angles: a transformation from a given co-ordinate
system to another is carried out by means of three successive 
rotations, performed in the sequence (i), (ii), (iii). A 
position expressed in the x, y, z frame is ultimately 
expressed in the x’, y', z' frame.
\\
Contd
Fig. 6,8. (contd.)
,1K fv\
y' = L(i{>) n'
z ' I 'V
where L(\'') = cos '!> sin ^ (A
. -sin ^ cos <1» 0
v ° 0 V
describes a rotation about the t ' axis
Hence the complete transformation is given by M M
y' = L y
[ * ) zl
Where L = LCtJì ) L(0 ) L(<^ )
= / cosifi cosi|i -cos0 sinij) siruj>? cosip sin$ + cos0 cos<{i sin^ sirty sin© 
'-sinty cos<J> -cos9 sin<{> cosify-sin|> sin<t> + cos0 cos<|) cos\{^  cosi|» sino 
sin9 sin(> -sin© cosi|> - cos0
/
/
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Matrix transformations exist between these systems such that
lx' (x 2) (h\
y ii y2 L2L1 s
z ( 2 \ h j
and [ V r\
Y1 - L“1 L“1 " L1 L2 y
U J
(6.5)
( 6.6)
The co-ordinates of a drug molecule relative to the DNA helix are given by
lx (X2\
y -  L2 y2
\z k /
where Lz is given by
LW2) L(62) L(+2) (6.7)
and the full form of the matrix can be seen from Inspection of Equation 
(6.4), attached to rig. 6.8. The tilt of the drug relative to the plane 
perpendicular to the DNA helix axis is given by the rotation of the 
drug about the DNA helix axis is given by *2 and the tv,1st of the drug 
about its own axis is specified by if»2 (Fig. 6.9),
Similarly, the transformation from the DNA helix to the fibre co­
ordinate system is accounted for by a matrix which takes the same form 
as L2 with the appropriate changes in subscripts. The appropriate 
Eulerian angles are shown in Fig. 6.10 where G]L is the tilt of the DNA 
helix axis relative to the fibre axis (and will later be referred to in 
terms of the disorientation of the fibre), ^  describes the rotation of 
the DNA axis about the fibre axis and ^  specifies the twist or rotation 
about the DNA helix axis. The rotation ^  can be set to zero since it 
has already been accounted for by ^  from the previous transformation; thus
w
Fig. 6.9 Angles involved in the drug to DMA1 transformation
D N A  . h e l i x
Fig. 6.10 Angles involved in the DNA to fibre transformation
\\  ' \ •
- 125 -
Ll =
cos ^  -cos sin ^  sin 0^  sin $
sin <j>\ cos ®jl cos ^  -sin 01 cos $ (6.8)
\
sin 0, cos A
If the transition dipole moment in the co-ordinate system of the drug
molecule is assigned an arbitrary direction 
ordinate system it will be given by
T =
» then in the fibre co-
(6.9)
For parallel* light incident along the direction (Fig. 6.10) and 
polarised at 45° to the and Z^ axes (so that Ex » Eu), the cosines of 
the angles between T and the and Z directions will be given by T. y
Aand T. Zj, and the dichroic ratio will be given by
D ( 6. 10)
<(T. Z1)2>
where "< >" denotes that the expressions are integrated over <j>2 (from 0 
to 2ir) and 4>2 (from 0 to it) to provide averaging at the molecular level, 
and over ^  (from 0 to 2tt) to give averaging at the fibre level.
The resulting expression (Appendix AI) for a fibre is 
. _ I, 2 cos20 - SP
D “ ^ + 2 Sin^e + SP ' (6.11)
where P = 3  cos^9 - 1 (0 is the drug tilt relative to the DNA
molecule, previously subscripted asg^) 
and S is a disorientation parameter given by
S(0X) = ^in >, where 0^  ^is the tilt of the DNA helix
axis relative to the fibre axis.
Explicitly, /
* In practice the light will not be exactly parallel, but the effect of 
divergence is small even at quite large numerical apertures. Seeds 
(195ll has shown that there would be an increase in absorbance of about 
0.01 0D unit when a specimen of unit optical density is measured 
through an objective of 0.3 numerical aperture.
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n
2 2n
s ( e x ) =
/  /
• 2n sin 01. N( <^ ) sin ^  d<^ dQ^
o_
u_
2
/
o
o_________________________
2tt
/ N(01,<j)1) sin ^  d |
o
( 6.12)
where N(0 is the density of states function describing the
distribution of DNA helices about the fibre axis (Fig. 6.11), sin 6^  
results from the area element in spherical polar co-ordinates and the 
denominator normalises the expression.
A physicalVreasonable model for the distribution of the DNA helices 
about the fibre axis is to assume that a gaussian distribution of 
orientations exists in any cross-section of the sample (Libertini et al., 
1974 ), thus
NO <^ ) expf -eíl
i l J.
where 6 is the half-width of the distribution, 
states function leads to a probability function
(6.13)
This density of
. 2 ir
= Itt / N 9^i* V  sin 0i d
o
which is shovm in Fig. 6.12. )
When 01 is small, so that sin 01 * 0 ^  the disorientation parameter 
2S reduces simply to 2<$ ; but for the general case, integration of Equation 
(6.12) gives
where
S
*<7Í>
F($)
(6.14)
o
Fig. 6.11 Illustrating the density of states function N(e^ ) and
the probability function P(6^)
N(e^r<{ii), "the density of states function, is proportional to the 
number of DNA helices pointing into an area bounded by 0^ and 6^ + d©.^ 
and 4»^ and 4>^ + d4>^ . It is assumed to have a gaussian form,
’N(6,, ♦,) OC expf -'0,
U « 2
where « is the half-width>0f the function, and rotational symmetry is 
assumed to exist so that the function is independent of the azimuthal 
angle 4>^ . .
As e1 increases the area bounded by and 0;L + d0 increases, 
and the fraction of DNA helices within this area is given' by the 
probability function where
. . 2tr '
PiV  = 2» / sin e,. dejL ’ .
Os
The probability function is shown plotted against 0;l in Fig. 6.12.
<
different disorientation half-widths, 6(after Libcrtini ct al,
' . . ' 1974)
The areas under each curve are 
equal. At small values of i 
the distribution becomes 
^  gaussian, but as & increases the 
sin 0, term begins to dominate 
until at i + “ the distribution 
becomes purely sinusoidal.
Fig. 6.12 (i) The probability function as a function of 8^ for
*i The maximum of the curve shifts 
from 0^ = 0 °  to 0^ = 90° as 5 
is increased from near zero 
(complete orientation) to infinity 
(complete disorientation). This 
does not mean that there is 
preferential alignment at 90°, 
but rather that the area element 
is increasing from the pole to 
the equator. At 0.^ = 0° the 
probability goes to zero (because 
Cf the sine term) since the area • 
element at the pole approaches 
zero. This does not cause any 
difficulties since contributions 
are always summed over a'finite angle 0( during the integration.
(ii) Percentage of DMA helices lying within a cone of half-angle 8^  
as a function of 6 (after Libertini et al., 1974)
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and is known as Dawson's integral (Appendix All). This integral 
can be reduced to a simple series (Appendix AIII),
where r is the Gamma function. This summation converges rapidly and can 
be calculated easily using a simple subroutine in a computer program. 
Summation to one hundred terms was found to give a ->3sult indistinguishable 
from summing to five hundred terms.
It is instructive to consider the expressions for the dichroic ratio,. 
D, for several special cases -
(i) For a fibre which is perfectly orientated, S = 0 and 
Equation (6.11) reduces to Equation (6.3) derived for 
a completely orientated specimen.
(ii) For a completely disorientated fibre NO^, $^) = 1, i.e. all
Equation (6.11) gives a value for the dichroic ratio 
of unity i.e. a completely disorientated fibre shows 
no preference for absorption in a particular direction, 
as is expected.
(iii)There is a unique value of the drug tilt for which the 
dichroic ratio is always equal to unity, irrespective 
of the value of the disorientation parameter S. This 
value is 54°44' (i.e. cos"1^  = tan*”^  /2). This is 
in agreement with the computer simulated results 
obtained for a fibre by Porumb (1976).
-1)^1 Z2r-1
r(r + X)
all orientations of the DNA helices within the specimen 
are equally probable. Integrating Equation (6.12) 
(Appendix AIV) gives a value for the disorientation 
parameter S of - . Substituting this value into
v
(iv) The dichroic ratio for zero base tilt has the simple
form D » § - fc (6.(6.15)
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Corresponding results for orientated films are given in Append!:: B.
In general, for the same S value, the dichroic ratios of films will always 
be smaller than those for fibres, though for a given half-width <S the values 
for a film will be larger than those for a fibre (Figs. B.5, 6.13). This
results from the different relationships between S and 6 in the two cases.
6‘3 *2 The Dichroic Ratio in Terms of the Transition Dipole Tilt
The dichroic ratio may be expressed in terms of the transition dipole 
tilt,a , instead of the drug tilt, 0. A similar treatment to that 
described in Section 6.3.1 leads to the expression
n _ cos2 a - ^ l
2sin^+ SP« (6#16)
2where P * = 3 cos a - 2
and S has the same significance as before. This expression has a 
similar form to Equation (6.11) which gives D in terms of 6, and it agrees 
■with a less explicitly defined expression produced by Zbinden (1964) if 
appropriate notational changes are made.
Again, it is instructive to consider several special cases -
(i) For a perfectly orientated fibre, S =0 and Equation (6.16) 
reduces to Equation (6.2) derived less generally.
(ii) For a completely disorientated fibre, S takes the value 
% and the expression reduces to give a value for the 
dichroic ratio of unity, as expected.
(iii) Thex*e is a unique value of the transition dipole tilt 
angle for which D=1 for any disorientation. This 
value is" 35°16' (i.e. cos”* s sin“* /%) , in 
agreement with the computer simulated results of 
Porumb (1976).
(iv) The values of D for zero tilt (a = o )  are given by
' \
Fig. 6.13 The variation of the dichroic ratio, D, of a fibre v/ith
the tilt of the drug Chromophore 0, for various valuer 
of 5 (Equation (6.11))
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D = h - %• This is identica.1. to Equation (6.15),D
which is as it should be. V/hen the drug tilt, 0, 
is non-zero the value of a falls between zero and 
0; but when 0 takes the value zero, a must also drop 
to zero. Thus the cases when 0 = 0  and a = 0 are 
physically the same.
It should be stressed that the cases when “ = 90° 
and 0 = 90° are not equivalent. In the former case, 
all the transition dipoles are constrained to point 
along the helix case and none point perpendicular to 
it. In this case, for a perfectly orientated fibre, 
the dichroic ratio must fall to zero. In the latter 
situation, the transition dipoles are not constrained 
to point in a certain direction within the plane of 
the drug, and although the drug is aligned parallel 
to the helix axis the dipoles may contribute to 
absorption in a direction perpendicular to it. For 
a perfectly orientated fibre, this results in the 
dichroic ratio dropping to 0.5, and not to zero.
In most cases of interest in this study, the drug is 
expected to be constrained roughly perpendicular to 
the helix axis so that 0 and a will be small, and 
the values for D using either Equation (6.11) or 
(6.16) will be similar.
g 3^3 Comparison of the Previous Treatments
The fact that both equations (6.11) and (6.16) reduce to give the 
expected values of D under a number of simplified circumstances (Table 6.2), 
and that they are both identical^if ^ = 45° (the situation previously 
discussed in Section 6.2) is a strong indication that they are correct.
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The expressions for D are shown plotted as a function of 0 and a for 
various disorientation half-widths <5, in Fig. 6.13 and Fig. 6.14 
respectively. Comparison with the computer simulated'plots of Porumb 
(1976), reproduced in Figs. 6.6 and 6.7, shows that both sets of curves 
are similar but that the values of D currently proposed are generally less 
than those predicted by Porumb at the same angles of tilt (0 or a). The 
differences are only very slight for small gaussian half-widths (5 $ 10°) 
and for large half-vddths (6 5 35°), but are appreciable (i.e. the 
differences in D approach 10%) for intermediate values of the half-width. 
This probably reflects the method by which Porumb performed his cylindrical 
averaging. Since he did not have an analytic solution to the problem, 
the absorbances were summed for values of <j>2 (in the range 0 to 2it), $,
(0 to 2it) and 6^(0 to it) sampled at finite intervals. The final values 
for D are sensitive to the size of these intervals.
\\

- 131 -
6.4 Birefringence
Birefringent (or doubly refracting) materials behave anisotropically 
to the passage of light through them. Light entering a falrefringent 
material can be regarded as being comprised of two components, each 
polarised at right angles to the other. The two components travel through 
the material with different velocities (i.e. they have different refractive 
indices), and usually in different directions. In tetragonal, trigonal 
and hexagonal crystals there is one direction of propagation in which 
double refraction does not occur. This direction, whicn is the same as 
that of the c crystallographic axis, is 'called the optic axis, and such 
crystals are termed uniaxial. Crystals of the orthorhombic, monoclinic 
and triclinic systems possess two optic axes and are called biaxial. In 
a DNA fibre, the crystallites comprising it are orientated about the fibre 
axis. Only one optic axis (corresponding to the fibre axis) exists 
because the azimuthal orientation of the crystallites is random and, even 
if the crystallites themselves were biaxial, the effect would be averaged 
out in all directions except the fibre axis.
Uniaxial materials have two sets of wave surfaces (Fig. 6.15), One 
set is a series of spheres representing the behaviour of the component 
(called the ordinary ray) which always travels with the same speed in all 
directions, and the other set (for the extraordinary ray) is comprised of 
ellipsoids of rotation indicating that the speed varies with direction.
The axis of rotation of the ellipsoid is the optic axis, and in this 
direction light travels with a single velocity. The ellipsoid may lie 
inside or outside the sphere'.
For a given direction of propagation the difference in speed of the 
two components is given by the difference in radius of the sphere and 
ellipsoid. The refractive indices are inversely proportional to these 
radii, and their difference alsoxincreases with the separation of the two
(¡¡)
%
(i)
Figure 6.15. Wave surfaces of (i) a positive and (ii) a negative 
uniaxial material. .
Figure 6.16. A negative uniaxial crystal, showing the components ' 
of E and k.
\\
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surfaces. The Pointing vectors k for rays of light travelling along and 
perpendicular to the optic axis are shown in Fig. 6.15 for a negative 
unia;dal crystal. The associated electric field oscillate in planes: 
perpendicular to these vectors and are shown marked E r and E . The 
"fast" direction is associated with the condition where the ray is 
travelling fastest (i.e. it is experiencing the smallest refractive index); 
but it lofers to the direction of the associated electric field and not to 
the direction in which the ray is travelling. The "slow" direction is 
perpendicular to the "fast" direction.
Thus in Fig. 6.16, k^is larger than k # so that the direction of 
its associated electric field E # (vis. along the optic axis) is called the 
"fast" axis, and the refractive index in that direction, n , is smaller 
than that for the perpendicular direction, n
The retardation, V ,  of the two rays relative to each other is 
r = (ny - nA)t (6.17)
where t is the thickness of the fibre. The difference » i ” njL»
is known as the birefringence,A n, and so
r =  (6.18)‘
For a negative uniaxial crystal, such as calcite, the birefringence 
is less than zero; and for a positive uniaxial crystal, such as quartz, 
it is greater than zero.
6.4.1 The Physical Basis of Birefringence
During the passage of light through a medium, the oscillating electric 
field distorts the electron clouds within the constituent atoms or 
molecules. This distortion is known as polarisation. The (electron)
* polarisability relates the induced dipole moment, which is a measure of 
the charge separation, to the electric field causing it. At a given
frequency
p = cxEl \\ (6.19)
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where p is an induced dipole moment,a is the polarisability and 
is the local electric field.
The continual reversal of the direction of polarisation in a medium 
through which light is passing results in the atoms themselves acting as 
radiators and emitting secondary waves. These waves are slightly retarded 
with respect to those of the incident light, and it is the interference 
between these two sets of waves that brings about the reduction in the 
velocity of light in the medium. The greater the polarisability, the 
greater is the amplitude of the secondary waves and the more the velocity 
is reduced (i.e. a larger refractive index).
E le c tro n ic  p o la r is a b i l i t y  and r e fr a c t iv e  index are r e la te d  by means 
o f  the L orentz-Lorentz equation*
2
n - 1 M 
+ 2 * J3 - N a 3 o ( 6 . 20 )
where n is the refractive index, M is the molecular weight, is the 
density, Nq is Avogadro's number and a is the electronic polarisability.
This equation can be applied to the component polarisabilities and 
refractive indices (Hartshorne and Stuart, 1970).
Thus
n\ — 1  n j  — 1  M 4 t N ( ~ — a )  , .
I rfj + 2  ~ n ^  ~  3 °  11 -1- (6 .2 1 )
where the subscripts 11 and JL refer to the directions parallel and 
perpendicular to the optic axis (or fibre axis) respectively.
For the case of a polynucleotide, the molecular weight, M, and the 
polarisabilitics, a, can be taken as being equal to those for the monomer 
unit. If the entire molecule were considered, both sides of‘equation 
(6.21) vrould simply"be multiplied by N, the number of monomers in the 
molecule, as long as electronic interactions between the units were
* It should be noted, however, that this equation only takes into account 
the mutual induction effects of atoms linked by primary bonds, and 
ignores molecular interaction: it should therefore be applied cautiously 
with crystals of very low birefringence.
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negligible.
In nucleic acids, it has been shown (Tsvetkov, 1963) that it is the 
bases which are anisotropic and result in the birefringence, the super­
phosphate backbone.being practically isotropic and contributing little to 
the birefringence. If electronic interactions between the bases were 
significant, then one side of Equation (6.21) would have to be multiplied 
by an interaction function, f(N). We will assume that these interactions 
are negligible (i.e. f(N) =1), and that therefore the birefringence is 
independent of the number of nucleotides in a molecule.
Differentiating the Lorentz-Lorentz relationship gives 
6n . dn
(n2 + 2)2
= K.d*
. ' „ 4tt N0 o. where K = —
If the birefringence is small ($0.3 , to maintain an accuracy of 
0.1%), the differential equation may be applied to the finite difference: 
6n .An
where
md
(n + 2)k
K = n»> * n-i 2
A n  = n ft - nj_.
= K.Aa ( 6 .22 )
Using values of Aa = -15&3 (Frisman et al., 1962) * * ««/N
•«3
(Tsvetkov, 1963) and ,P = 1.63g cm (Seeds, 1951) results in a value for 
the birefringence of -0.4. This is at least four times larger than any 
experimental measurements on B-DNA (Porumb, 1976), though the disparity 
arises mainly through the value used for the density. A value of 
1.63g cm”3 corresponds to the density of dry DNA, but in a fibre it will 
be considerably diluted by water and the dilution will result in smaller 
values for both the refractive indices and hence the birefringence. The
actual water content will be a function of relative humidity, but the
Y
dilution factor would appear to be of the order of 4 - 6.
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Transforming the Lorentz-Lorentz equation gives
n = I - 2 (6.23)
J  1 -  8b
where the constant K contains the density term as before. The form
of this relationship is shown in Fig. 6.17 for different values of the
—3density. If the density is less than or about 0,4g cm , and n^ and n^ 
are just below and just above 1.6 (their mean value), this would indicate 
that the polarisabilities ot^ and ct^are both greater than 10oR3, and are 
critically dependent on the density. This is in agreement with 
calculations for an adenine-uracil base-pair, using a simple Huckel scheme, 
which indicate that the ^-electron polarisability in the plane of the base- 
pair (i.e. perpendicular to the helix axis) is around 175$3 (Takashima,
1968).
6.4.2 Intrinsic and Form Birefringence
The birefringence of a fibre can be thought of as being composed of 
two parts: a terra arising from the optical anistropy of the polynucleotide 
helices themselves (called the intrinsic birefringence), and a term resulting 
from a preferential orientation of the elongated helices (called the form 
birefringence). Even optically isotropic molecules embedded in an 
isotropic medium can possess a form birefringence which arises from the 
deformation of the electric field at anisotropically-shaped phase 
boundaries (Steiner and Beers, 1961).
By considering an arrangement of thin isotropic rods, of diameter 
smaller than the wavelength of light, orientated parallel to the fibre 
axis as a system of parallel capacitors it has been shovel (Weiner, 1912)
that
2 2 
n H " n i- "
/ 2 2 ,2
Vo <no “ n > •
(v + i) nQ2 .+ vQi?
(6.24)
where v, vQ are the volume fractions of the rods and the material in which 
they are immersed: and n, nQ and the refractive indices of the rod and
Fig, 6,17 The.Lorentz-Lorentz relationship between the refractive 
index, n, and the polarisability, a, for different
densities, jO
n
- 136 -
medium respectively. It can be seen that the form birefringence,
^nf C = n|| - n± ), is always positive in this case. Flow birefringence, 
light scattering and Kerr effect studies indicate that a rigid rod model can 
be invoked to explain the optical properties of DNA (Weill et al., 1963). 
Previous investigators (Hoshino et al., 1962, Tsvetkov, 1963; Porumb,
19?6; Maeda, 1978) have treated the total birefringence of a fibre as being 
the sum of two terms - the intrinsic and the form birefringence,
^ "total " 4n +Ant (6.25)
where An is related to bond polarisabilities, andAnf is related to 
Equation (6.24) in which the assumption had been made that the rods (viz. 
the DNA helices) were isotropic.
A more realistic approach would be to consider the rods as being 
anistropic from the beginning, and to compute the total birefringence 
when these rods are imbedded in an isotropic medium. in this treatment, 
the intrinsic and form effects would not be separable. It has been 
shown (Ninham and Sammut, 1976) for the case of infinitely long parallel 
cylinders of radius, a, and centre-to-centre spacing,^, immersed in an 
isotropic medium that the composite dielectric constants are given by
e* = e + f (eu w e )m m' (6.26)
for the direction parallel to the cylinder axis, and
lc * €„ (1 + 2fl- e r a s ’ (6.27)
for the perpendicular direction. In these equations, is the dielectric
( 1
constant of the medium, er , e are the dielectric constants of the rods,
2*a2f'is the volume fraction of the rods (and equals for hexagonal
- em *
packing) and Arm = ■ r 7—-£—r ”*■ m
In using these expressions, the fibre is considered as being composed 
of DNA molecules, behaving like rigid rods, inbedded in a matrix of water 
molecules. This treatment does not take into account the symmetry 
connections between the individual DNA molecules (viz. the crystallinity
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of A -DNA and semi-crystallinity of B-DNA), but since the polarisability 
of the base-pairs is almost isotropic in the plane of the bases (Tahashima, 
1968) these equations should apply to DNA systems.
The refractive indices of the composite fibre would be given by
A.___
rm
nA ' - n tl + . ]c rn\ [ 1 - f A ] J (6.28)
and
where
4  -  nm(l + f6) (6.29)
6 = er “ Si 
T c m
The total birefringence is then
. H
^total c " c
n f  (A - f*B)m. ; (G.30)
wherv A ~ 6~ Arm and B =  ^ The relationship between the total 
birefringence int o w  and the volume fraction f'is parabcUc, and i. 
schematically displayed in Fig. 6.18. The pammeters A and'B are ^
functions of sm, o. and e A . A valUQ nf. i, -0,2, l r Vaiu" of (1-33> can be taken for c„_
but e, and .6. are unknown. The intrinsic birefringence of WIA.
"v” • "r ’ iS h°,,ever CMsid^ d *>.*«. a value of around -o.i (’Isvotkov 
1963; Porumb, 1976) and values of the individual refractive indices have ’ 
been assumed by various sources (Seeds, 1951; Tsvetkov, 1963) to lie in 
the approximate range 1 .4  to 1 .7 . a  plot of the birefringence, i " , 
against the volume fraction, f, for various combinations of „ and
is shov/n in Fig. 6,19. A
In a ENA fibre, as the relative humidity rises the fibre takes up '
water. This may «suit in a change in the diameter of the DNA helices, 
considered as rods, and/or in a change in the intermolecular separation! 
The values of both of these parameters can be measured from an X-ray 
diffraction photograph of the fibre at a particular humidity, and used to
^  n  total
Figure 6.18. Schematic drawing of the relationship betv/een the 
birefringence, An.^.^, and the volume fraction, 
f 1, for n^ n^.
W
\
A t^otal
<
Figure 6.19 The total birefringence, ^ n -^ota *^ aG a function of the 
volume fraction, f1, for various combinations of n ( and
nlX-
\\\
UlC
Ti^
J
- 138 -
give the volume fraction f'. The measured (total) birefringence can then 
be plotted against f', by talcing the birefringence and diffraction 
measurements in parallel over a range of humidities. This is considered 
to be better than considering the birefringence directly as a function of 
the humidity because humidity values from hygrometers are notoriously 
inaccurate and, in any case, they sample the environment around the fibre 
rather than that within the fibre. porumb (1976) adopted this latter 
scheme and attempted to normalise the birefringence results obtained at 
different humidities by using measurements of the volume swell of the 
fibres at each humidity.
In addition to the variation of Antotal with f', other factors will 
need to be considered. The disorientation half-width, 6, may be expected 
to change with changing humidity and affect the birefringence; and the 
base tilt, Q, will change abruptly if the fibre undergoes a conformational 
change from A to B DMA resulting in a major change in the birefringence. 
The effect of base tilt is considered explicitly in the following section.
The Effect of Base Tilt (on the Intrinsic Birefringence)
Consider a fibre in which the bases are tilted by an angle 0 to the 
plane perpendicular to the helix axis (Fig. 6.20). The polarisability 
perpendicular to the plane of the base-pair, aL, is very small, and the 
polarisability in the plane of the base-pair, aT, can be taken as 
isotropic (Takashima, 1968).
For a perfectly orientated fibre (B - 0), the nee-male ON to the plane 
of the base describe a cone of semi-angle ® about the fibre axis 0Z 
The polarisabilities parallel and perpendicular to the fibre axis and 
a,, are given by (Hartshorne and Stuart, 1970).
«j.*3 “L t a.r sin2^  (6.31)
o„ = aL cos20 + cty sin20and (6.32)
Helix axis
Figure 6,20. The system described in Section 6.4.3
is small ;0<T is isotropic in the 
plane of the base-pair.
since e - Bi, when 6 = 0 .  The augle B.. depends on the angular orientation, 
*' 0f the teSe abOUt the hellx axis- »ding vector geometry it can be 
shown that
cos sin 0 sin <(>
Substituting this into Equation (6.31) gives
2 g
“1.“ V in 6 sin * + \  <i- sin o sin2 * ) (6,33)
Subtracting Equation (6.33) from (6.32) and cylindrical, averaging (i.e. 
integrating over ij>) gives
Ao = an - ax = (aL - aT)(l-1.5 sin2 e) (6#34)
Using equation (6.22),
in = It (1 - 1.5 ain2 6) <6.35)
»/here the constant K absorbs both the anisotropy in the polarisabllity 
and the concentration dependent terms. This relationship has been quoted 
by Porumb (1976) and is shovm as the curve <5 = 0° in Fig. 6.21. when 
the tilt is zero the intrinsic component of the birefringence assumes its 
maximum negative value. It becomes zero for e = 54°44* (viz. sin"1 ¡^) 
and for linger tilts it becomes positive. It is practically constant in 
the range 6 = 0° - 5°, and for a change of tilt from 0° to 20° (as 
encountered during the B to A transition in DMA) it drops in magnitude by 
21%. Since the total birefringence includes a contribution from the form 
birefringence (which is always positive) the total birefringence would 
reduce to zero at an angle smaller than 54° 44'. Form birefringence and 
intrinsic birefringence are inter-linked, but Porumb (1976) has considered 
the case where the form term is arbitrarily given a value of 58% of the 
magnitude of the intrinsic term. For this case, the total birefringence 
would go to zero at" 6 = 32°, and its variation would be faster with 6 than 
shown in Fig. 6.21 for the intrinsic component, but still slower than the 
variation in dichroic ratio with 0(Fig. 6.13),
Equation (6.35) holds for the case of a thin film as well. The 
dipole moments of the bases are not constrained to take up an orientation
Fig. 6.21 The intrinsic component of the birefringence of a fibre 
as a function of base tilt, 0, for various disorientation 
half—v/idths, 6.
A n
The vertical plotting is on a relative scale, since the 
constant IC lias been set to unity (Equation 6.39)
in the plane of the film surface. In fact, even if the dipole of one 
base were so positioned the dipole moment of the next one along the helix 
would have its polarisahility at an angle to the surface of the film due 
to the continuous rotation of the base-pairs relative to each along a 
PNA double helix. An earlier treatment (Seeds, 1951) constrained all 
the dipole moments to lie in the plane of the film surface and gave
An = K (1 - 2 sin2 6)
This gives zero birefringence at 45° (intuitively obvious for this 
restricted model), but for the reason just outlined this is a poor model 
by which to describe a real film.
6.4.4 The Effect of Disorientation (on the Intrinsic Birefringence)
In practice, a fibre will be subject to disorientation of the DMA 
helices about the fibre axis, and rhe disorientation may be described by 
a gaussian function of half-width 6 (Section 6.3.1). The effect of 
disorientation has been treated numerically by Porumb (1976), but an 
analytic expression may also be obtained.
For a disorientated fibre,
An = K' (c*n - a^ ) (6.36)
where K* contains the concentration terms and the dependence on the
base tilt.
Substituting for and gives 
An « K{aL<cos2fil.>+aT<sin2Mll>_ ( a ^ c o s ^ + a ^ s i n 2^ ) (6.37)
where "< >" indicates averaging at both helix and fibre levels. From 
2 2Appendix C, sin 8jj and sin can be expressed as functions of the base 
tilt,6 , and the disorientation parameter, S (defined in Section 6.3.1), 
and these functions will be referred to as fa (0, S) and fg(0 , S) 
respectively.
Since <cos2 (angle)> = 1- <sin2 (angle ) >, Equation (6.37) becomes
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¿n= K' i o J i - M e , * ) )  -  (o ^ a ^ te .s j+ ii jf  (e,S))j
= K- Caj-OjHye.S) - f a(8,S)) (6.38)
The relevant expressions for f J S . s )  and ^ ( e . s )  can then be substituted.
(i) The fibre case
Usins the expressions for fJ S .s )  and f^ S .S ), from Equations (0.3) 
and (C.4) respectively, in Equation (6,38) gives
An = K (1 - 1 , 5  sin2 6 _ 0.75SP) (6.39)
where P = 3 cos 6 -1, This relationship is shown in Fig. 6.21 for 
various gaussian half-widths, 6.
For a perfectly orientated fibre S = 0, and Equation (6.39) reduces 
to Equation (6.35), For a completely disorientated fibre s = %
(Appendix AIV) and the intrinsic birefringence goes to zero, as indeed 
it must. Tlie expression predicts that there is a unique angle (viz. 
54°4 4>) at which the intrinsic component of the birefringence becomes 
zero, for all values of the disorientation parameter. The intrinsic 
birefringence of a fibre at zero tilt angle is proportional to (l - 1 . 5 s ) .
Fig. 6.21 should be compared with the computer simulated results of 
porumb, reproduced in Fig. 6.22. The results are identical for 6=0°
(viz. a perfectly orientated fibre), and are very similar for small 
6(^10°) and lares !(30°- 40°). They differ by up to 4!! for intermediate 
values of S, and this is thought to be due to the summation method used 
by Porumb to perform his averaging.
The contribution of the drug chromophores has not been considered 
explicitly in this treatment. The chromophores will have a large 
polarisability in their plane, probably larger than that of a base-pair. 
If they are orientated similarly to the base-pairs, as they would be if 
bound intercalatively, they will enhance the negative birefringence of 
the polynucleotide fibre.
V s
( ’ 030)  3 s u a  3HJ. JO J/IIJ^Q 
0Ö OS 0¿ 03 ÖQ OV  08 03 OT
tj J o j  (sq.tun OAjq.t>X!Xt u t ) u y  j o  uoTq-Bta-eA OATq.cxo~ sqq- 
'JuxMoqs ‘ (9¿GT) q m o c o j  jo s q x n c o j  p oq.t3X nun: s-aoq.nduoo © m  2 3 ' G *3 T ¿
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(ii) The film case
Substituting the expressions for fQ (0 ,S) and fg(e ,s) relevant to 
the film from Equations ( C.5 ) and ( C.6) respectively, into Equation 
(6.33) gives
An = K(1 - 1.5 sin2 6 - SP) (6.40)
and this relationship is shown in Fig. 6.23.
For a completely orientated films = 0 and this reduces to Equation 
(6.35), while for a completely disorientated film S = % (Appendix AIV) 
and the birefringence reduces to zero. Again, there is a unique angle,
54° 44’, for which the birefringence is zero for any disorientation.
The intrinsic birefringence for zero base tilt is proportional to (l - 2S), 
which results in a greater magnitude of the birefringence for a film than 
for a fibre with the same disorientation parameter, S. However, the 
mag*-iitude of the intrinsic birefringence of a film is smaller than that of 
a fibre for a given disorientation half-width, A, because of the different 
* relations between S and S for the two cases.
\\\
Fig. 6.23 The intrinsic component of the birefringence of a film as 
a function of base-tilt, 6, for various disorientation 
half-v/idths, <$.
• K (Equation 6.40) has been set to unity.
A n
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6.5 Summary
The more important equations that have been derived relating to the 
birefringence of a fibre are given in Table 6.1. In Chapter 7 the 
birefringence of DNA-drug fibres, of different DNA/dvug contents, are 
measured at different humidities. Using the X-ray results of Chapter 5, 
in particular the relevant values of the intermolecular separation and 
the DNA helix diameter, the change in the birefringence with f (the volume 
fraction of the rods) may be followed to investigate the effect of v.ater 
uptake on the fibres and to test the applicability of Equation (6.30).
TABLE 6.1
Summary of Some Birefringence Formulae
“ total "  V  (A -*> (6.30)
•where A - 6 _ Arm
' rm
Completely
orientated • An = K (l - 1 . 5  sin2 0) 
fibre
Disorientated
fibre An » K (1 - 1.5 sin20 - 0.75 SP)
By comparing the values of the birefringence observed for DNA-drug fibres 
with those for DNA fibres, information on the orientation of the drur> 
molecules and their anisotropy may be inferred (Equation (6.39)). The 
values for different drug contents at different humidities can be used to 
indicate the extent of binding at each humidity, and can be compared with 
the indications obtained from X-ray diffraction.
A summary of the expressions derived for the dichroic ratio of fibres 
is given in Table 6.2. The experimental results on DNA-drug fibres
(6.35)
(6.39)
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presented in the next chapter will be analysed in terms of the relationship 
between the dichroic ratio, D, and the tilt of the drug (Equation (G.ll)) 
since the direction of the transition dipole moment is not known for the 
three drugs used in this study. The values of dichroic ratio, obtained 
at different humidities can be used to indicate the orientation of one or 
more bound species using the predictions from the X-ray diffraction and 
birefringence results for the fractions bound at each humidity.
TABLE 6.2
Summary of Dichroic Ratio Formulae for Fibres
D in terms of 0 D in terms of a
Disorientated
Fibres
,, 2 cos2© - SP 
/z + 2 sin^ e + SP
(Eqn. (6.11) & Fig. 6.13)
2- SP'
C O S  0 (  -  - 7 7 -
2 sin^a+ S-Ql
(Eqn. (6.16) «Sc Fig. 6.14)
Completely
Orientated
Fibres
yz + cot2 0
(Eqn. (6.3) & Fig.- 6.5)
cot2 a
(Eqn. (6.2) & Fig. 6.3)
Where P = 3 cos q^ -1 
2 ’P'= 3 cos a -2
\\
/
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APPENDICES FOP CHAPTER 6
APPENDIX A
AI Expression for the Pichroic Ratio, D
From Section 6.3.1, a transition dipole moment T can be represented 
in the co-ordinate frame of the fibre as
T =
\ zi
= > i V o
Using Equations (6.4) and (6.8 )» which refer to Figs. 6.9 and 6.10, 
this gives
/
T =
T \
h i
cos'f’ (cos ^  cos 4*2 - COS02 s*rW,2^ \
—cos®. sin<()^  ( cosij)^  sin<j)2 - cose2 cos^ sin^2) y 
+sin®£ sin<|>^  (sinQ2 sinijjg)
sin^ (cosiJj2 cos<f>2 - cosô2 sinj2 sin^2) 
+COS0, cos<j>^  (cos4i2 sin<|>2 - cos6„ coa)i2 s i m O  
-sin® ^  cos«j)^  (sin02 sirajig)
+sin01 (co# sin}> - ooc80 cosa0 siraj>„) 
+cos®^ (sirf)2 sin},2) 2 ^ 2 2 y
(A.l)
where has been set to zero as explained in the text (Section 6.3.1). 
The terms containing 02, the drug tilt, are of particular importance since 
they will remain in the final expression for the dichroic ratio when 
integration over the other angles has taken place.
T.Y-j^  and T.5^, used to find D, are respectively the second and third 
terms in this column vector.
For the integrations, the following expressions are used
if or 2ir
/ sin x cos x dx = 0
\
\\
o
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TT or 2 TT
/ sin2 x dx = | or TT, respectively
o
if or 2ir
t 2 ITj cos x dx - 2 or ir, respectively
(i) For a fibre
For a perfectly orientated fibre ^  = o), averaging over $ (from 0 
to 27r), $2 (from 0 to »), and (from 0 to 2n) gives
A ,2<(T.7t)% _ %(1 + cos2ep)
U < (T.z, )*» /a sin^ -©,.
a COt^flg + /2
which is the same as Equation (6.3), derived in Section 6.2 by a less 
general method.
For a disorientated fibre, 6.^  4 0 (i.e. the helix axes are not aligned 
with the. fibre axis) and the situation is more complicated.
<(T.^)2> = g (1 + cos262 + <cos2ei> + ccos^-j» cos202 + 2<sin261> ■ 2 Vs m  e2)
Putting S = xsin^j»,
«(T.Yj )^ » | il + cos262 + (1-S) + cos262 (1-S) + 2S sin202 ) 
= | (2(1 + cos^g) + S(1 - 3 cos202))
= | (2(1 + co s26 2 ) - SP)
• where P = 3 cos' 0, - 1 
Similarly,
a 2 2 2 p<(T.Z1) > = <sin 0^ (/4 + % cos q2 ) + '4 <cos sin
=  |  (1 + cos202) + 4 ( l  -  s )  sin202
= (sin^ + |£)
2 2 ■
(A.2)
. 2
e2
\\ ( A . 3)
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Thus, dropping the subscript on 6^,
1 (2 (1 + c o s202 ) - SP)
D = - ~  i—
Yi (sin 02 + |=.)
2 22(sin 6 + 2  cos 6) - SP— n\ ------- 2--------~ ~ ---
2 sin 0 + SP
V 2 cos29 - SP 
/z + 2 sin20 + SP
which is Equation (6.11) in the text.
(AJ4)
(ii) For a film
In the case of a flto, ^  is set to zero i.e. the film is considered 
so thin that there is no disorientation of the helices across any section 
perpendicular to the film surface. The density of states function,
N(®1’ ^), and the probability function, P ^ )  de^ are defined for 
essentially a two-dimensional situation, as explained in detail in Fig. B.3. 
Integrating over ^  (from 0 to 2tr) and ^(from 0 to 2tt) gives
<(T.^)2> = )4/{<cos2 01> + <cos201> cos2©g + 2<sin201> sin202 >
= ^{(1-S)(1 + cos202 ) + 2 S sin262)
= /i{(l+cos 02 ) + S(2 sin ©2 - cos202 _ i)}
= )i{(l+cos2e2) - Sp}
(A.5)
The denominator «(T.Z^ >, is the same as for the fibre case. Thus
D _ % ((1 + cos26) - SP}
% isin20 + |£)
= '4 + 2 cos2e ~ I  sp '
2 sin2 0 + ^ SP •
\
(A.6)
which is Equation (B.2) in Appendix B
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All The Disorientation Parameter, S
The disorientation, ^ is defined as 
S (0^) = <sin20^>
/P<. 61) sin^81 d6.|
/  p ( e 1 ) dQ±
where P (0^) is the probability function describing the distribution 
of DIIA molecules about the fibre axis.
(i) For a fibre
As explained in the text
2n
P ^ )  = ¿Ti / K(01,<l'1) sin ^  d ^
°  2 .
0-
Assuming a gciussian distribution (viz. N( e,, ) °Cexo (---- )) then1 1  262
it
2 - 1
S =
I  ^ 2 <5" . 3sin ei d ei
% £ FJ e sin 0]L d0^ 
o
The upper integration limit for 0^'may be increased to °°; since they 
are both exponentially decaying odd functions this would result in the same 
scaling for both the numerator and the denominator. The denominator is 
similar to the standard integral (Abramowitz and Segun, 1968).
dt
2 x
“ 2 • -* TS
. / sin(2xt) dt = ^  e a / e^
o o
and the right-hand side of this can be expressed in terms of the Dawson 
integral ,
F(z) = e / e^\dt
\o
2 Z • 2
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Using these,two equations, and setting t = 0 , x = 14t a = - 4  
2 £
x (5
2 = 7a = 72 giV0S
e
26/ e sin 9^ d0 1 B / , 2 S 2 jFiJ-)
and an extension of this, using sin3 ^  = j£(3 sin0;L - sin 3 6^  is
6?oo _ 1
r 2^/ e sin3ei ^3F(^|)
Using these standard integrations, the orientation parameters, 
given by
F < %
S = %(3 - — ■ )
f (t| )
which is Equation (6.14) in the text.
(ii) For a Film
For the film case
p ^ )  = K(e1,^1) de
so that 2
* - 61
/ e2  ^ sin2 0 d6
A X X
s  =
n „e|
/ 26 * Ae d0.
Both of these integrals are of a standard form (Abramowitz and 
1968) and give
^  »252
S = X  (1 - e )
quoted as Equation (B.3) in Appendix B.
\\
and
S, is
Según,
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AIII The Dav;son Jnterral as a Seri.es
F(z) = —  (w(z) - e”Z )
where
f \ r (iz)w(z) = l —
n
n + 1)n=0 2
(Abramowitz and Segun, 19G3)
The even terms in the expansion of w(z) are equal to the terms in the 
2
expansion of e*”Z so .these cancel (N.B. f(l) = 1  0ni ^(n + 1) — nT(n)).
The odd terms give
-, » _ A  ,iz__ (iz) 3 • (iz) 5
21 T ( |)  T ( |)  r(Z )
.)
Mow f(/z) =- /ir so that
F(z) _ éu l ( - D ^ 1  **“1“ 2 * r(r + yt) ■
r=l
. £  i _
= U  " 3 + 5 3
2*2
/
\\
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AIV Values of S for a Completely Disorientated Srecimen 
(i) For a Fibre
F(6)
For large (i.e. large disorientation)
= (w (6) - e"
F(fi) w( i)
1
= 3 + o(
_1
«52)
Therefore,
1
3
Thus,
2 F<Sf> 2S = < sin 6> = %(3 - ---— ) = -
F(^)
Xii) For a Film
2fi2The expression S * % (l - e 0 ) takes the value 0.5 as 6 g6es to
infinity (i.e. complete disorientation).
\\
APPENDIX B
The Linear Dichroism of a DMA-Drug Film
Several experimental studies (Rupprecht et al., 1969; Kurucsev and 
Zdysievn.cz, 1971; Kelly and Kurucsev, 1976) of linear dichroism have been 
carried out using DNA-drug films rather than fibres.
A previous analysis (Seeds, 1953) of a perfectly orientated film has 
considered the film to be so thin that the normal to the drug Chromophore 
is constrained to be in the plane (YZ) of the film (Fig. B.l). v/ith this 
assumption the angles previously referred to as 6 and a are equivalent. 
Using Seed's notation,
D = El 003 a = cot2 a
2E r san a
vu.J./
since Ea = E, as before.
This relationship is shown in Fig. B.2. The dichroic ratio varies 
from zero to infinity, and takes the value of unity when <* = 4 5°.
If disorientation within the film is considered, analytic expressions 
analogous to Equations (6.11) and (6.16) may be obtained. The transformation 
matrices given in Equations (6.6) and (6.8) still hold, but $ can be 
considered equal to zero (i.e. the film is considered thin enough such 
that all tho disorientation occurs in the plane of the film). The density 
of states function, lU0^, 4^) is defined somewhat differently (Fig. B.3) 
than in^the case of a fibre and the gaussian probability function, P ^ )  d 
is shown graphically in Fig. B.4.
The dichroic ratio for a film can be shown to be given by
v . x + 2- ^ - - ? sp
2 sin2 0 + SP
where P has its previous signifidance,
(B .2)
and S is still <sin^9j> but the
zFigure B.l. The co-ordinate system for an infinitely thin, 
perfects orientated film (after Seeds, 1953),
Figure B.2. A plot of the dichroic ratio, D, as a function of tilt 
angle, o((=e) (see Equation B.l),
Film axis
Figure B*3 •
The thin film is regarded essentially as a 2D case, there being 
no misalignment of the helices in the X* direction (viz.jzi^ =0).
is the density of states function, again assumed 
gaussian in 5^; it is proportional to the number of DNA helices 
pointing in a direction from the film axis,
is proportional to the probability of a DNA helix 
pointing within the limits 0 ^ and 0^ + d0^.
p(©1)de1 « N(elt fS1) <3^
\\
Figure B.4 The probability function for a film. The
probability function is a standard gaussian with half- 
width,S . In the limit of complete disorientation 
(S-»oo) it becomes a horizontal line, indicating that 
all values of 0 ^ are equally probable.
Vv ' . .
- 153 -
integration is performed over 6^ values from zero to 1T and no geometric 
sin 0^ term appears in the expression i.e. 
it
/ sin 61 P(91) d01
s = 2-----------------------
7 Ptep
O
= %{, 1
-26e
2
)
(B.3)
The relationship given by Equation (B.2) is plotted in Fig, B.5; 
comparison should be made with Equation (6.6) and Fig. 6.13 pertaining to 
the fibre case. For the same value of S the dichroic ratio for a film is
always smaller than that for a fibre, although for a given gaussian half- 
width, 6, the film values for D are larger than the fibre values. This 
results from the different relationship between S and $ in the two cases 
(compare Equations (6*14) and (5.3)).
C onsidering the s p e c ia l cases -
(i) For a perfectly orientated film S = 0 and Equation (B.2) 
reduces to Equation (6.3).
(ii) For a completely disorientated film
iK^, = 1
and the probability function can be represented by a straight 
horizontal line (Fig. B.4). S becomes equal to 0.5 (Appendix 
A Iv), and thus the dichroic ratio is equal to unity.
(iii) The dichroic ratio is always equal to unity when 0 = 54°44', 
irrespective of the value of the disorientation parameter, S.
(iv) For 0 = 0 ,  the aichroic ratio is given by D = ~ - 1 which
is the same as with a fibre.
S im ila r ly ,  an exp ression  fo r  D in  terms o f  a may be d erived .
Y\
F1£ure b.5
'The dicliroic ratio, D, of a film as a. function of 0 , for 
various values of S (Equation (B.2))
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cos2 ct - SP>
. 2 ,2 s m  a + SP'
(B.4)
where P' has its previous significance. This expression should be 
compared v/ith (6.16) fox- a fibre. Equation (B.4) is shown graphically in 
Fig. B.6, which should be compared v/ith Fig. 6.14. It should be noted 
that, as in the fibre case, the angles 6 and a are different; a lies 
between zero and 6. Equations (E.2) and (B.4) are identical if $ » = 450 
(Fig. 6.2).
The earlier analysis of Seeds (1953) did not recognise a difference 
between 9 and because it considered the film as a 2-dimensional 
structure.
For the limiting cases -
(i) S = 0 for a perfectly orientated film, and Equation (B.4) 
reduces to Equation (6.2) just as it did in the fibre case. 
(Note that it does not reduce to Seed's expression (Equation 
B.l), which describes a less realistic model).
(ii) For a completely disorientated film, S = % and D takes the 
value unity.
(iii) The dichroic ratio is always equal to unity when a = 35°16', 
for any value of S.
(iv) The values of D for zero tilt (a = 0) are given by D = - - 1,S
This is the same expression as obtained v/ith 0 = 0°, which 
is the same physical situation.
\\
FicUre B>6 The dichroic ratio, 
various values of 8
D, of a film as a 
(Equation (R.4))
function of fGr
■ * > - “ —        ~  '  ------- - ----- — -------------------------- ;-----
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APPENDIX C
Egressions Relevant to the Birefringence Calculations
Using the notation of Fig. 6.4, if the vector T represents the 
direction normal to the base-pair then
T . ^  = cos(90 = sin n,
(C.l)
T.y^ = cos(ftj_ - 90) = sin
(C.2)
Averaged values for the squares of these expressions have been 
obtained in Appendix A (Equations (A.3) and (A.2) for a fibre, and 
Equations (A.3) and (A.5) for a film). The averaging has taken place at
both helix and fibre (or film) levels. These averaged quantities are
functions of the base tilt, 6 , and the disorientation parameter, S, and 
they will be referred to as 'fa(e ,D) and f^(0,S)
(i) For a fibre
fa (e,S) =
(ii) For a Film
«sin2^ »  = V2 (sin2e + }
<s i n \ >  = I {2(1 + cos2 6 ) - SP}
(C.3)
(C.4)
f0 (e,s) . 2 n  1/ r • 2  a . S P l<sin Qt> = Yz {sin 0 + x-}
2 2f (e,s) = <sin fìj_> = X {(1 + C O S  0) - SP}
3
(C.5)
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CHAPTER 7
Linear Dichroism and Birefringence : 
Experimental Results
7.1 Technical Limitations on the Measurements
The absorbance of monochromatic radiation of wavelength, X, by a 
specimen may be expressed as
A(X) = log IQ - log I (7.1)
where IQ and I are the intensities of the radiation incident on the 
specimen and transmitted by it respectively. In a single-beam micro­
spectrophotometer successive measurements are taken on a microscopic area 
*dth the specimen in place and then absent, using the same optical path.
The measured values of I and I depend on the emissivity of the lamp 
(which is greater towards the red end of the spectrum), the spectral 
transmission of the optical system (which is greatest around 500nm, the 
-wavelength at which the monochromator grating is blazed), and the frequency 
response of the photodetector (which is greater in the blue region of the 
spectrum). If the optical and electronic properties of the microspectro­
photometer are unaltered during the time required to take these measurements, 
systematic errors will be reduced. A double-beam microspectrophotometer 
employs a beam-splitter to direct the incident light either alternatively or 
simulataneously to the specimen and the reference, but for microscopic use 
the attendant requirement for identical light paths is more difficult to 
satisfy than tha time stability requirement in single-beam instruments 
(Clarke, 1972; Mielenz, 1972; Mielenz and Eekerle, 1972).
In order to measure the dichroic ratio, D, of a specimen in a single-
s'
beam system, four spectral runs are required (viz. the background and 
specimen-transmitted spectra for light polarised parallel and perpendicular 
to the optic axis of the specimen). This imposes a further restriction on 
the time stability of the system,' because the optical and electronic
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properties must remain constant over the increased length of time required 
to take these measurements. The birefringence of a specimen is measured 
in white light by rotating a compensator to find the dark compensation 
fringe (Section 7.3). There is no time stability restriction on this 
measurement since the effect of the different polarisations (giving rise 
to different refractive indices, n |( and n^) is observed simultaneously and 
not sequentially.
7.1.1 An A lte rn a tiv e  Technique fo r  Measuring the D ichroic Ratio
The four log (transmission) curves can be collected in two spectral 
runs by using an adaptation of the method of Jaffe et al. (1967). A 
multiple waveplate of quartz, placed between the polariser and the specimen 
stage and oriented such that its optic axis is at 45° to the polarisation 
direction of the polariser, acts as a wavelength dependent polarisation 
modulator. The originally plane-polarised light will emerge from the 
waveplate elliptically polarised, due to the relative retardation,<KM, 
introduced.
- *(X) e ~  .An(X)t (7.2)
A
where t is the waveplate thickness and An(X) is the birefringence of quartz 
at the wavelength X. When <K X) equals an even multiple of tt, the plane 
polarised light emerges with its polarisation unaltered; and when it 
equals an odd multiple of ir.the light will emerge plane polarised in a 
direction at right angles to its polarisation direction on entry. The 
observed transmission will be that corresponding to the resultant 
polarisation. The frequency of these changes depends on the thickness of
the waveplate.
With reference to Fig. 7.1,
¿n( \>) _ An( rv^ i) 1
\i V l  t
(7.3)
XFigure 7.1 Schematic log(transmission) curvet) for a dichroic 
sample usirg a multiple v/aveplate of quartz
Figure 7.2 Schematic illustration of the full microspectrophotometer 
system.
\\
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The repeat, AX (=X - X^), should be chosen so that it i3 small enough to
allow easy interpolation of the envelopes by eye, but large enough so that 
the spectral bandwidth passed by the monochromator does not diminish the 
magnitude of the oscillations because of averaging. For a repeat interval 
of around 5nm, An(Xn) and An(Xn+^) can be ’taken as equal for quartz. This 
is because the dispersion of the birefringence of quartz is small, 
n(XF ) - n U c)
An(\J = 3 x 10D'
■ where X^, is 486.lnm, Xc is 656.3nm and X^ is 546.lnm. Thus
t s Xn+l*Xn __________An(Xn).(Xml - X^ (7.4)
For example, with Xn = 500nm and X^^ = 505nm, and An (500nm) = 0.00911 
the required waveplate thickness is 5.5mm. A crystalline quartz optical 
flat, with its optic axis in the plane of the polished faces, 6nun. thick, 
flat to ^ and with faces parallel to 15 seconds of arc, was constructed to 
order by Gooch and Housego Ltd., Ilminster, Somerset. The expected 
repeat interval AX, according to Equation (7.4), is 4.6nm.
Spectra are taken with and without the specimen in position (viz. the 
•specimen* and 'background' runs), the envelope of the oscillating traces 
providing the four data sets required. These are input via a D-ilac 
pencil follower to the program 'MICRO», which computes the dichroic ratio 
as a function of wavelength. This method is time-saving, and it reduces 
the time stability requirements of the system. Any difference in the 
envelopes for the »background* case is due to non-uniformity of the 
po la riser and/or variations in the polarisation sensitivity of the 
photomultiplier. In practice, these differences were so small that they 
were not resolved.
7.2 The Microspectrophotometer
A single-bean microspectrophotometer, with polarised light facilitie 
was used to investigate the birefringence of DNA and DNA-drug fibres and 
the linear dichroism of DNA-drug fibres. The system was described by 
Porumb (1976), and v/as operated over wavelengths from 400 to 650nm. The 
microspectrophotometer (Fig. 7,2) consists basically of two parts - 
(i) The Optical System
The central part of this is a Zeiss polarising microscope.
A fibre is placed in a humidity cell (Section 2.3) which is 
positioned on the rotating stage of the microscope* The 
specimen is illuminated by pulsed monochromatic light 
originating from a 12V, 10CW quartz iodine lamp. The mono­
chromator is of a symmetric Czemy-Tumer design, equipped with 
a plane diffraction grating blazed at 500nm. The entrance 
slit determines the spectral bandwidth, and the exit slit 
determines the intensity of the light reaching the specimen.
The settings normally used were 2nm for the bandpass and 0.5mm 
for the exit slit.
The emergent beam is periodically interrupted by a 
vi bra ting-vane chopper operating at 110Hz. The beam illuminates 
an adjustable field aperture, whose setting determines the area 
in the object plane to be illuminated. A 45° mirror joins up 
the optical axis of the monochromator section with the optical 
axis of the microscope. The optical bench supporting the lamp 
and monochromator were permanently decoupled from the support 
carrying the field aperture and 45° mirror, in order to 
facilitate alignment of the optical axes. The image of the 
condenser diaphragm and the field aperture were both in the 
centre of the field of view of the microscope when alignment
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was completed* Before using the equipment each session the 
condenser lens v/as centred using the internal light source of 
the microscope, and minor adjustments were made, if necessary, 
to centre the field and measuring apertures accurately.
The light, having passed through the specimen, is detected 
and measured by an RCA 931 A photomultiplier tube operated at 
lkV from its own stabilised power supply. A part of the beam 
is also directed to the inclined binocular head for viewing the 
fibre and the field aperture. The measuring aperture is 
located close to the photomultiplier window and can be viewed 
with the aid of a pilot lamp. It determines the fraction of 
the illuminated area that is sampled by the photomultiplier.
The field aperture was set to illuminate a portion about %rds 
of the width of a fibre to minimise the cylindrical lens efiect 
of the fibre and yet allow sufficient light to pass through it 
(Porumb, 1976), and the measuring aperture was adjusted to 
give a slightly smaller area within the illuminated area.
For the fibres used in this study the illuminated area is 
around 65ym x lOOym. ’
(ii) The Electronic System
This amplifies the output of the photomultiplier system, 
separating out the signal from the noise by phase sensitive 
detection i.e. it considers only that part of the photo­
multiplier output that is in phase with a signal from the beam 
chopper (Abernethy, 1973). A d.c. signal proportional to the 
light intensity is directed to a log amplifier, which has been 
calibrated so as to deliver an increase in voltage output of 
IV for every ten-fold increase in input. This output signal
drives the Y deflection of a Bryans X-Y plotter. The Y
\ ,
deflection can be calibrated in absorbance units using voltages
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measured on a digital voltmeter, since the deflection produced 
by a voltage of IV is equivalent to 1 OD unit. The X 
deflection is linear with wavelength and is produced by a 
ramp voltage from a potentiometer which is turned by the 
monochromator shaft. A range control unit allows the spectra 
to be scanned between pre-selected wavelengths.
A DNA-drug fibre reduces the intensity of the transmitted
light by such a large factor 103 - 104) that the logarithm
of the photomultiplier output rather than the signal itself is
recorded, in order to obtain the plots for the background and
specimen over the full wavelength range on the scale of the
plotter. There is an absolute limit to the absorbance which
can be measured of about 3.8 OD units for a 2nm bandpass.
This is due to stray light in the system. Stray light is
defined as the radiation reaching the detector whose wave*
lengths are outside the region isolated by the monochromator
(Slavin, 1963). It arises as scatter from the optics or from
the walls in the monochromator, and from ambient light which
has not passed through the chopper, reaching the detector.
Electronic noise would start to be troublesome for optical
densities greater than 4.0 (Porumb, 1976). Heterochromatic
stray light may be reduced to some extent by reducing the
exit slit to lnm, but then the intensity of light transmitted
through the fibre would be even lower. The optimum
arrangement was when the background intensity was so high as
to just avoid overloading the phase-sensitive detector (PSD)
when it was set at its lowest sensitivity. With a fibre in
position the PSD sensitivity could then be increased to
record a measurable signal, which was still above the stray
\\
light level. v
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A spectrophotometer cannot measure absorbances higher than 
the stray light level, and even at levels below this limit 
the absorbance peaks will show some flattening (Technical 
Memo UV—71-2, Varian Instruments, 1971). The level at which 
this flattening becomes noticeable is around 3.5 OD units judged 
from the absorption spectra of fibres of differing M values.
It was necessary to use thin fibres of fairly low drug/DNA 
ratios in order to minimise this effect. It was the intention 
of this thesis to make optical measurements on the same fibres 
as were used for the X-ray diffraction analysis. In order to 
obtain X-ray diffraction patterns within a reasonable exposure 
time, the fibres could be no thinner than about OOym. The 
phenanthridines studied here have large absorptivities, and if 
the measured absorbance was to be less than about 3.5 OD units 
M could not be less than about 20 for fibres of this size.
The fluorescence emission spectrum of ethidium bromide has 
its maximum intensity at around 595nm and its fluorescence 
quantum efficiency is known to increase 2 1-fold on binding to 
double-stranded DNA (Le Pecq and Paoletti, 1967). Despite 
this, fluorescence will have no significant effect on the 
absorption spectrum, since it occurs in all directions and 
only a negligibly small proportion is collected at the very 
small solid angle sampled by the measuring aperture and 
• photomultiplier.
It would be possible to automate the collection of the absorbance 
data by using a system such as that schematically illustrated in Fig. 7.3. 
The binary-coded decimal output of the auto-ranging digital voltmeter 
would be connected to a micro-computer, which would store the digital log 
intensity readings in memory.,  ^ The micro-computer would also take the 
place of the range control unit in Fig. 7.2, and the user would input the
From Digital 
Voltmeter 
(in BCD) \
Stepping
Motor
• Magnetic — 
"audio" <  
cassette
Paper tape  
punch
Micro -  
Computer
A
Y
-?• X-Y plot
CRT spectrum ' 
display
VDU
Figure 7.3 A schematic diagram to show the improvements suggested 
for the automation of data collection from the micro­
spectrophotometer
Figure 7.4 A biréfringent fibre between crossed polariser and analyser
\
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wavelength range over which each scan should be recorded, and the 
wavelength resolution required. Instead of using the ramp voltage from 
a potentiometer to calibrate the wavelength, the micro-computer would 
control tiie stepping motor directly by sending it appropriate current 
pulses. This would avoid the analogue-to-digital conversion that would 
be required if the ramp voltage scheme were retained. An initialising 
arrangement would need to be incorporated into the proposed scheme, for 
use at switch on, whereby a certain position of the monochromator drive 
shaft would be recognised by the stepping motor. Data could be routinely 
stored on a magnetic "audio" tape cassette, and nominated spectra could be 
translated on to paper tape for input to the program 1MICRO1, The user 
could communicate with the system via a video display unit, VDU, and the 
data could be displayed as it is being recorded on an XY plotter and/or 
on a cathode ray tube display.
The proposed scheme would eliminate the tedious and time-absorbing 
digitisation of the spectra by the D-Mac pencil follower which is currently 
employed. The user could communicate conveniently with the system and 
nominate the wavelength range and resolution through the VDU keyboard.
He would obtain an instant graphical display of the data, and could choose 
either to abort the spectral run, change the resolution within it or 
accept the spectrum. Some minor adjustment of the optics is required 
before a series of spectral runs. A standard spectrum (of a filter, say) 
could be stored in the micro-computer and compared with a trial spectrum 
of the same filter at the beginning of a session. If they agree to within 
an acceptable tolerance the user would be instructed to proceea; if they 
did not, he would be requested to re-adjust the optical system.
\\
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7.3 Birefringence
In order to measure its birefringence, a fibre is placed in a 
humidity cell on the specimen stage of the polarising microscope such that 
the fibre axis is at 45 to the crossed polariser and analyser (Section 
2.3.4.2). When reaching the fibre, the electric vector of the light is 
resolved into E( and E± (Section 6.4). These two components travel 
through the fibre at different velocities, because of the different 
refractive indices n ^ and n^. They will travel different optical paths 
and will emerge generally out of phase. Along the axis of the analyser 
they will project as Ef and E| (Fig. 7.4). If their path difference is 
zero or an integral number of wavelengths, they will cancel and extinction 
will result. For white light all the wavelengths will cancel only for 
zero path difference,while for higher path differences only one wavelength 
at a time will be cancelled exactly. The others will be transmitted to 
varying extents to give what are known as Newton's colours. For large 
path differences the fringes overlap to such an extent that only white light 
is seen. In theory,if the central fringe can be identified uniquely then 
the white light fringes permit very accurate measurements to be made of 
optical path differences and hence birefringence.
The birefringence was measured using the internal white light source
of the polarising microscope and an Ehringhaus rotary compensator. The
fast direction of the compensator was superposed on the slow direction of
the fibre. Rotation of the compensator changes its thickness in the light
path and thus varies the retardation which it produces. The resultant
path difference across the fibre plus compensator is reduced until -the
interference colours viewed in the microscope fall in Newton's scale.
Continued rotation of the compensator produces a dark compensation band 
"fell(the zero order band) in the middle of the fibre. The retardation 
produced by the calibrated compensator at this angle is equal and opposite
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to that of the fibre. The birefringence An is calculated from
path difference
- fibre thickness (7.5)
Exact compensation in white light can only be achieved if the 
relative dispersion of the birefringence of the compensator matches that 
of the fibre. Any marked difference between them will result in the 
compensation band being broadened and coloured, which leads to a 
phenomenon known as "fringe-jumping" i.e. the zero order band becomes 
ooloured while an adjacent (formerly coloured band) appears black (Faust 
and Marrinan, 1955; Hartshorne and Stuart, 1970). This problem was 
encountered only for those fibres whose birefringence was so large that 
tilt angles of 20° and above were required. For these fibres the 
problem was overcome as suggested by Hartshorne and Stuart (1970). The 
band that was dark at 95% R.H., when the birefringence was lowest, was 
assumed to be of genuine zero order. This band was followed as the 
specimen was dried down, as well as recording readings for the apparently 
dark band. At 55% R.H. the angles corresponding to the original band 
(now coloured) and the false dark band were determined. The readings at 
intermediate humidities were then corrected in proportion to this 
difference, and the corrected angles were converted into path differences 
by interpolation in the calibration table for the compensator.
7.3.1 Discussion of Results
The birefringence for a DNA fibre and for several DNA-phenanthridine 
fibres is shown as a function of relative hi*midity in Fig. 7.5. In each 
case the broken lines indicate the result of "normalising" the measured 
birefringence according to the method of Porumb (1976), to allow for the 
swelling of the fibres with increasing humidity. As the relative
humidity of the fibres is increased, they swell and the substantial
\
increase in volume (which can be of the order of 60-100% between 80% R.H. 
and 95% R.H.) causes a dilution in the polarisable material and a
Figure 7.5 (i) The birefringence of a typical DNA fibre and typical DNA- .
ethidium fibres as a function of relative humidity. (The 
full lines indicate the measured birefringence, and the 
broken lines indicate the normalised birefringence.)
• DMA-proihidiunn fibre(M=l6) I
!
(ii) The birefringence of typical DNA-dimidiurn and DNA- i
prothidium fibres as a function of relative humidity \
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consequent reduction in the measured birefringence. Unless this effect 
is considered explicitly it will obscure all other trends. In any case, 
it makes the birefringence results rather difficult to interpret 
quantitatively•
In general, the swelling of a fibre is a macroscopic consequence of 
an Increased separation of the oriented DNA helices and a swelling of the 
amorphous regions in the fibre due to uptake of water. Falk et al. (1963) 
have shown that water is adsorbed initially by the strongly hydrophilic 
POg groups and then by the P-O-C and C-O-C oxygens as the humidity is 
increased to around 65% R.H. At this humidity, about six water molecules 
are adsorbed per nucleotide. The carbonyl groups and ring nitrogen atoms 
of the bases become hydrated above 65% R.H. At these humidities the 
helices are generally in the A-conformation. X-ray measurements show 
that the crystal packing parameters of the A-form do not change "ith 
relative humidity. The very small observed swelling of a fibre in this 
humidity range confirms this, and is probably a result of the expansion of 
the amorphous regions between the crystallites. At around 75%-80% R.H, 
the molecules hydrating the carbonyl groups and ring nitrogens fill the 
grooves of the DNA helix, which has by now completed the transition to the 
B-conformation. At about 80% R.H., all exposed hydration sites are 
probably filled and a further increase in the ‘humidity causes the helices 
to move apart, resulting in the large observed increase in the dimensions 
of the fibre. X-ray diffraction measurements (Section 5.5.1) confirm the 
increase in intermolecular separation at these humidities.
In order to interpret the clianges in the observed birefringence with 
humidity, due allowance would need to be made for these complicated changes. 
The birefringence itself depends in a complex manner on the amount of water 
in the system, even if changes in the DNA conformation and disorientation
were not considered at this stage. Even in the simplified notion of the
V.
birefringence being the sum of two terms, the intrinsic and the form
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birefringence, it should be noted that the form term does not vary 
linearly with the fraction of water in a fibre (Equation (6.24)), so that 
'•normalising* the observed birefringence according to the dimensions of the 
fibre at each humidity is inadequate. In the more realistic treatment 
(Section 6.4.2) in which the two terms are not separable, ’normalisation* 
is unnecessary. Nevertheless, .the author has normalised his results in 
order to compare them with previous studies (e.g. Porumb, 1976).
The basic feature of the normalised birefringence is the increased
magnitude with increasing humidity. Fig. 7.5 shows that all the fibres 
\
exhibit a normalised birefringence which is fairly constant at low 
humidities, and rises steeply at around 80% R.H. This is a similar trend 
to that observed with DNA-daunomycin and DNA-adriamycin fibres (Porumb, 
1976). The size of the change is much too large to be explained in terms 
of a reduction in the disorientation of the DNA helices within the fibre.
In any case, the results of Chapter 5 indicate a slight increase in 
disorientation as the humidity increases, which would cause a decrease in 
the magnitude of the birefringence and not the observed increase. With 
the proviso that the normalisation is reasonably adequate to describe the 
hydration effects, the observed (normalised) results are consistent with 
an A to B transition of the DNA conformation in the fibres at around 80% 
R.H., The change in tilt angle from 20° to about 6° (Table 1.1) would 
result in a significant increase in the birefringence. Porumb (1976) has 
reported that if the form birefringence were taken as 58% of the intrinsic 
term, the total birefringence would increase by about 50% as the tilt 
angle changed from G° to 20°.
The magnitude of the birefringence is larger for all the DNA-drug 
fibres than for the control DNA fibres, and it increases with increasing 
drug content within a fibre (Fig. 7.5). This indicates that a significant 
proportion of the total birefringence of the DNA-drug fibres is due to the 
anisotropy of the drugs, bound at a specific angle, adding to the anisotropy
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of the base-pairs. If the drugs had been bound at a random orientation 
they would not contribute to the total birefringence. The birefringence 
values are lower for prothidium fibres than ethidium and dimidium fibres 
of the same M value, suggesting either that the prothidium chromophores 
are less anisotropic or that they bind at a larger angle to the plane 
perpendicular to the helix axis. Although prothidium contains an 
additional pyrimidyl moiety, this is unlikely to substantially affect the 
polarisibilities of the chromophore. Hence it is more likely that the 
lower observed values of birefringence with prothidium reflect binding 
at a larger tilt angle than is the case for ethidium and dimidium.
As the relative humidity is raised, the normalised birefringence of 
all the fibres increases. In the DNA control fibre, this is accounted 
for by the conformational change from A to B-DNA, which results in a 
reduction in the tilt of the base-pairs from 20° to 6°. For dimidium 
and ethidium fibres, the increase in the'normalised birefringence over the 
same humidity range is at least as large as in the control DNA fibre.
This suggests that as well as the base-pair tilt being reduced the tilt 
of the drugs also decreases at high humidity. It is consistent with a 
proportion of the drug leaving external binding sites and moving into 
intercalation sites as the humidity is increased. With the prothidium 
fibres the situation is more difficult to interpret. The bound dru£p 
contribute less to the total birefringence, and the observed increase in 
birefringence at higher humidities may reflect the change in the tilt of 
the base-pairs with little, if any, rearrangement of the bound drug 
molecules.
The problem of normalisation is circumvented if the birefringence i*3 
considered as a function of f', the volume fraction defined in Section 
6.4.2. Using this approach, the birefringence can be considered as a
complete term, not as one comprising intrinsic and form components. In
V
theory, the measured birefringence could be plotted against the volume
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fraction and the trends interpreted directly. in practice, with D M  
systems the situation is more complicated.
The parameter f • depends on the radius of the D M  helix, considered 
as a rod, and its ihtermolecular separation. The latter quantity is 
fairly readily deduced from X-ray diffraction patterns, but the radius 
of the helix is more difficult to measure especially from diffuse D M — 
drug patterns. The radius of the helices does not change with humidity 
(although there may be a slight increase at humidities above about 85%
R.H. if the hydration shell is included), and can probably be taken equal 
to the value for the control D M  at the same humidity for moderate drug 
loadings. The radius was taken as 9.96? at low humidities (£ 80% R.H.)
&nd 10.20? at high humidities. These are the optimised distances of the 
02 oxygen of the phosphate group from the helix axis in A-DNA and B-DM 
respectively (Arnott and Hukins, 1972). The size of the crystal
v
lattice of A-DNA does not vary with humidity, so that the intermolecular 
separation, a (and hence f'), will be constant over all the humidities over 
which the fibres are in a predominantly A-type configuration. In line 
with this, the measured values of the birefringence are essentially constant 
for all fibres which give A-type X-ray patterns. Consequently, all the 
birefringence measurements over a humidity range of 50% to 75% R.H. map 
on to a single value of f>. The parameter, a, was taken as 23.15? for
and 26*4? at 92% R.H. and 98% R.H, respectively, as measured in Section ■ 
5.5.1. For the DNA-drug fibres the intermolecular separation varied with 
the drug used and the M value of the fihre (Chapter 5). However, the 
variation was not great and all the D M  and DM-drug birefringence 
measurements at high humidity map on to a small range of f ' in the Antotal
vs. f 1 plot.
A-DNA (i.e. x /a2 ♦ b2 where the lattice parameters are a = 22.24X and 
b » 40.62? (Fuller et al., 1965)). For B-like patterns, a is the 
intermolecular separation. For the control 3-DNA, the values were 25.8?
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Fig. 7.6 shows tte results of plotting the data for a control D M  
fibre and a DNA-ethidium fibre (M * 12). The results appear to be 
consistent with the theoretical plots. The experimental data is confined 
to small regions in f'-space corresponding to the A and B conformations, 
and this makes interpretation of the results difficult. In particular, 
the expected discontinuity due to the A-B transition cannot be identified. 
It is possible to extend the range if a series of results were taken at 
100% R.H., and the fibres were allowed to swell over a period of time. 
However, this would result in a loss of orientation within the fibre and 
it would be difficult to arrange for the X-ray diffraction patterns (from 
which a is measured) to be taken at exactly the same conditions of swelling 
as the birefringence measurements were taken. In any case, results at 
100% R.H. will not help to characterise the discontinuity corresponding to 
the A-B transition.
The two schemes outlined are both rather unsatisfactory for the 
treatment of the birefringence data. In the first case, the theoretical 
simplifications and implicit assumptions are too far-reaching, and in the 
second case the experimental results are mapped on to two very small 
portions of the possible data area rendering the trends in the data 
virtually unrecognisable. However, it has been ascertained that the 
drugs bind to the DNA in a largely preferential orientation relative to 
the helix axis. With B-like patterns this orientation is probably close 
to perpendicular to the helix axis for ethidium and dimidium, because of 
the large increase in the observed birefringence of these fibres relative 
to the values lor DNA fibres,and because the birefringence continues to 
increase with increased drug content. There are problems in separating 
out the relative contributions of the drugs and the base-pairs to the 
observed birefringence. Nevertheless, the smaller birefringence of the 
DNA-drug fibres at low humidity, compared with the values at high humidity, 
suggests that the chromophores are tilted at a considerable angle from the
Piotai
Figure 7.6 Observed birefringence as a function of the volume fraction 
f. (See Fig. 6.19 for an explanation of the full lines)
Figure
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perpendicular plane to the helix axis at low humidities. With the 
prothidium fibres there appears to be no major re-orientation of the 
chromophores as the humidity is varied, and the birefringence measurement 
suggest that the prothidium chromophores bind at a considerable tilt 
angle at all humidities. The complicated nature of the hydration 
changes and the lack of knowledge of the polarisabilities of the drug 
chromophores make a more quantitative interpretation of the data very 
difficult.
W
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7.4 Linear Dichroism
7.4.1 Theory of Analysis in Terms of Two Bound Drug Species
The theoretical dependence of the linear dichroism on the tilt angle 
of the drug chromophores has been dealt with extensively in Chapter 6.
For the visible absorption bands, light is assumed to be absorbed 
isotropically in the plane of .the chromophore. Equation 6.11 and Fig. 
6.13 represent this situation, for a single mode of binding in which the 
chromophores assume a preferential orientation with respect to the helix 
axis. The situation in which a fraction of the drug molecules is bound 
by a different mode, with either a different preferred orientation or a 
random orientation, is more difficult.
If the drug chromophores in a fibre are oriented, and if and Aj_ 
are the absorbances measured with light polarised parallel and 
perpendicular* to the fibre axis, then the expression
A = + 2Aj_) (7.6)
gives the isotropic value of the absorbance, which would be recorded 
using unpolarised light. This is also the value that would be recorded, 
for any direction of polarisation of the light, if the chromophores were 
randomly disorientated. If there are two bound species, one with the 
chromophores characterised by a distinct orientation and the other with 
the chromophores randomly disordered, then the measured dichroic ratio, D, 
can be expressed as
F'(Da  - 1) + (2Da +1)
D = (2Da + 1) - 2F'(Da  - 1) (7*7)
where F* is the fraction of drug molecule« bound according to the first 
scheme, and D. is the dichroic ratio that would be measured if all theA
drug molecules bound by this method. This expression may be rearranged
so as to give an equation for F* in terms of D and DA
V
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(2Da + 1) (1 - D) 
(2D + 1) (1 - Da) (7.8)
If the chronophore orientation, 0, and the disorientation half-angle 
of the fibre, 6 , are knovm then can be found from Fig. 6.13.
Measurement of the dichroic ratio, D, will then permit the solution of 
Equation (7.8) to find the fraction of drug bound with a specific 
orientation.
The situation may arise in which the drugs arc distributed between 
two binding species, each of which is characterised by a distinct orientation 
to the helix axes. In this case the experimentally observed dichroic 
ratio,. D, is given by
F(Da - Db) + Db (2Da +1)
D = (2D. + 1) - 2F(D. - D )
A  A  B
where F is the fraction bound in the first species, and D., D_. are theA B
dichroic ratios if all the drug belonged to the first and second species 
respectively. This can be rearranged to give
(2DA + 1) (D - DB) 
F = (2D + 1) (DA - Db) (7.10)
Equations (7.9) and (7.10) reduce to Equations (7.7) and (7.8)
respectively, if the second species is randomly orientated, by setting
D = 1. In principle, one may write a relation of the type (7.10) for ext
the fraction bound by scheme A at any relative humidity. In particular 
it can be applied at the lowest and highest relative humidities measured, 
viz. 55% and 92% respectively in this study. In general, there would be 
too many unknowns to solve for F' uniquely at both humidities. However, 
in a particular case, the results from using other techniques (such as 
X-ray diffraction) may provide sufficient data to solve the equations, 
especially if the data indicates simplifications that can be applied to 
the binding model.
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7.4.2 Experimental Results
The spectra recorded from a control DNA fibre are shown in Fig.
7.7. DNA has no absorption band in this wavelength range and the 
recorded absorbance of about 0,4 0D units is the combined result of the 
cylindrical lens effect of the fibre (Section 7.2) and of light scattering 
by the specimen, particularly by salt crystallites and impurities 
present in the fibre. The measured absorbance depended on the thickness 
of the fibre but was always between 0.3 and 0.4 OP units at 650nm for the 
size of fibres normally used. These effects are also present presumably 
in the absorption spectra of the DNA-drug fibres, and allowance should 
be made for them in order to obtain absorbance values specific to the 
DNA-drug interaction. A correction for the vertical translation of the 
baseline was performed by subtracting the measured value of the absorbance 
at a wavelength where the drugs do not absorb (viz. 650nm) as suggested 
by Fraser (1953). The dichroic ratio should be constant over those 
wavelengths where absorbance arises from a single transition (Ding et al., 
1972). The measured dichroic ratios were always constant to within 
1 5% over the spectral range if a horizontal rather than an inclined base­
line correction was used, so that the error introduced by using this method 
was not serious. In any case, a correction scheme which was a function 
of wavelength (to allow for differential scattering) could only be 
estimated and probably would be different for each fibre.
7.4.2.1. Ethidium and Dimidiurn
Typical absorbance spectra for a DNA-ethidium fibre at low and high 
humidities are shown in Fig. 7.8. In each case the spectra are similar 
to those obtained from the complex in solution (Chapter 4). From the 
positions and relative intensities of the peaks it can be deduced that 
most of the drug is bound to the DNA in the fibre.
Plots of the log of the intensity against wavelength using the 
multiwave quartz plate attachment were compared with the values obtained
2-0 ~i A
Figure 7.8 (i) The absorption spectra of a DNA-ethidium fibre (M=19) 
at 92% R.H.
650
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using separate spectral runs. The results taken with the quartz plate 
did not traverse the full intensity range between the separate traces.
This may have been due to the time constant of the lock-in amplifier 
being set at too high a level. Reduction in the time constant results in 
additional noise being superimposed on the signal at these small signal 
strengths. Also the spectral band-pass of 2nm, required to obtain 
sufficient light through the DNA-drug fibres, is probably too large relative 
to the 5nm wavelength interval over which a complete oscillation occur.
The method is likely to be more successful for thinner fibres, though 
these would not be amenable to X-ray study. For the present study, however, 
it was decided to take the spectral traces separately, without using the 
quartz plate.
As the relative humidity is increased the general tendency is that 
the absorbances decrease, due to the dilution effect caused by the swelling 
of the fibre. However, the absorbances, A^ and Aj_, do not vary in the 
same proportion, presumably because simultaneous with the swelling there is 
a redistribution of the drug within the fibre. As a result of this, the 
dichroic ratio for ethidium and dimidium fibres changes with humidity as 
illustrated in Fig. 7.9 and Table 7.1.
In general, it is estimated that the dichroic ratios were obtained 
to an accuracy of around - 8%, The variability of the results for a 
particular drug, at a given humidity and M value, can be accounted for by 
this uncertainty and by the differences in the disorientation lialf-angle,
6, amongst the fibres. Over the limited K value range that could be 
measured the dichroic ratio appears to be independent of the proportion'of 
the drug in the fibre. There is no statistical significance to the small 
difference in the dichroic ratios of the two ethidium fibres (M = 19 and 
M = 24) presented in Fig. 7,9. An ethidium fibre with M = 24 was 
measured with a dichroic ratio as high as this II = 19 fibre (Table 7.1). 
Similarly, the dimidium fibres show no significant change in dichroic
TABLE 7.1
The Dichroic Ratios of some DNA-Drug Fibres as a Function of the Relative Humidity
Relative 
. Humidity \ 
{%)
Ethidium
M=19 M=24 M=19
Dimidi um
M=23
Prothidium
M=23
55 1.55 1.40 1.30 1.50 1.40 1.40 1.35 1.10 1.00 1.04
65 1.55 1.50 1.02
75 1.65 • 1.65 1.60 1.45 1.55 1.09 1.04
85 2.00 1.93
92 3.08 2.80 3.10 3.00 2.65 2.95 1.00 1.00 1.02
95 3.10 2.90 2.70 3.05 3.05 2.60
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Figure 7.9 Representative traces of the dichroic ratios of DNA-_
pbenanthridine fibres as a function of relative humidity
ratio with drug content. Indeed, the values for all the measured 
diraidium and ethidium fibres are the same for a particular humidity, 
within the estimated accuracy of the experimental method.
The problems of normalisation encountered with the birefringence 
measurements are avoided in this study, because the dichroic ratio, D, 
is a ratio rather than a difference of two quantities. Swelling 
corrections affect both the numerator and denominator equally, and 
therefore the ratio is independent of them. The consequent simplification 
in the analysis of the results is considerable, and the dichroic ratio 
measurements are much more amenable to quantitative interpretation than 
the birefringence measurements.
7.4.2,2 Prothidium
The results from DNA-prothidium fibres are very different (Fig. 7,9 
and Table 7.1). The dichroic ratio of several fibres, at the minimum M 
value that could be measured (M = 23), were taken over the humidity range 
from 55/i to 95?o R.H, Fibres with M values less than 23 could not be 
measured successfully, because the high absorptivity of prothidium resulted . 
in a flattening of the absorbance peaks at low humidities for fibres of 
80-100ym in diameter. For all of the measured fibres the dichroic ratio 
stayed very close to unity, and maintained this value over the complete 
range. The absorbance spectra are similar to the solution spectra 
recorded at high M values (Section 4.4,3), suggesting that most of the 
drug in the fibre is located close to the DNA.
7.4.3 Discussion of the Results
7.4.3.1 Ethidium and Dimidium
The experimental values of the dichroic ratio for DMA-ethidium and 
DNA-dimidi urn fibres are greater than unity, indicating that the drug 
molecules have a preferential orientation in the fibre. In particular, 
they are consistent with the drug being orientated essentially perpendicular
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to the fibre axis as would be the case for intercalation. The dichroic 
ratios reported here for these drugs are larger than those previously 
obtained using oriented DNA-acridine films (Neville and Davies, 19S6; 
Kurucsev and Zdysiewicz, 1971), but are generally smaller than those 
obtained with DNA-anthracycline fibres (Porumb, 1976). Films are generally 
less well orientated than fibres, and the anthracyclines may bind 
preferentially perpendicular to the fibre axis at a higher binding fraction, 
F, than do the phenanthridines.
As previously mentioned, the measurements were limited to fibres with 
a low proportion of drug (M £  20). The solution spectroscopy (Chapter 4) 
and X-ray diffraction results (Chapter 5) indicate that at these M  values 
a high proportion of the bound ethidium or dimidium would be tightly bound 
to the DNA, and that at high humidities (*.80% R.H.) this is likely to be 
by intercalation. The intercalatively bound drug would assume an 
orientation similar to that of the base-pairs (viz. about 6° from the plane- 
perpendicular to the helix axis).
The observation that the dichroic ratio, at a particular relative 
humidity, does not vary with M for large M values suggests that, in these 
fibres, both ethidium and dimidium distribute themselves between the 
different binding modes in a constant proportion. The dichroic ratio does 
not reflect the absolute amount of drug in a fibre at a specific 
orientation, but rather the fraction of the bound drug assuming this 
particular orientation. At low M values the proportion of drug inter­
calated would drop, due to the excluded site effect, and more drug would 
bo free or bound externally, so that the dichroic ratio would be expected 
to fall.
The fact that the dichroic ratio does not continue to rise at 
humidities greater than 92% R.H. confirms the conviction that no further 
intercalation takes place after 92% R.H. is reached. All of the drug 
cannot be intercalated at these humidities since the theory would predict
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a dichroic ratio of about 11.6 in this case, for a drug tilt of 6° and 
a disorientation half-angle of about 7° to 9°. The small drop in the 
dichroic ratio above 92% R.H. recorded with some of the fibres correlates 
well with the increase in disorientation measured from the X-ray 
diffraction patterns at these high humidities. It is unlikely that the 
drop reflects any of the drug slipping out of the intercalation sites 
since the hydrophobic drive towards intercalation is expected to be even 
stronger at these high humidities.
The drop in the value of the dichroic ratio, for both ethidium and 
dimidium, as the relative humidity is reduced below 92% indicates a change 
in the distribution of the bound drug between the intercalated and 
externally-bound sites. The reduction implies that a proportion of the 
intercalated drug slips out of its site and becomes free or externally 
bound. The retention of the absorbance maximum at around 520nm indicates 
that all of the drug is maintained close to the DNA, and probably remains 
bound to it. Some care needs to be taken when comparing these spectra 
with the solution spectra of Chapter 4. In the latter case a maximum 
absorbance of 520nm was considered as proof that no free drug was present 
in a complex. In the case of a fibre it cannot be regarded as presumptive 
evidence since, in a fibre, all the drug molecules are likely to be 
constrained close to the DNA, and hence absorb at 520nm, whether they are 
v bound to the DNA or not.
By the time 55% R.H. is reached all the DNA-drug fibres exhibit an 
A-type diffraction pattern and this would preclude any appreciable 
intercalation. The observation that the dichroic ratio remains greater 
than unity at this'humidity indicates that all the externally bound 
molecules cannot be bound in a random orientation. If all the externally 
bound drug is considered to be bound according to a particular scheme, 
then the value of 1.4 - 0.2 for the dichroic ratio at this humidity can 
‘ be interpreted in a number of ways.
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The molecules may be assumed to b* loosely attached to the exterior 
of the DNA helices, with a mean orientation approximately perpendicular to 
the helix axes. The disorientation parameter corresponding to the measured 
dichroic ratio would then reflect both the disorientation of the helices 
in the fibre and the additional orientational freedom enjoyed by the 
externally bound drug. For this situation, Fig. 6.13 indicates a 
disorientation half-angle of around 45° i 5°. This includes a value of 
about 5° - 9° for the disorientation of the helices, so that the drug 
molecules would be envisaged as "wobbling" over a half-angle of about 
36° - 40°. Although the external binding mode is largely ionic (Chapters 
4 and 5), the charge on the dimidium and ethidium chromophores is 
delocalised. Therefore, binding is not directional and a "wobble" of 
this magnitude may be reasonable.
An alternative explanation of the measured values of the dichroic 
ratio is that the drugs are bound rigidly to the helix, such that their 
disorientation is the same as that of the helices, and their chromophores 
are oriented at a considerable angle to the plane perpendicular to the 
helix axes. Fig. 6.13 indicates that for a dichroic ratio of 1.4 t 0.2 
this angle would be 48°t 3° for an isotropic transition dipole moment.
(Fig. 6.14 indicates that, for the case where the transition dipole moment 
direction is known, the dipole would be tilted at 31° t 2° from 
perpendicularity). This angle is somewhat larger than the angle of 
ascent of the DNA helices (approximately 27° for A-DNA, and 32° for B-DNA), 
but even if the externally bound diroidium and ethidium were envisaged as 
being attached to a su^r-phosphate chain, this does not preclucte 
orientations of the chromophore larger than the angle of the chain. The 
experimental values could also be accounted for by an intermediate 
situation in which there is some "wobble" of the drug molecules, and they
are bound at a tilt angle, 0, less than 48°.
\\
As the humidity is increased to 92% R.H. the measured dichroic ratio 
rises to around 2.9 - 0.25 indicating a substantial re-orientation of the
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drug chromophores, A fraction, F, of the bound drugs can be considered
as leaving the external binding site, and moving to an intercalation site.
In this position "themolecules are bound rigidly with a tilt, 0 , of about
6° and a disorientation half-angle, 6, equal to that of the helices
themselves, viz, 5 - 9 , If all the drug was bound intercalatively the
dichroic ratio would be 11.6 (from Fig. 6.13), and if it is all bound
externally (as is proposed to be the situation at 55% R.H.) the dichroic
ratio is 1.4 - 0.2. Equation (7.10) may be applied to a DNA-ethidium
fibre at 92% R.H. V/ith the experimentally determined dichroic ratioy
D, equal to 2.9 t 0.25, and values of 11.6 and 1.4 t 0.2 for and DQ
respectively, the expression predicts that the fraction of ethidium
intercalated at this humidity is 0.52 t 0.07. The value of F is fairly
independent of the value of D^, so long as it is large in comparison with
Dg. It is almost proportional to the difference in the measured dichroic 
*
ratios at high (92% R.H.) and low (55% R.H.) humidities, (D - Dg).
The values for DNA-dimidium fibres are very similar to those for BNA-;
ethidium, and considering the variability within fibres containing the 
same drug and the uncertainty in determining the dichroic ratios, the 
value of F, the proportion of dimidium drugs intercalated at 92% R.H 
can be taken as being essentially the same as for ethidium i.e , 0.52 i 0.07, 
As mentioned earlier this proportion appears to be independent of the 
drug content for large M values (M = 19-24).
This interpretation of the linear dichroism results can be compared 
with that for the X-ray diffraction results. Values for the fractions of 
ethidium and cumidium intercalated at 92% R.H. were calculated from the 
observed pitch values of the diffraction patterns in Sections 5.5 and 
5,6, using Equation (5.9). The values for F depend on the unwinding 
angle assumed. The minimum unwinding angle consistent with intercalation
is 12° (Pigram, 1968). If this figure is taken, a value for F of 0.90 isV
obtained for both ethidium and dimidium at moderate binding levels (i.e
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M » 5). If a larger value for the unwinding is considered, then the 
value of F will be correspondingly lower. For instance, an unwinding 
of 26°, proposed in several publications (e.g. Wang, 1974; Pulleyblank 
and Morgan, 1975; Tsai et al,, 1977), results in a value for F of 
0.65 - 0.70.
The value of 0.52 i 0.07 suggested by the linear dichroism studies 
is in fair agreement with the X-ray diffraction results that have assumed 
an unwinding of 26° at the intercalation site. This value of F can be 
used in conjunction with the X-ray results to suggest a value for the 
unwinding angle. However, the unwinding angle found in this way becomes 
very sensitive to the value of F, for F values considerably less than 
unity. For F = 0.52 t 0,7 the predicted unwinding angle, on the basis 
of the diffraction results, would be 34° i 3°. This i3 similar to the 
revised estimate by Lerman (1964) of the unwinding angle, viz, 36°, though 
it is higher than the total unwinding of 29° (Tsai et al,, 1975) and the 
unwinding at the intercalation site of 26° (e.g. Wang, 1974; Pulleyblank 
and Morgan, 1975; Tsai et al., 1977) proposed for ethidium bromide.
The value of F determined from the dichroism studies, and hence the 
predicted unwinding angle, depends on the accuracy of the dichroic ratio 
measurements and on the applicability of the theory used to analyse the 
results. The inaccuracy of the measurements is a consequence of the 
variability of the fibres, and the assumption of a horizontal base-line 
(Section 7.4.2), but both factors are considered to be included in the 
uncertainty estimates of D and Dg. The esalutation of F using the scheme 
adopted by the author does not depend on an interpretation of the binding 
at low hum i di t i e s, ,a It hou £h possible binding schemes have been proposed. 
The only assumption is that the drugs remain positioned in the same way 
at high humidities, except for a fraction F which slips into intercalation 
sites. If the drugs which are not intercalated at 92% R.H. substantially 
change their orientations then this would affect the analysis. In
- 182 -
particular, if these drugs change their positions such as to contribute 
a smaller amount to the total observed dichroic ratio, D, then the value 
of F obtained will be systematically lower than the actual fraction of 
intercalating drugs. If this were the case it would help to account for 
the difference in the value of F obtained in this chapter and that 
obtained in Chapter 5, assuming an unwinding angle of 26°.
7.4.3.2 Prothidium
The dichroic ratio cf the DNA-prothidium fibres is close to unity 
over the complete range of relative humidities measured (Fig. 7.9). A 
value of unity can be interpreted in a number of ways. There could be 
complete disorder in the orientations of the molecules; or they could all 
be orientated at an angle of about 55° to the plane perpendicular to the 
helix axis (Fig. 6.13); or there could be a mixture of these two schemes. 
Since prothidium is doubly charged a substantial proportion of it is 
expected to bind strongly to two adjacent phosphate groups of the 
sugir-phosphate chain and these molecules would not be able to "wobble" 
appreciably (Chapter 8). An alternative method of binding would be 
between the two sugar-phosphate chains, but again this would appear to 
bind the drug rigidly (Chapter 8).
The observed dichroic ratio can best be explained in terms of some 
of the molecules being randomly oriented, and the remainder being tightly 
bound. These rigidly bound drugs may be distributed between a number of 
specific binding schemes, but the overall effect would be that they were 
equivalent to being all bound at 6 = 55°. Some of the drug could be 
bound along the sugar-phosphate chain, with a range of tilts probably 
around 40° (the angle of ascent of the helices), and some could be bound 
across two adjacent sugar phosphate chains, at a tilt angle close to 90°. 
The small observed values of the dichroic ratio exclude the possibility
of any appreciable intercalative binding, in agreement with the X-ray
\ .
diffraction results of Chapter 5.
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There is no evidence of any significant re-orientation of the bound 
prothidium molecules as the humidity is changed. The dichroic ratio 
remains essentially constant. The association constant for prothidium 
binding to DNA is so large (Section 4.4.3) that, once bound, it is 
probably reluctant to leave its binding site. This can be interpreted 
in conjunction with the DNA-prothidium diffraction patterns, in which a 
significant proportion of A-type diffraction was observed for most fibres 
even at 92% R.H. This suggests that a considerable proportion of the 
drug may be bound across the two strands in DNA, and these may tend to 
resist the A to B conformational transition of the DNA as the humidity is
increased
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7.5 Summary
The birefringence results are difficult to interpret uniquely. For 
ethidium and dimidium, they are consistent with a substantial proportion 
of the drug being bound perpendicular to the helix axis at 92% R.H., and 
most of it leaving this site to bind at larger tilt angles when the 
humidity is lowered to 55-75% R.H. For DNA-prothidium fibres of similar 
M values the birefringence is lower, and is only slightly higher than the 
DNA values, indicating that the prothidium molecules are oriented in such 
a way that they contribute little to the birefringence resulting from the 
anisotropy of the base-pairs. The prothidium molecules could be binding 
at sites with fairly large tilt angles.
The dichroic ratio measurements have been interpreted assuming that 
no intercalation is possible at low humidities. For all three drugs, 
the binding at low humidities is envisaged as being largely electrostatic 
in character. For ethidium and dimidium, the results can be interpreted 
as a mixture of fairly rigid binding to the sugar-phosphate backbones 
(withe £ 48°) and loose binding perpendicular to the helix axis, with 
the drug "wobbling" through a half angle of about 33°. The "wobble" 
would be less if chromophores were bound at an angle intermediate* between 
6° and 48°. For prothidium, the attachment to the DNA helices would be
more rigid.■ A proportion of the drug may be bound along a sugar-phosphate 
chain, and some is probably bound between two adjacent chains. In 
addition, there are probably drugs bound in a random orientation.
As the humidity is raised to around 92% R.H., the dichroio ratio of 
the ethidium and dimidium fibres increases. The measured values indicate 
that about 52 7% of the drug becomes intercalated at 92% RH. Together with
the X-ray diffraction results, this suggests an unwinding angle of 34° - g° 
at each intercalation site. This would be an overestimate of the unwinding 
if the externally bound drugs were to diange their orientation as the
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humidity was raised from 55% to 92% R.H., such as to contribute less to 
the dichroism at high humidity. The prothidium fibres maintain a low 
dichroic ratio as the humidity is raised to 92% R.II,, implying no 
significant change in the orientation of the bound molecules.
The observation that the dichroic ratios of the DNA-ethidium and 
DNA-dimidium fibres at 92% R.H. 5.s fairly independent of M, at the large 
M values used in this study, is an indication that kinking of the DNA 
is not an important feature of intercalation at these levels of binding. 
Bending or kinking of DNA alters the symmetry of the helix, thereby 
changing the spatial averaging of the transition dipole moments. Random 
distortions of the helix make DNA more isotropic, and would cause the value 
of the dichroic ratio to fall (Ding et al., 1972). If the dichroic ratios 
of fibres at a moderate drug loading (II ^ 5-15) were measured, the 
situation could be further resolved. If the drugs remained distributed 
between the binding schemes in the same proportions for this range of M 
values, a constant dichroic ratio would be evidence that the helix remains 
linear and is not kinked at an intercalation site.
Porumb (1976), in a preliminary study, has reported a value (viz. 3.2) 
for the dichroic ratio of a DNA-ethidium fibre at 92% R.H. similar to 
the values quoted here. However at low humidities he reported a much 
larger value (viz. 2.4) than those measured in this work. Since the 
measurements are taken at high humidities first, and then recorded as 
the humidity is lowered, it is possible that the fibre had not equilibrated 
properly to the low humidity conditions in his study. The ionic 
conditions and/or the degree of orientation in his fibre may have been 
somewhat different, The difference in the dichroic ratios at low and 
high humidities is critical in determining the fraction intercalated at 
high humidity. The much smaller difference suggested by Porumb (1976)
results in a much smaller fraction of intercalative binding ( F 0.20)
V
at 92% R.H,, which would imply an unreasonably large value for the
unwinding angle.
Theoretically, it is possible to combine the linear dichroism and 
X-ray diffraction results to predict the unwinding caused by the 
intercalation of ethidium or dimidium, taking into account the 
disorientation within the fibres. In practice, however, the results are 
limited by the difficulty in comparing fibres of the same M value using 
the two techniques. The dichroic ratio could only be measured at M 
values greater than or about 20 for fibres that are sufficiently thick 
for X-ray diffraction, because of the large absorptivities of these drugs 
and the stray light limit of the microspectrophotometer. However, the 
pitch of these fibres is close to the pitch of the DNA control fibres, so 
that the ratio of the pitch of the drug fibres to that of the control 
cannot be estimated accurately. This would result in a very large 
uncertainty in the unwinding angle. Pitch values corresponding to M 
values of say, 5 to 15 can be distinguished much more readily from the 
pitch of the control DMA, but these fibres are different from those 
investigated by linear dichroism.'
This work has considered the trend in the pitch values obtained by 
X-ray diffraction over a wide range of M. At low M (M ^ 5) the values 
of the pitch appear to saturate, probably due to excluded site effects.
At high K(M £ 20) the values are difficult to distinguish from the control 
values, but the proportion of drug intercalated has been assumed to be 
similar to the proportion intercalated in fibres of moderate M value 
(M = 5-15). The F value from the dichroism measurements can then be used 
in parallel with fairly precise pitch measurements to obtain a reasonably 
precise estimate of the unwinding angle. The accuracy of this estimate 
depends on the validity of assuming that F is the same for a fibre at 
M = 20 as it is for a fibre of II = 5-15.
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CHAPTER 8
CONCLUSIONS AND MODEL-BUILDING STUDIES
8.1 Conclusions from the Experimental Studies
The biological activity of a number of drugs, with a variety of 
anti-tumour, anti-leukaemia and antimicrobial action, has been shown to be 
due to their interaction with nucleic acids (e.g. Waring, 1964; Bolron et 
al., 1969). The main aim of this thesis was to characterise the 
interaction of three phenanthridine drugs with DNA, by combining information 
obtained from spectroscopy and equilibrium dialysis of the complexes in 
solution with results obtained from X-ray. diffraction, birefringence and 
spectroscopic (including linear dichroism) studies of o_dented fibre 
specimens of the same complexes. Some techniques such as visible spectro­
scopy are particularly convenient to apply to DNA-drug solutions, although 
this is hardly comparable with the physiological state; other valuable 
techniques such as high angle X-ray diffraction must be applied to semi­
solid specimens such as fibres, in which the concentrations of DNA, ions 
and water are probably comparable to those in the chromosomal material of 
living cells. A major element of this study proved to be the development 
and/or detailed evaluation of a number of analytical techniques which can be 
applied to many DNA-ligand systems.
Ethidiura bromide has been studied previously by a number of investigators 
(e.g. Waring, 1965; Le Pecq and Paoletti, 1967; Plumbridge and Brown, 1977), 
but this work has extended these studies in several areas. A detailed 
comparison of the binding to DNA of ethidium and the two related drugs, 
dimidiurn and prothidium, allows their properties to be related in some 
detail to the general features and specific differences in their structures. 
The results of this work have been related to detailed models of the binding 
of the individual drugs (Section'8.2.29, and it is hoped that this approach 
may contribute to the development of new, more specific chemotherapeutic
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agents with reduced toxic side effects,
A detailed study of the binding parameters in solution was carried 
out for the three drugs, binding to various natural D M  samples of varying 
G-C content. The solution spectra of the complexes were taken for a large 
number of binding ratios using a novel mixing scheme developed by the 
author. The current work has obtained good isosbestism in the spectra of 
DM-ethidium and DNA-dimidium complexes at low and high ionic concentrations, 
and fairly good isosbestism for DM-prothidium complexes at high ionic 
concentrations. This indicates the existence of only one spectroscopically 
distinct binding mode in these instances. If more than one binding species 
exist, they must all involve binding close to the D M  base-pairs so that 
the effects on the drug spectra are similar.
The binding has been analysed according to the theory for the excluded- 
site model proposed by McGhee and Von Hippel (1974), using a computer 
program written by the author. In general, this theory provided a good 
fit to the experimental data, which lends credence to the applicability of 
this treatment. The data, presented in the form of Scat chard plots, is 
non-linear and cannot be treated realistically by the previously employed 
analysis (used by Waring (1965), Paoletti and Le Pecq (1967), and Plumbridge 
and Brown (1977)), which assumed no occlusion of neighbouring sites by a 
bound drug. Supplementary data from equilibrium dialysis measurements 
confirmed the results from the solution spectroscopy studies, although the 
dialysis data was not so precise and was not used in the curve-fitting 
program to find the binding parameters.
Values for the association constants and the binding site sizes have 
been obtained for each drug. For both ethidium and di mi dium, the 
association constants are lower at high ionic concentration and the binding 
site size is increased at high ionic strength. This is accounted for by
an ionic character to the binding. At higher ionic concentration the
\\
charged drug chromophores are in competition with a larger proportion of 
sodium cations, from the buffer, for attachment to the negatively charged
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phosphate sites on the helix. The phosphate anions will be screened to a
larger extent and this will inhibit drug binding. Fewer sites will be
available for binding the dru& resulting in a large value for the apparent
binding site size. Dimidium is bound less tightly than ethidium, and
exhibits a slightly smaller binding site size. For prothidium, the 
0
association constant is much higher, rendering its determination more 
difficult. The value probably reflects the doubly-charged nature of the 
drug, and the multiplicity of possible binding sites (Section 2.2.3).
Indeed, the binding curves suggest that at least two binding modes (with 
similar spectra but different binding parameters) are operating. These 
effects have contributed to an absence of isosbestism in the DNA-prothidium 
spectra at low ionic concentration, and these spectra were not analysed 
quantitatively. For clinical applications, drugs with very large 
affinities for DNA may prove to be very useful, provided that they also 
have some specificity. To this end, an ethidium bromide dimer has been 
synthesised and it exhibits a binding affinity for DNA about three orders 
of magnitude larger than that for the monomer (Gaugain et al., 1978).
Previous spectroscopic studies (Waring, 1965; Paoletti and Le Pecq, 
1967) were unable to detect any specificity in the binding of ethidium 
bromide to natural DNA's, but more recent studies (Krugh et al., 1975;
Krugh and Reinhardt, 1975; Patel and Canuel, 1976) using dinucleotide and 
tetranucleotide solutions have reported a binding preference for purine 
(5 * - 3») pyrimidine sequences. The current work has been able to detect 
a strong G-C specificity in the binding of ethidium bromide to natural DNA 
polynucleotides. At low ionic concentration, the specificity is more 
marked and the drug -prefers to bind to a sequence of two G-C pairs, although 
the precise nature of this sequence specificity (viz. whether GpC, CpG, GpG 
or CpC) could not be ascertained. Further studies of this type using 
synthetic polynucleotides may prove useful in clarifying the specificities 
operating, but difficulties are anticipated in differentiating between
%
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consequences arising from the presence of different base-pairs and those 
arising from the conformational differences believed to occur with synthetic 
polynucleotides (Bram, 1972; Bram and Tougard, 1972; Brain, 1973), 
Nevertheless, detection of a specificity for ethidium binding to natural 
DNA's represents a significant advance-.on previous studies.
The binding of dimidium to DNA is less specific. At low ionic 
concentrations, it shows a preference for G-C pairs but at high concentration 
the specificity is only very slight. The specificity shown by both these 
drugs is not considered an absolute preference, but rather a relative 
preference, for G-C base-pairs. The level of binding at saturation is too 
high to be accounted for by binding to G-C base-pairs alone. It seems 
likely that dimidium binds more readily to A-T base-pairs than does ethidium, 
and this would explain the smaller binding site sizes obtained for dimidium. 
Its binding is able to continue to a higher level because it is not limited 
to such an extent by the absence of G-C pairs. For both drugs, the 
binding site size reflects a situation close to nearest-neighbour exclusion.
The results for prothidium binding to different DNA types are very 
different. Both the association constant and the binding site size are 
constant with varying G-C content, indicating that there is no specificity 
in the binding for a particular base-pair. The initial binding saturates 
at about r = 0.5 (viz, one bound drug for every two base-pairs) but then 
continues, presumably by a different mode, to. larger levels. Since 
prothidium is a larger molecule than either ethidium or dimidium, this 
suggests that the binding modes operating with prothidium are different to 
the primary binding mode for ethidium and dimidium. In particular, if • 
these latter two drugs are binding primarily by intercalation it suggests 
that prothidium may not bind intercalatively. In any case, the pyrimidyl 
moiety of prothidium would be expected to discourage the intercalation of
prothidium because of possible steric hindrance (Section 8.2.2.3).
\ \
Previous X-ray investigations of the intercalation process (Neville
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and Davies, 1966; Pigram, 1968; Porumb, 1976) have been extended or 
supplemented by considering the helix parameters of the complexes at a 
number of DNA/drug ratios and at different relative humidities. The DNA 
pitch rises markedly with increasing drug content to an asymptotic value 
of around A7% for ethidium fibres, and 49/? for dimidiurn fibres. These 
asymptotes can be accounted for by a saturation of the binding due to 
neighbour exclusion effects, and the larger value for dimidium correlates 
well with the lower values for the binding site size of this drug obtained 
in the solution studies. The pitch increases can be more readily explained 
in terms of intercalative rather than external binding. At humidities less 
than about 80% R.H., the diffraction patterns revert to an A-type intensity 
distribution suggesting that all of the intercalated drug molecules have 
moved out of these binding sites, to become either free or externally bound. 
For prothidium, there is no measurable change in pitch relative to the 
control DKA fibres, at any humidity or drug concentration. This excludes 
intercalation as a major binding scheme, in agreement with the indications 
of the solution spectroscopy study.
It has been recognised (Neville and Davies, 1966; Pigram, 1968; Porumb, 
1976) that the relative humidity of the fibre environment greatly affects 
the balance between intercalated and non-intercalated drug in the fibre.
In particular, it has been suggested that at, say, 92% R.H, all the bound 
drug may not be intercalated. Due to a lack of knowledge of the fraction 
of drug intercalated, it is not possible to determine absolutely the 
unwinding angle of the DNA helix at the intercalation site by X-ray 
diffraction methods alone. However, if a value for the unwinding angle is 
assumed, the fraction of drug intercalated may be calculated. For an 
unwinding of 12° (Fuller and Waring, 1964), the pitch measurements obtained 
in this study at high humidity suggest that for ethidium 90% of the drug is
intercalated at moderate binding levels (M 5-15), and this proportion
V
falls to about 67% when saturation is approached. For dimidium, with this
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unwinding angle, the proportions are 90% and 76% respectively. If an 
unwinding angle of 26° is assumed (l/ang, 1974; Pulleyblank and Morgan,
1975; Tsai et al., 1977), then about 63% of the ethidium would need to be 
intercalated at moderate binding levels, and 49% close to saturation.
For dimidium the values would be 68% and 55% respectively.
The spectra of DNA-drug complexes can be recorded easily in solution 
to yield the fractions of free and bound drug, the very evidence which is 
required for the interpretation of the X-ray diffraction results on the 
fibre. Therefore, in parallel with the X-ray diffraction studies, the 
birefringence and linear dichroism of fibres were measured using a single­
beam microspectrophotometer. Unfortunately, only the spectra and dichroic 
ratios of fibres of relatively low drug content (M 20) could be measured 
directly, for fibres of sufficient thickness 80ym) to be suitable for 
X-ray diffraction. At smaller M values, the large absorptiviti.es of the 
phenanthridines gave rise to absorbances greater than the stray light limit 
of the equipment. Scattering of light by the fibres resulted in a shifting 
of the baseline absorbance levels, but consistent results were obtained if 
corrections were applied by referring the baseline to a region where the 
drugs do not absorb viz. 650nm. The absorption spectra of the fibres were 
similar to the spectra of the corresponding DNA-drug complexes in solution 
where all the drug is bound. Thus, it appears that in the fibre state all 
of the drug is located close to DMA, and most of it is probably bound to DNA 
at all humidities between 55% and 95% R.H,
The theory of the birefringence and linear dichroism of fibres (such 
as those of DNA-drug complexes) has been developed in depth. The 
disorientation of the DNA helices has been considered explicitly in the 
analysis, by adopting a model in which the helices are considered to be 
oriented about the fibre axis according to a gaussian distribution function.
Numerical solutions to the analyses have been presented.\ \
There are difficulties in the interpretation of the birefringence
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results because of a lack of knowledge on‘the polarisabilities of the drug 
chromophores, and because of the swelling of the fibres with increased 
hydration. Nevertheless, the results are consistent with a large 
proportion of the ethidium and dimidium ohromophores being roughly 
perpendicular to the helix axis at high humidities, and this proportion 
being much less at low humidities. For prothidium, the chromophores would 
appear to be attached at a considerable angle to the plane perpendicular 
to the helix axis, and there is probably little reorganisation of the 
binding as the humidity is changed.
The dichroic ratio monitors the effect of all the drug molecules, 
whereas X-ray diffraction primarily reflects only the effect of specifically 
oriented molecules such az intercalated drugs. The linear dichroism 
results are easier to interpret than those for birefringence, since the DMA 
contributes no appreciable absorption to the fibre in the visible region of 
the spectrum. Values of the disorientation of the helices within a fibre 
are obtained from the arcing of the diffraction spots and are used in this 
analysis.
For ethidium and dimidiura the dichroic ratio is low (1.4 - 0.2) at 
low humidities (55 - 75% R.H.). The diffraction results have indicated 
no intercalation at these humidities, and the fibre absorption spectra 
indicate that probably all of the drug is bound. Some of the drug must 
be bound at specific orientations in order to give an observed dichroic 
ratio greater than unity, but the general ionic association of the drug to 
the DNA is unlikely to result in well-defined orientations. The binding 
is probably a combination of binding at random orientations with binding at 
preferred oriuntatigns. This latter group could include drug molecules 
almost perpendicular to the helix axis with a "wobble" of about 38° and 
molecules rigidly bound to the helix with a tilt angle of about 48°, but it
is more likely to comprise molecules bound with parameters intermediate
N\between these two extremes.
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At 92% R.H. the dichroic ratio of the ethidium and dimidium fibres is 
larger (2.90 - 0.25), and this can be identified with a substantial 
fraction of the drug becoming intercalated at this humidity with a tilt 
angle of about 6°. If it is assumed that the externally bound drugs 
retain the same distribution of orientations as they had at 55% R.H., then 
the results indicate that 52 £ 7% of the drugs are intercalated at 92%
R.H.. The fraction intercalated appears to be constant, with M, for large 
M values (M = 19-24) well away from nearest-neighbour exclusion effects. 
Ionic conditions within the fibre are expected to be an important factor in 
determining the balance between intercalated and externally bound drugs, 
since they will affect the association constants for the binding.
For prothidium fibre?, the dichroic ratio is close to unity over the 
relative humidity range measured. This indicates that there is probably no 
substantial reorganisation of the bound drug molecules as the hianidity is 
varied. A value close to unity suggests that a large proportion of the 
drug is probably bound with random orientations. Any molecules bound with 
a specific orientation must have an average tilt, 0 , close to 55°, to 
maintain a dichroic ratio close to unity. This could result from some of 
these molecules being bound along a sugar-phosphate chain (6 ^ 40 ) and
f \ j  _
some being bound between tvx> adjacent chains (0 ^ 90 ). In both instances 
the binding is likely to be fairly rigid, and no appreciable "wobble11 is 
envisaged. The possible binding schemes consistent with the experimental 
results are discussed in detail in Section 8.2.2.
Unfortunately, the results from the linear dichroism and the X-ray 
diffraction studies cannot be strictly compared. The fibres used in the 
dichroism studies must have a small drug concentration, and the measured 
values of the pitch of these fibres are almost indistinguishable from the 
value for the control DNA fibres. This would be expected at these M 
levels even for complete intercalation. However, if it is assumed that 
the same proportion of drugs is intercalated in fibres of moderate drug
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content (M % 5-15) as in those of low drug content (M K 20), and that the 
externally bound drugs maintain a similar distribution of orientations at 
low and high humidities, then the results of the two studies may be combined 
to give some estimate of the unwinding angle. With these assumptions, the 
estimated unwinding at an intercalation site by either ethidium or dimidium 
is 34 i 8°. This cannot be regarded as an empirical determination of the 
unwinding angle, because of the simplifications assumed, but merely an 
estimate consistent with the results from both the X-ray and linear dichroism 
studies. The substantial uncertainty in this estimated value is mainly due 
to variability in the fibres leading to a range in the measured dichroic 
ratios. It is not accounted for by the different disorientations of the 
individual fibres. The estimated value is somewhat higher than the 26° 
unwinding proposed by Wang (1974) and others, but it is closer to this 
finding than to the earlier estimate of 12° suggested by Fuller and Waring 
(1964).
' \
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8.2 Model Building: Studies
8.2,1 A Review of Previously Proposed Models
For a variety of dru^, their method of binding to DMA has long been 
envisaged as intercalation. Such an interaction was first proposed on 
the basis of X-ray diffraction, flow birefringence and low-angle X-ray 
scattering of DNA-proflavine complexes (Lerman, 1961). Lerman showed that 
the DMA would have to unwind at an intercalation site, and built a model with 
an unwinding of 45°. Later he revised this value to 36° (Lerman, 1964), 
but it should be emphasised that these were examples of possible models, 
not the best possible models resulting from extensive model-building studies. 
Since that time an accumulation of evidence, using many different physical 
techniques, has supported this binding scheme (see Section 1.2 for 
references), and intercalation is now accepted as the primary binding mode 
in the interaction with DMA of many drugs containing fused aromatic rings.
Fuller and Waring (1964) suggested that intercalated ethidium lies 
across and between successive base-pairs, with the phenyl and ethyl groups 
lying in the large groove of the DMA. Such a position allows the formation 
of hydrogen bonds between the 3- and 8-amino groups of the ethidium cation 
(Fig. 1.8) and phosphate groups on the two strands of DMA. The steric 
hindrance between the DMA and the phenyl and ethyl groups determines to a 
Large extent the precise position of the intercalated chromophore. The 
complex is stabilised by the two hydrogen bonds, and by stacking interactions 
with the base-pairs with which there is good overlap. The aromatic triple 
ring is hydrophobic and the phenyl substituent is hydrophilic. The drug 
v/ill be strongly driven towards intsrealativo binding on energetic grounds, 
because in this position the triple ring v/ill be in a non-polar environment 
and the phenyl group will be projecting into an aqueous environment. The 
amino groups will also form favourable bonds.
On the basis of skeletal model building, Fuller and Waring (.1964)
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proposed that an unwinding angle of only 12° for each ethidium molecule was 
sufficient to allow intercalation, and that this small unwinding might be 
significant kinetically. From a detailed consideration of the DNA 
stereochemistry, Pigram (1968) concluded that 12° would be the minimum 
unwinding required for entry of any drug into an intercalation site and 
that models could be built for unwinding angles larger than this, up to at 
least 36° and possibly even 45°, More recently there have been a number 
of papers suggesting that the unwinding angle is significantly larger than 
this minimum value, and a value of 26° has been proposed for ethidium 
bromide (e.g. Wang, 1974).
Intercalation of ethidiura bromide into the miniature double helix 
Gp iodoC has been observed at atomic resolution by X-ray crystallography 
(Jain et al., 1977) and a detailed molecular model has been proposed.
These authors have postulated that drug intercalation gives rise to a 
helical screw axis dislocation in DMA, a variable whose magnitude determines 
the relative ring overlap between the intercalated drug chromophore and the 
adjacent ba.se-pairs. For ethidium, the helical axes of 3-DNA are estimated 
to be displaced by approximately lft (Sobell et al., 1977). Base-pairs on 
either side of the intercalation site are twisted by 10°, giving rise to an 
unwinding of 26° by the intercalated ethidium. The base-pairs are tilted 
relative to one another by about 8°, resulting in a "kink" at the 
intercalation site (Tsai et al., 1977; Jain et al., 1977). The large 
unwinding angle reflects the conformational changes in the sugar-phosphate 
chains accompanying intercalation. These primarily reflect the difference 
in sugir puckering about the intercalation site, C2* endo (5' - 3') C3' endo, 
rather than the C2' endo puckering assumed by Fuller and Waring (1964) for 
qTl the nucleotides, and alterations in the glycosidic torsional angles 
that describe the base-sugar conformation. Berman et al. (1978) have
suggested that the unwinding angle can be directly related to the size of the
\\
intercalating drug, and they have reported that proflavine, which lacks the 
bulky ethyl and phenyl substituents, may intercalate into a dinucleoside
- i9a
monophosphate with an unwinding angle as low as 3°,
Jain et al. (1977) report that the phenyl and ethyl groups of ethidium 
are found to lie in the narrow groove of the miniature double helix, 
exactly opposite to their orientation in the Fuller-Waring model. This 
difference could reflect the presence of the iodine atoms on the cytosine 
residues of the miniature double helix which, because of their bulk, may 
interfere with intercalation from the wide groove. The mixed sugar 
puckering necessarily predicts that intercalation be limited to every other 
base-pair at maximal binding ratios (i.e. a neighbour exclusion model), 
providing an attractive rationale for the observed limits to the binding in 
solution (Chapter 4) and the limits to the pitch increase in the fibre 
state (Chapter 5).
However, the details of drug binding to dinucleosides may not be a 
completely accurate model for drug-nucleic acid polymer associations, since 
the chemical structures and the environments are somewhat different in the 
two cases. For example, in the ethidium-dinucleoside complex there is 
only one phosphodiester link to each sugar, so there need be no consideration 
of the continuity of the sugir-phosphate chain. The structure of the 
9-aminoacridine-dinucleoside complex (Seeman et al., 1975), showing successive 
bases parallel, but unstacked, and pointing away from each other and 
hydrogen bonded in a non-Watson-Crick fashion, clearly demonstrates that not 
every drug-dinucleoside structure may be appropriate for extrapolation to 
interactions involving polynucleotides. More detailed work on the linear 
dichroism of the DNA-drug fibres at a variety of M values may be able to 
indicate whether or not a kinking of the helix occurs at intercalation • 
sites in the DNA polymer (Section 7.5).
Computerised model-building studies of drug-nucleic acid systems 
(Section 8.2,2) have been used to elucidate the details of the binding to
a polynucleotide. These techniques allow best use to be made of the
\v
limited experimental data available by incorporating known stereochemical 
features of the structure into the analysis. Although they may produce
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interesting and precise models, they are usually unable to consider all 
of the energetic aspects of the interactions satisfactorily.
8.2.1.1 The Kinetics of Intercalation
Kinetic studies of the mechanism of drug binding have proposed that 
intercalation occurs via a multi-step reaction (Li and Crothers, 1969; 
Sakoda et al., 1971; Schmechel and Crothers, 1971). The drug first 
attaches externally to the double helix in a fast-order process involving 
long range electrostatic forces, which is followed by the insertion of the 
drug between two adjacent base-pairs in a time roughly of the order of one 
millisecond. This phase will probably involve the effects of the drug 
perturbing the local dielectric and various more short range dipole 
interactions (which may account for a base-pair specificity).
The externally bound drug may partly overlap the base-pairs in some 
instances (Li and Crothers, 1969), which would explain why the two bound 
forms would have similar absorption spectra and be indistinguishable in 
equilibrium binding studies (Chapter 4). Even at low binding ratios, an 
appreciable amount of the drug may be externally bound in solution. Values 
range from 5% to 30% of the total drug bound for proflavine, and they are 
possibly even larger at very low salt concentrations not accessible in 
conventional temperature-jump experiments. Similar values have been 
suggested for ethidium (Bresloff, 1974)• Larger amounts of externally 
bound drug are presumably present in the fibre state, due to the hydrophobic 
drive towards intercalation being smaller at lower humidities, and this is 
consistent with the values predicted in Chapters 5 and 7.
The oonformational change in the DNA required if intercalation is to 
take place may be understood in terms of the natural flexibility of DNA 
along its helix axis. This allows an accordian-like longitudinal flexing 
of the DNA molecule. The resulting strain energy in the sugar-phosphate
chains can be relieved by a simultaneous altering of the sugar pucker to the
\
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mixed pattern across the dyad axis (Sobell et al., 1977)♦ This results 
in a kinking of the helix with a consequent partial unstacking of the base- 
pairs* A conformational change such as this would require minimum 
stereochemical rearrangement and would also involve small energies. The 
change could result from normal modes in the DNA that are excited at thermal 
energies* Once formed, the kink could straighten and base-pairs separate 
to create the space for drug intercalation. The presence of externally 
bound drug molecules might further induce this change. The process would 
be continuous so that the DNA bases would soon overlap with the intercalated 
drug, and this would provide additional stacking interactions which would 
stabilise the interaction. The number of kinks present at any given time 
in a given region of DNA is likely to be a function of the base sequence 
(and to a lesser extent the base-pair composition), since the unstacking 
energy of the bases depends on the nature of the bases themselvas. This 
dependence of the number of kinks on the base sequence could provide a 
rationale for the reported sequence specificity of ethidium (Krugh et al., 
1975; Krugh and Reinhardt, 1975).
Kallenbach (1979) has examined the equilibrium and dynamics of 
transient base-pair breakage by following proton exchange rates using NMR 
techniques, and has concluded that there are transient open states analogous 
to Sobell's model of DNA »breathing'. However, the basis for kinking, 
alternating sugar puckering about the intercalation site, has been challenged 
by the results of Berman et al. (1979), who find that for dinucleoside 
complexes the nature of the sugar pucker is unimportant. Rich (1979) has 
plan examined the crystal structures of several of these model intercalation 
complexes, and concludes that the sugar puckering in them depends on whether 
or not the particular drug involved interacts with the phosphate group in the 
backbone.
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8.2.2 Models for DMA-Phenanthridine Complexes
8.2.2.1 Ethidium Bromide
Alden and Arnott (1975) examined models for the intercalation of 
simple planar chromophoras into DNA in search of a general intercalation 
mechanism compatible with an extended, but unstrained, D M  duplex in 
which base stacking is considered the principal binding force, and therfe 
are no drug-DM interactions. They found that the most favourable 
conformation involved the changing of two torsion angles and a mixed sugar 
puckering (C3* exo (5* - 3») C3» endo) on either side of the intercalation 
site. The model had a rotation of 90° over three residues about the 
binding site, so that the total unwinding caused by intercalation was 18° - 
though this was not localised just to the two bass-pairs adjacent to the 
intercalated drug.
Goodwin (1977) has extended these studies using a linked-atom model 
building computer program. Fig. 8.1 shows a computer drawn representation 
of the co-ordinates obtained by him for a general intercalation unit of 
four base-pairs (without ax intercalated chromophore), in which all the 
sugar puckers are C2' endo and the untwist is 19°, The drawing was 
produced by a program 'DRAW written by the author. It was displayed on 
an Imlac refresh tube, and photographed off the screen for inclusion in 
this thesis (Section 2.3.5). The hydrogen atoms have not been included 
in the drawing, although they were considered in the original model-building 
program. The drawing shows some unacceptably large geometric constraints.
In particular, an oxygen atom of the lower phosphate group tends to 
interfere with the lower sugir ring giving rise to very short Van der Waal’s 
contacts. Goodwitf found that untwisting angles of 12° and 28° gave
intercalation structures with the least Van der Waal’s contact energy, and 
these were considered superior to structures with intermediate minding angles.
If a mixed puckering scheme was ^dopted (either the C3' exo (5' - 3') C3' endo
\
of Alden and Arnott (1975) or the similar C2’ endo (5* - 3 ‘) C3' endo of
%
Computer-drav.n general intercalation unit with an unwinding 
oangle of 19 . Only one sugar-phosphate chain is shown; 
the other is dyad related. The drug would be intercalated
between base-pairs 2 and 3
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Sobell et al. (1975)) then the stereochenically most reasonable conformation 
was found to be one with an overall unwinding of 28°, incorporating a 25° 
unwinding at the intercalation site, and this v/as superior to the 
intercalation scheme where all the sugar puckers were C2' endo.
Goodwin (1977) also built a number of models incorporating an ethidium 
bromide molecule in the intercalation site. The previous general 
intercalation units were used as the starting points. The starting 
co-ordinates for the ethidium molecule were taken from Subramanian et al, 
(1971), and the DNA and ethidium conformations were co-refined. If the 
sup^r puckers are all taken as C2' endo the best model energetically was 
found to be that in which the ethidium unwound the helix by 12°, and the 
ethyl and phenyl groups projected into the narrow groove of the DNA.
However, the relatively close proximity of the two sup^r-phosphate chains 
in this model seems likely to lead to short non-bonded atomic contacts.
The difficulty in building a model in which these groups project into the 
large groove is due to the fact that the two outer rings of the ethidium 
chromophore approach too closely the atoms of the sugar-phosphate chain, 
when the ethidium molecule is in a position to achieve good overlap with 
the base-pairs. It is not possible on the basis of these studies alone 
to conclude which of these possibilities is the more likely to occur.
In models with all the sugars adopting a C2' endo pucker and with an 
untwist of 26° at the intercalation site, it is not possible to have 
hydrogen bonds between the amino groups of ethidium and the phosphate 
oxygens because these oxygens protrude out from the helix and not into 
the intercalation gap. A more superior model, stereochemically, can be 
built based on a mixed sugar pucker intercalation unit with an untwisting 
angle of 26°. The- ethyl and phenyl groups project into the narrow groove 
of the DNA and the base overlap is good (Fig. 8,2). There are five rather 
poor non-bonded contacts with this model, but they all involve hydrogen 
atoms and hence are not apparent in the drawing. There is no kinking of
Figure 8.2 (i) Cthidiun hronicie built into a mixeu pucker
(C3 exo/C3 encio) intercalation unit, with an 
unwindin anr.le of 20°.
(ii) The view shown in (i), rotated anti­
clockwise around the vertical axis by 75°.
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the helir in this structure as proposed by Jain et al. (1977). Work is 
continuing within this research group to incorporate base-unstacking into 
the model-building program. The computer drawings produced using this 
model could then be compared with the computer sketches presented by 
Sobell et al. (1977) for ethidium-dinucleoside complexes.
Several ideas have been proposed by various authors (e.g. Krugh and 
Reinhardt, 1975; Kastrup et al., 1978) to explain the strong G-C 
specificity in the binding of ethidium to natural DNA's. Strong electro­
static binding to the exterior of the helix cannot be expected to exhibit 
any considerable specificity, since the drug interacts primarily with the 
phosphates which are uniformly placed along the sugar-phosphate chain 
irrespective of the base-pair composition. Any specificity is more likely 
to occur in the unwinding of the helix and unstacking of the base-pairs, 
and in the subsequent interactions between the intercalated drug 
chromophore and the base-pairs at the intercalation site. The energetics 
of both of these stages are likely to be sequence-dependent. The 
intercalation process involves a delicate interplay of hydrophobic, 
electrostatic, Van der V/aals, hydrogen bonding and other forces so that it 
will be some tine before a unified theory is developed that adequately 
incorporates all of the effects operating.
A theoretical analysis (Pack and Loew, 1978) has shown that the stacking 
energies between the ethidium cation and the base-pairs are fairly constant 
for all combinations of bases at the intercalation site. In contrast,
■tfie energy involved in unwinding the double helix,to assume the geometry 
of the intercalation complex,shows substantial sequence differences. The 
results imply that^there may be a large class of intercalating drugs which 
exhibit a purine (S' - 3') pyrimidine sequence specificity.
There may be other factors operating for a particular drug. In the 
minor groove of DNA, the hydrogen-bonding groups on both G-C and A-T base- 
pairs are identical, except for the 2-amino group of guanine. Biriding to
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G-C base-pairs would be preferred if the geometry of intercalation were such 
as to allow an additional stabilising hydrogen bound to be formed between 
the drug and this group on guanine. On the other hand, the amino group 
could interfere with intercalation of a drug if it were to provide steric 
hindrance. This latter possibility has been suggested to explain the A-T 
specificity of the intercalation of a chemically synthesised derivative of 
the quinoxaline antibiotic, triostin A (Lee and VJaring, 1978).
Muller and Crothers (1975) have reported that, for a series of 
proflavine and acridine orange analogues, the G-C specificity of the binding 
increases as the visible absorption band of the free drug chromophore 
moves to longer wavelength. This implies a relationship between specificity 
and polarisability of the chromophore. The G-C basepair is more polar than 
A-T, and should therefore be able to interact more favourably with an easily 
polarised ring system, which is inferred from a long-wavelength absorbance 
spectrum. Since the dipole moment of a G-C pair is in a fixed direction, 
optimum specificity of binding should require that the local polarisation 
of the base-pair match the preferred polarisability axes of the chromophore• 
Steric effects can contribute to this specificity, since they will limit 
the possible binding geometries, A further possibility is that the base- 
pair sequence affects the formation of kinks in the DMA, which then become 
intercalation sites (Sobell et al,, 1977).
If simple molecules such as ethidium can exhibit sequence preferences, 
then aromatic amino acids strategically located on enzymes may play an 
important role in the very selective recognition process involved in protein- 
nucleic acid interactions. Thus the "bookmark" hypothesis proposed by frown 
(1970) is plausible,.especially if the "bookmarks" (the aromatic residues of 
the protein) could also recognise the "pages of the book" (the intercalating 
sites).
8.2.2.2 Dimidiun Bromide y
The structure of dimidium is very similar to that of ethidium, the only
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difference being the substitution of a methyl in place of the ethyl group 
on the quaternary ring nitrogen. Wakelin and Waring (1974) have found 
little difference between the two drugs in their unwinding of closed 
circular DNA. The equivalence binding ratio, at which closed and nicked 
circles cosediment, is centred around 0.050 for ethidium and 0.052 for 
dimicliurn. This current study has found small differences in the parameters
of binding. However, at a molecular level, the binding would seem to be 
very similar to that of ethidium, so that the computer-refined models 
presented in Section 8.2.2.1 would hold just as well for dimidium.
Sterically, there is little difference between the methyl group of dimidium 
and the ethyl group on ethidium.
It is interesting that Watkins (1952) reported that quaternisation of 
the ring nitrogen atom markedly increases its basicity, and causes significant 
changes in the curative powers of the drug, Ethidium was shown to be many 
times more active (and less toxic) than dimidium against Trypanosoma 
congolense in mice. Physical measurements on aqueous solutions of drugs 
at physiological pH's indicated that there were significant differences in 
the small concentration of drug present in the pseudo-base form, although 
these differences cannot be detected spectroscopically. The' increased 
concentration of neutral component (either of the pseudo-base or ion-pair) 
was suggested as the explanation for the increased rate of diffusion of 
ethklium across the cell membrane and into the trypanosome cytoplasm. It 
is possible that this difference in the pseudo-base concentration nay 
account for the observed differences in the binding parameters, and in 
particular the enhanced G-C specificity of ethidium.
It is unlikely that the small difference in the electron-withdrawing 
character of the ethyl and methyl groups could account for a change in the 
direction of the dipole moments in the chromophore, sufficiently large to 
explain the difference in the specificities on polarisability grounds.
Since ethidiun and dimidium were obtained from different sources (Section
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2.1.2), it is possible that there was pome difference in the purity of the 
samples. However, various previous studies have produced similar results 
for ethidium using samples from different suppliers, so that it is thought 
that this may not be a significant problem.
8.2.2.3 Prothidium
Prothidium binds very tightly to DMA, as evidenced by its large 
association constant. The attachment is considered to be strongly 
electrostatic, since the binding is strongly affected by the ionic 
concentration of the environment. Strong electrostatic binding would be 
expected to show no base-pair specificity, since the environment of all the 
DNA phosphates is similar. The results presented in Section 4.4.3 confirm 
this expected lack of specificity.
The birefringence and linear dichroism results suggest that the drug 
is bound at a considerable angle from perpendicular to the helix axis, and 
the X-ray diffraction patterns show that prothidium causes little if any 
change in the secondary structure of the DNA. Wakelin and Waring (1974) 
have reported that prothidium unwinds closed circular DNA, but they have 
not given any details. In any case, this is not evidence of intercalative 
binding. Steroidal diamines such as irehdiamine A and malouetine unwind 
the DNA helix (Waring, 1970; Waring and Chisholm, 1972), but irehdiamine A 
has a thickness of 5.2& so that a conventional type of intercalation is not 
possible, and Gabbay and Glaser (1971) have suggested that the steroidal 
diamines bind in the minor groove of DNA.
In the prothidium molecule, both ring nitrogens are quatemised so that 
there is a strong charge localisation. The pyrimidyl moiety is fairly free 
to rotate about the amide bond to the phenanthridine triple ring. 
Nevertheless, the preferred conformation of the drug is likely to be when 
it is fully extended such that the pyrimidyl moiety makes an angle of about 
]20° with the triple aromatic ririg, and lies on the same side of the triple 
ring as the main part of the aminated phenyl substituent. The separation
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of the two positive charges is about 8$ (Cain et al., 1969), which 
corresponds to the distance between adjacent phosphate groups along a 
strand of the double helix. Electrostatic forces are much stronger 
than hydrogen bonds or hydrophobic effects, so that it is envisaged that 
electrostatic binding to neighbouring phosphates is the prime mode of 
attachnent, . certainly at low and moderate ionic concentrations. Fig.
8.3 shows a possible model for this situation, although the precise 
orientation of the drug is not known.
The prothidium molecule presents more groups for possible hydrogen 
bonding than does ethidium or dimidiun. The amide group between the 
aromatic ring is likely to form only a weak hydrogen bond. On the 
pyrinidjlmoiety, the lone pair is available for protonation and would 
normally participate in strong hydrogen bonds. However, the presence of 
the charged quaternary nitrogen is thought to shift this ability towards 
■the attached amino group, which is then likely to become the stronger 
hydrogen bonding centre in this ring. The 3-amino group of the 
phenanthridine ring and the amino group in the 4-position of the phenyl 
ring are both likely to be even stronger hydrogen bonding centres. The 
inter-strand distance between phosphates across the minor groove in B-DNA 
is about 12.sS, and across the major groove it is about 16.sS. In A-DNA 
the interstrand separation of the phosphates is around 14.4 - 16.sS. All 
of these distances are comparable with the separation of the various 
hydrogen bonding groups of prothidium. Thus, there is a multiplicity of 
possibilities for hydrogen bonding across the strands in DNA. A possible 
inter-strand binding scheme is shown in Fig. 8.4 for binding across the wide 
groove of B-DNA. JCt is possible that binding across the strands would 
resist the conformational change of DNA that occurs as the humidity is 
varied. This would account for the significant amount of A-type diffraction
occurring at 92% R.H., and is consistent with the dichroism results. The
\ \
models proposed are largely speculative and must remain so until more
Figure 8.3. CPK model of B-DNA with a prothidium molecule
externally bound by electrostatic attachment to 
two phosphate groups of the backbone.
Figure 8.4 . CPK model of B-DNA with a prothidium molecule
bound across the major groove.
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definite data on the position and orientation of the bound drugs is 
obtains d.
Intercalation could be considered as a possible mode of binding for 
prothidium, although it would be less favourable than with ethidium and 
dimidium. The bulky pyrimidyl group can provide steric hindrance to 
intercalation depending on its orientation, and it would control the depth 
of insertion of the chromophore if intercalation were to take place. Its 
orientation may also affect the direction of the dipole moment of the 
chromophore, which would change the strength of the drug/base-pair 
interaction.
It would be sterically possible for the prothidium to intercalate 
"sideways" by insertion of part of the triple ring between adjacent base- 
pairs approximately perpendicular to the helix axis. This is more likely 
to occur from the narrow groove of the DNA, since there is then the 
possibility of some additional stabilisation by the formation of a 
hydrogen bond to an amino group of a base-pair. This possibility is shown 
in Fig. 8.5. The poor overlap with the base-pairs makes it a less 
favourable position than the position adopted by ethidium and.dimidium.
The much lower unwinding angle which would result from this binding would 
lead to much smaller pitch increases in the DNA, and the fact that no 
increase in pitch was measured does not preclude a small fraction of the 
drug binding in this way. Indeed, "sideways" intercalation has been 
proposed for another bulky phenanthridine, RD 16101, to explain its binding 
parameters (Vakelin and Waring, 1974). Skere ochemically it seems likely 
that this mode of binding could continue to fairly high binding levels, and 
it would not be so ^ restricted by neighbour exclusion as the more established 
intercalation positions. Indeed, it may be that neighbour exclusion may 
be due, in part, to a thermodynamic limitation, which may be less restrictive 
for a drug of high DNA affinity.
V.
It would be possible for prothidium to bind from the large groove into 
an intercalation position similar to that adopted by ethidium, but the
intercalated sideways from the minor groove.
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pyrimidyl moiety would need to be rotated close to the phenyl substituent 
(Fig. 8.6). This is not the preferred conformation of the prothidiuml
molecule, but it could be constrained to adopt this conformation if the 
drive towards intercalation was large enough. A difficulty with this 
scheme is that it would probably result in the close approach of the 
amino-groups on the pyrimidyl and phenyl moieties.
In conclusion, intercalative binding seems to be less likely for 
prothidium. Strong electrostatic binding along a sugar-phosphate chain 
is proposed as the most likely binding scheme, and there may also be a 
considerable amount of binding across the grooves to an adjacent chain. 
These schemes involve such strong forces that it is unlikely that much of 
the drug would leave the^t sites and move into an intercalative position, 
although sterically intercalation cannot be excluded. The low solubility 
of prothidium suggests that the hydrophobic drive towards intercalation 
may not be large.
The large association constant for prothidium binding to DMA makes it 
an attractive chemotherapeutic agent. The fact that it does not 
intercalate to any great extent may not render it ineffectual provided that 
it could be given some specificity. The oligopeptide antibiotic netropsin 
is a non-intercalator, but it is thought to inhibit enzymes such as DMA 
polymerase by blocking access to the minor groove of DNA or by stabilising 
the double helix (Sutherland et al., 1978). Prothidium does have the 
disadvantage, however, of being doubly-ionised which would inhibit its 
passage through cellular membranes.
s'
Figure 8.6. CPK model of B-DNA with a prothidium molecule
intercalated from the major groove.
-  210 -
8.3 Summary and Proposals for Further Work
The theory of the analysis of solution spectra has been thoroughly 
appraised, and a program written to analyse the experimental data in terms 
of an excluded site model for the binding. The author has developed and 
tested a novel mixing scheme to facilitate the collection of accurate 
binding data, and this has been used to investigate the specificities of 
three phenanthridine drugs for particular base-pairs using three different 
natural DMA's. -
The absorption spectra of DIIA-drug fibres have been recorded on a 
microspectrophotometer, and the birefringence and linear dichroism of the 
fibres have been measured over a range of humidities. Unfortunately, 
these investigations have been limited to fibres of low drug content (M £ 20) 
because of the stray light limit of the microspectrophotometer. The fibres 
have been somewhat variable in quality, but it has been the experience of 
this research group that ionic considerations, and the viscosity of the gel 
from which the fibre had been pulled, are important factors in determining 
the quality of a fibre. Other drugs may result in better fibres than those 
obtained with the phenanthridines.
The X-ray diffraction studies have been somewhat supplementary to the 
spectral investigations, although they have confirmed earlier results on 
DNA-ethidium systems and shown that the binding of dimidium causes a similar 
unwinding of the DKA-helix. In contrast, the binding of prothidium does 
not increase the pitch of DNA. The methods described could be applied to 
an extensive X-ray diffraction investigation of new dru^. Some model­
building studies have been undertaken, especially for the binding of
✓ '
prothidium (di)bromide. The results for prothidiun must remain rather
speculative until more precise data on the orientation of the drug is 
obtained from other techniques.
The solution spectra of DNA-prothidium complexes were particularly 
difficult to analyse. It may prove useful if spectra were obtained at
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intermediate salt concentrations, and the results extrapolated to low salt 
concentration using the scheme of Record et al. (1976). The investigation 
of the binding could be supplemented by an extended equilibrium dialysis 
study. It would be particularly interesting to investigate the binding of 
the dinethylated form of prothidiun, although difficulty in dissolving it in 
aqueous solution is envisaged. Removal of the positive charges should 
result in a compound which would find intercalation a more attractive 
proposition.
The approach developed in this thesis could be extended to the 
investigation of other drugs interacting with nucleic acids. It should be 
possible to find the fraction of these drugs intercalated at particular 
relative humilities, and obtain an estimate of their unwinding angles. The 
estimates would be more certain if the variability in the .quality: of 
fibres could be reduced, and if the dichroic ratio could be measured for 
moderate M values (M ^  5-15). This may be possible using films or fibre 
sections, if sufficiently good orientation can be achieved. The theory of 
the birefringence and dichroism of films has been presented in this thesis 
along with that for fibres. It would seem that a polymer such as cis-
polybutadiene would be a very suitable substrate for making films, since it 
will stretch but will not allow the drug to penetrate it. A solution- of 
a DKA-drug complex could be gently poured on to the substrate, as it floated 
on a mercury bath to maintain a horizontal disposition. When the complex 
had dried, it could be orientated by stretching the polymer substrate and 
its optical properties measured. If a DNA-drug film of about 5 - lCp n we re 
prepared, then films with small M values (M 'u 2) could be measured. These 
films could then be folded to produce a thickness suitable for X-ray 
diffraction. In this way specimens over a range of M values could be 
compared directly by the two techniques, and a better estimate of the 
unwinding angle of an intercalating drug could be obtained.
It would be interesting to extend these studies to the cytotoxic
This drug iuis two bulky sugar residues, yet itantibiotic nogalamycin
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still appears to intercalate (Al-Jubory, 1978). The antibacterial agents, 
steffimycin and steffimycin B, have been shown to intercalate and micro- 
crystals of the DNA-steffimycin complex appear to crystallise out at low 
humidity. It would be useful to apply the dichroism techniques to fibres 
containing these drugs, in order to characterise the orientation of the 
drugs. The formation of drug micro-crystals is of special interest in 
relation to cancer therapy, where the drug crystals could be implanted near 
to a tumour. Tins could provide a steady, prolonged release of the drug 
to a localised region. A further area for fruitful study would be the 
drugs such as echinomycin, which are believed to be bisintercalators 
(Wakelin and Waring, 1976), Investigations by the methods proposed in 
this thesis would shed light on the conformation adopted by these drugs on 
binding and the extent to which they intercalate.
\
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